
<html lang="en"     class="pb-page"  data-request-id="b94c07a1-6c0f-4d8e-ad5b-c3a571b426b2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm200677b;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease" /></meta><meta name="dc.Creator" content="David S.  Millan" /></meta><meta name="dc.Creator" content="Mark E.  Bunnage" /></meta><meta name="dc.Creator" content="Jane L.  Burrows" /></meta><meta name="dc.Creator" content="Kenneth J.  Butcher" /></meta><meta name="dc.Creator" content="Peter G.  Dodd" /></meta><meta name="dc.Creator" content="Timothy J.  Evans" /></meta><meta name="dc.Creator" content="David A.  Fairman" /></meta><meta name="dc.Creator" content="Samantha J.  Hughes" /></meta><meta name="dc.Creator" content="Iain C.  Kilty" /></meta><meta name="dc.Creator" content="Arnaud  Lemaitre" /></meta><meta name="dc.Creator" content="Russell A.  Lewthwaite" /></meta><meta name="dc.Creator" content="Axel  Mahnke" /></meta><meta name="dc.Creator" content="John P.  Mathias" /></meta><meta name="dc.Creator" content="James  Philip" /></meta><meta name="dc.Creator" content="Robert T.  Smith" /></meta><meta name="dc.Creator" content="Mark H.  Stefaniak" /></meta><meta name="dc.Creator" content="Michael  Yeadon" /></meta><meta name="dc.Creator" content="Christopher  Phillips" /></meta><meta name="dc.Description" content="This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease. Structure ..." /></meta><meta name="Description" content="This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease. Structure ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 28, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200677b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200677b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200677b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200677b" /></link>
        
    
    

<title>Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200677b" /></meta><meta property="og:title" content="Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0009.jpeg" /></meta><meta property="og:description" content="This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease. Structure based drug design and “inhalation by design” principles have been applied to the optimization of the lead series exemplied by compound 1a. Analogues have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissociation kinetics to deliver prolonged lung p38 inhibition. Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events. High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug–drug interactions. Furthermore, pharmaceutical properties such as stability, crystallinity, and solubility were considered to ensure compatibility with a dry powder inhaler. 1ab (PF-03715455) was subsequently identified as a clinical candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200677b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200677b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200677b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200677b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200677b&amp;href=/doi/10.1021/jm200677b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7797-7814</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200642w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2007084" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease<a class="ref internalNav" href="#pdb" aria-label=""></a><a class="ref internalNav" href="#ded" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Millan">David S. Millan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+E.++Bunnage">Mark E. Bunnage</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+L.++Burrows">Jane L. Burrows</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+J.++Butcher">Kenneth J. Butcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+G.++Dodd">Peter G. Dodd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++Evans">Timothy J. Evans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Fairman">David A. Fairman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha+J.++Hughes">Samantha J. Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Iain+C.++Kilty">Iain C. Kilty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arnaud++Lemaitre">Arnaud Lemaitre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell+A.++Lewthwaite">Russell A. Lewthwaite</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Axel++Mahnke">Axel Mahnke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Mathias">John P. Mathias</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Philip">James Philip</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Smith">Robert T. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+H.++Stefaniak">Mark H. Stefaniak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Yeadon">Michael Yeadon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Phillips">Christopher Phillips</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>§</sup>Worldwide Medicinal Chemistry, <sup>∥</sup>Allergy and Respiratory Research Unit, <sup>⊥</sup>Department of Pharmacokinetics, Dynamics, and Metabolism, <sup>#</sup>Department of Drug Safety, and <sup>∞</sup>Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div><div class="corresp-info">To whom correspondence should be addressed. Phone: +44 1304 643497. Fax: +44 1304 651987. E-mail: <a href="/cdn-cgi/l/email-protection#462227302f22682b2f2a2a272806212b272f2a6825292b"><span class="__cf_email__" data-cfemail="fd999c8b9499d3909491919c93bd9a909c9491d39e9290">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200677b&amp;href=/doi/10.1021%2Fjm200677b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7797–7814</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 5, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 May 2011</li><li><span class="item_label"><b>Published</b> online</span>28 October 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 November 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200677b" title="DOI URL">https://doi.org/10.1021/jm200677b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7797%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%2BS.%2BMillan%252C%2BMark%2BE.%2BBunnage%252C%2BJane%2BL.%2BBurrows%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D22%26contentID%3Djm200677b%26title%3DDesign%2Band%2BSynthesis%2Bof%2BInhaled%2Bp38%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BChronic%2BObstructive%2BPulmonary%2BDisease%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7814%26publicationDate%3DNovember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200677b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4546</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">68</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200677b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Millan&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;E. Bunnage&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;L. Burrows&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;J. Butcher&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;G. Dodd&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. Evans&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Fairman&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;J. Hughes&quot;},{&quot;first_name&quot;:&quot;Iain&quot;,&quot;last_name&quot;:&quot;C. Kilty&quot;},{&quot;first_name&quot;:&quot;Arnaud&quot;,&quot;last_name&quot;:&quot;Lemaitre&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;A. Lewthwaite&quot;},{&quot;first_name&quot;:&quot;Axel&quot;,&quot;last_name&quot;:&quot;Mahnke&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Mathias&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Philip&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Smith&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;H. Stefaniak&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Yeadon&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Phillips&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;7797-7814&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200677b&quot;},&quot;abstract&quot;:&quot;This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease. Structure based drug design and “inhalation by design” principles have been applied to the optimization of the lead series exemplied by compound 1a. Analogues have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissociation kinetics to deliver prolonged lung p38 inhibition. Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events. High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug–drug interactions. Furthermore, pharmaceutical properties such as stability, crystallinity, and solubility were considered to ensure compatibility with a dry powder inhaler. 1ab (PF-03715&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200677b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200677b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200677b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200677b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200677b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200677b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200677b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200677b&amp;href=/doi/10.1021/jm200677b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200677b" /></input><a href="/doi/pdf/10.1021/jm200677b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200677b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200677b%26sid%3Dliteratum%253Aachs%26pmid%3D21888439%26genre%3Darticle%26aulast%3DMillan%26date%3D2011%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BInhaled%2Bp38%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BChronic%2BObstructive%2BPulmonary%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D22%26spage%3D7797%26epage%3D7814%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291489" title="Enzyme kinetics">Enzyme kinetics</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291411" title="Pharmacokinetics">Pharmacokinetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jmcmar.2011.54.issue-22/production/jmcmar.2011.54.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">This paper describes the identification and optimization of a novel series of DFG-out binding p38 inhibitors as inhaled agents for the treatment of chronic obstructive pulmonary disease. Structure based drug design and “inhalation by design” principles have been applied to the optimization of the lead series exemplied by compound <b>1a</b>. Analogues have been designed to be potent and selective for p38, with an emphasis on slow enzyme dissociation kinetics to deliver prolonged lung p38 inhibition. Pharmacokinetic properties were tuned with high intrinsic clearance and low oral bioavailability in mind, to minimize systemic exposure and reduce systemically driven adverse events. High CYP mediated clearance and glucuronidation were targeted to achieve high intrinsic clearance coupled with multiple routes of clearance to minimize drug–drug interactions. Furthermore, pharmaceutical properties such as stability, crystallinity, and solubility were considered to ensure compatibility with a dry powder inhaler. <b>1ab</b> (PF-03715455) was subsequently identified as a clinical candidate from this series with efficacy and safety profiles confirming its potential as an inhaled agent for the treatment of COPD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote withdrawn"><h4><span>†</span> Accession Codes</h4><p class="last">PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yis">2yis</a> for <b>1ab</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw">2yiw</a> for <b>1a</b>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yix">2yix</a> for <b>41</b>.</p></div><div class="extra-info-sec articleNote"><h4><span>‡</span> Dedication</h4><p class="last">This paper is dedicated to the memory of Mark H. Stefaniak.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">p38 Mitogen activated kinase (MAP) is a ubiquitous target in the research based pharmaceutical industry. It plays a central role in the regulation of biosynthesis and actions of key proinflammatory mediators such as IL1-β and TNF-α. These cytokines, and others, are important regulators of the immune response to infection as well as cellular stress.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Indeed biologics that bind or remove TNF-α, such as etanercept, infliximab, and adalimumab, have shown good efficacy in the clinic.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Similarly, the IL-1 receptor antagonist anakinra has proved to be efficacious in rheumatoid arthritis (RA), suggesting that modulating the levels of these proinflammatory cytokines provides clinical benefit in inflammatory disorders.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Small molecule inhibitors of p38, such as VX-745<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and BIRB-796<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>), have advanced to clinical trials in inflammatory diseases, with VX-745 demonstrating significant clinical benefit in RA in a 12-week study. However, despite promising preclinical and clinical efficacy with several other oral p38 inhibitors, their progression to phase III studies and beyond has been hampered by adverse findings, such as skin disorders, infection, and a lack of sustained efficacy in diseases such as RA.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The aforementioned inhibitor VX-745 was not progressed beyond the phase II RA trial because of CNS toxicity observed preclinically.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Morover, elevations in liver transaminases were observed, which declined rapidly after cessation of dosing.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Elevations of liver transaminases were also observed for BIRB-796 in a phase I 7-day multidose study.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> BIRB-796 progressed to a phase II study in Crohn’s disease patients but failed to show clinical benefit.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The compound is no longer listed on the companies' development pipeline, and it is assumed that it has been discontinued from further development.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Perhaps more worrying is a common feature observed in many of the clinical trials run with several different p38 inhibitors, which could be linked to the disappointing efficacy observed. In many of these studies a drop in C-reactive protein (CRP) levels (inflammatory biomarker) on drug treatment was observed, but this was not sustained after 2 weeks of dosing, suggesting possible redundancy in the p38 pathway.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> At this stage it is unclear whether this transient effect on serum biomarkers as well as the plateauing of clinical response is RA specific or not, and therefore, there has been significant effort in the pharmaceutical industry to investigate p38 inhibition in other inflammatory indications. Many respiratory diseases also show a significant inflammatory component, such as chronic obstructive pulmonary disease (COPD) and asthma. The global prevalence of COPD has reached epidemic proportions and is now one of the leading causes of death in the developed world.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Existing treatments for COPD patients are dominated by long acting bronchodilators, with anti-inflammatory agents such as inhaled corticosteroids being largely ineffective in treating the inflammation or progression of the disease.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> There is therefore a huge unmet medical need with regard to effective anti-inflammatory agents to treat COPD patients.</div><div class="NLM_p">Studies have demonstrated that p38 is activated in the alveolar macrophages of COPD patients, relative to control subjects, suggesting a link with the disease phenotype.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Small molecule inhibitors of p38 have also provided supporting evidence that modulating this pathway has the potential to show efficacy in respiratory diseases where inflammation is a key driver. Oral dosing of SB-239063 has been shown to reduce eosinophil infiltration following challenge with lipopolysaccharide (LPS) and also reduced the levels of IL-6 and MMP-9 in lavage fluid.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Another small molecule p38 inhibitor, SD-282, was efficacious in a mouse tobacco smoke model in which glucocorticoids were ineffective (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Inhalation as a route of delivery has also been explored with a p38α selective oligonucleotide which has shown efficacy when delivered to the lung in a model of asthma in the mouse.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Similarly, when a small molecule inhibitor of p38 (ARRY-371797, structure not disclosed) was dosed directly to the lung, it was shown to significantly reduce levels of proinflammatory cytokines, as well as neutrophil infiltration, in response to LPS challenge.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several oral p38 inhibitors have advanced to human clinical trials for COPD. PH-797804, losmapimod, and dilmapimod (Chart <a class="ref internalNav" href="#cht3" aria-label="3">3</a>) have all completed phase II trials for COPD.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Results from the phase II trial of PH-797804 suggest real promise.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In a 6-week study involving 230 patients, PH-797804 showed statistically significant improvements in FEV<sub>1</sub> (forced expiratory volume in 1 s) and clinically meaningful increases were observed on the transitional dyspnoea index. Interestingly, CRP levels remained low over the time course of the trial, and therefore, this result deviates from that seen in RA with other p38 inhibitors. However, it is reiterated that there is no credible reason why p38 pathway redundancy may not be observed in COPD, and therefore, it remains a significant risk. Longer clinical trials will help to answer this question. PH-797804 was also safe and well tolerated with p38 related adverse events such as skin rash observed in only approximately 7% of PH-797804 treated patients. To the best of our knowledge, data from other COPD studies, with other p38 inhibitors, have not been reported.</div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This promising result, as well as other preclinical studies discussed above, has prompted interest in the topical application of a p38 inhibitor directly to the lung of a COPD patient. Inhalation of a p38 inhibitor represents an intriguing opportunity to deliver powerful anti-inflammatory activity coupled with the potential to minimize systemically driven adverse events that may be p38 mechanism related.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> This paper will detail efforts to identify a potent, selective, and safe p38 inhibitor with pharmacokinetic and pharmaceutical properties suitable for lung delivery. The design principles adopted follow the “inhalation by design” philosophy outlined in a previous publication.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic strategy for preparation of target compounds <b>1a</b>–<b>ac</b> in this paper is based on the same general disconnection for each analogue. This involves synthesis of the benzylamines <b>2a</b>–<b>h</b>, which is then coupled with either a commercially available or synthesized arylpyrazole <b>3a</b>–<b>k</b> through a urea forming step (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Retrosynthetic Strategy for Preparation of Target Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The arylpyrazole portion of the target molecule was prepared by cyclocondensation of an arylhydrazine with a ketonitrile. The ketonitrile either was commercially available, as in 4,4-dimethyl-3-oxopentanenitrile, or was prepared from the corresponding commercially available precursors to afford <b>5a</b> and <b>5b</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The ketonitrile <b>5a</b> was prepared from commercially available ethyl 2-methyl-2-(methylthio)propionate by reaction with the anion of acetonitrile. Similarly ketonitrile <b>5b</b> was prepared by reaction of the commercially available methyl 2,2-dimethyl-3-hydroxypropionate with methanesulfonyl chloride followed by nucleophilic displacement with the sodium salt of methanethiol, affording <b>6</b>. This was followed by reaction with the anion of acetonitrile to afford the corresponding ketonitrile <b>5b</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) <sup><i>i</i></sup>PrNEt<sub>2</sub>, MeSO<sub>2</sub>Cl, DCM, 0 °C, 2 h; (ii) MeSNa, MeOH, reflux, 17 h, 17%; (b) NaH, CH<sub>3</sub>CN, THF, reflux, 5 h, 58–81%; (c) arylhydrazine, conc HCl, EtOH, reflux, 6 h, 23–95%; (d) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 18–89%; (e) THPOCH<sub>2</sub>CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 4 h, 71%; (f) TBDMSCl, imidazole, DMF, room temp, 16 h, 17–93%.</p></p></figure><div class="NLM_p">Arylhydrazines <b>4a</b> and <b>4b</b> were not commercially available and were therefore prepared from the corresponding commercially available aryl bromides (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). First, 5-bromo-2-chloroanisole was metalated with <i>n</i>-butyllithium followed by reaction with di-<i>tert</i>-butyl diazodicarboxylate to afford the corresponding diazo compound, which was deprotected in situ with hydrochloric acid, affording the hydrazine hydrochloride salt <b>4a</b>. <b>14</b> was prepared by a similar procedure as above, but first isolating <b>7</b> followed by in situ deprotection with hydrochloric acid and reaction with commercially available 4,4-dimethyl-3-oxopentanenitrile. Alternatively, the arylhydrazine <b>4b</b> could be prepared from the commercially available 4-amino-2-chlorophenol, by diazotization, followed by tin chloride mediated reduction of the diazo intermediate to furnish the desired hydrazine <b>4b</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The arylpyrazoles <b>3a</b>–<b>k</b> were prepared by cyclocondensation of the ketonitrile with the appropriate arylhydrazine, followed by deprotection and alkylation, affording <b>3d</b> and <b>3i</b>, or protection as silyl ethers, affording <b>3f</b>, <b>3h</b>, <b>3j</b>, <b>3k</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0016.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>n</i>-BuLi, di-<i>tert</i>-butyl diazodicarboxylate, THF, −78 °C, 2 h, 50%; (b) 4 M HCl, 1,4-dioxane, room temp, 16 h, 60%; (c) (i) conc HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, −10 °C, 0.5 h, (ii) 6 N HCl, SnCl<sub>2</sub>, −10 °C, 3.5 h.</p></p></figure><div class="NLM_p">The benzylamines <b>2a</b>–<b>h</b> were synthesized by reaction of commercially available 5-bromo-2-hydrazinylpyridine with various commercially available aliphatic and aromatic aldehydes to afford the corresponding hydrazones <b>15a</b>–<b>d</b> in good yields (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The hydrazone was then reacted with iodobenzene diacetate in a cyclo-oxidation reaction to afford the bromotriazolopyridines <b>16a</b>–<b>g</b>. Reaction with commercially available 2-mercaptobenzyl alcohol in a palladium catalyzed coupling afforded the benzyl alcohols <b>17a</b>–<b>g</b>. The alcohols <b>17a</b>–<b>g</b> were then converted to the benzylamines <b>2a</b>–<b>f</b> by reaction with methanesulfonic anhydride and displacement of the corresponding mesylate with ammonia in methanol. Finally, <b>2g</b> was prepared by debenzylation of <b>2d</b> with boron tribromide.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0017.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) EtOH, reflux, 1 h, 86–99%; (b) PhI(OAc)<sub>2</sub>, DCM, EtOH, room temp, 18 h, 68–88%; (c) 2-mercaptobenzyl alcohol, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, CsCO<sub>3</sub>, DMF, 90 °C, 2 h, 17–77%; (d) (i) (Ms)<sub>2</sub>O, DCM, room temp, 2 h, (ii) 7 N NH<sub>3</sub>/MeOH, room temp, 16 h, 38–98%; (e) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 51%.</p></p></figure><div class="NLM_p">To install the hydroxyethylene group in <b>2h</b>, <b>2g</b> was reacted with di-<i>tert</i>-butyl dicarbonate to doubly protect the amine and phenol to afford <b>18</b>. A selective deprotection of the carbonate was achieved with sodium carbonate to afford <b>19</b>, followed by alkylation to give <b>20</b>. Deprotection of the primary amine and removal of the THP protecting group revealed the desired coupling partner <b>2h</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0018.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (BOC)<sub>2</sub>O, <sup><i>i</i></sup>PrNEt<sub>2</sub>, DMF, room temp, 72 h, 100%; (b) Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 70 °C, 16 h, 87%; (c) THPOCH<sub>2</sub>CH<sub>2</sub>Br, NaH, <i>N</i>-methylpyrrolidinone, 55 °C, 16 h, 55%; (d) 4 M HCl, 1,4-dioxane, room temp, 2 h, 95%.</p></p></figure><div class="NLM_p">In several instances the aldehyde was not commecially available and was therefore synthesized. The aldehyde <b>21a</b> was prepared by benzyl protection of the commercially available 3-chlorosalicylaldehyde (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0019.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, THF, reflux, 30 h, 92%.</p></p></figure><div class="NLM_p">Aldehyde <b>21b</b> was prepared by taking commercially available methyl thiosalicylate and alkylating with (2-bromoethoxy)-<i>tert</i>-butyldimethylsilane to afford <b>22</b>. The ester was then reduced to afford the alcohol <b>23</b>, which was then oxidized to give the desired aldehyde <b>21b</b> (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0020.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) TBDMSOCH<sub>2</sub>CH<sub>2</sub>Br, NaH, DMF, room temp, 16 h, 81%; (b) (i) lithium aluminum hydride, THF, 0 °C → room temp, 16 h, 81%, (ii) Ba(MnO<sub>4</sub>)<sub>2</sub>, DCM, room temp, 24 h, (iii) MnO<sub>2</sub>, DCM, reflux, 16 h, 62%.</p></p></figure><div class="NLM_p">With benzylamines <b>2a</b>–<b>h</b> and the arylpyrazoles <b>3a</b>–<b>k</b> in hand we were able to conduct the urea forming reaction to synthesize target compounds <b>1a</b>–<b>ac</b>. This was achieved by one of two methods. We initially utilized carbonyldiimidazole as a carbonyl source to produce <b>1a</b>–<b>c</b>, <b>1j</b>, <b>1n</b>–<b>o</b>, <b>1y</b>, and <b>24</b>–<b>30</b>. <b>24</b>–<b>30</b> were then further manipulated to furnish target compounds <b>1e</b>–<b>f</b>, <b>1i</b>, <b>1k</b>–<b>1l</b>, <b>1p</b>, <b>1u</b> in good yield. (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Target compound <b>1y</b> did not require desilylation of the phenolic protecting group, as it was spontaneously removed during the urea forming step. The sulfoxides <b>1g</b>, <b>1m</b>, and <b>1q</b> were prepared by oxidation of <b>1f</b>, <b>1l</b>, and <b>1p</b>, respectively.</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0021.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) CDI, DCM, room temp, 16 h, (ii) <b>2b</b>–<b>f</b>, <b>2h</b>, <sup><i>i</i></sup>PrNEt<sub>2</sub>, DCM, room temp, 1 h, 23–100%; (b) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 46–85%; (c) H<sub>2</sub>O<sub>2</sub>, 1,1,1,3,3,3-hexfluoropropan-2-ol, room temp, 0.5 h, 22–80%; (d) PTSA, MeOH, 60 °C, 3 h, 67%.</p></p></figure><div class="NLM_p">For the synthesis of advanced lead compounds such as <b>1d</b>, <b>1h</b>, <b>1r</b>–<b>t</b>, <b>1v</b>–<b>x</b>, <b>1z</b>–<b>ab</b> we first formed the phenyl carbamates <b>31a</b>–<b>e</b> of the arylpyrazoles <b>3c</b>, <b>3d</b>, <b>3f</b>, <b>3h</b>, <b>3j</b>, respectively, followed by reaction of the carbamates with the benzylamines <b>2a</b>–<b>c</b> and <b>2g</b> to afford the desired target compounds in good yields (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). Target compounds <b>1h</b>, <b>1v</b>–<b>x</b>, and <b>1aa</b>–<b>ab</b> did not require desilylation of the phenolic protecting group that was on <b>31c</b>–<b>e</b>, as it was spontaneously removed during the urea forming step.</div><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0022.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) PhO(CO)Cl, pyridine, THF, 0 °C → room temp, 1 h, 86–100%; (b) <sup><i>i</i></sup>PrNEt<sub>2</sub>, DMSO, room temp, 16 h, 23–96%; (c) THPOCH<sub>2</sub>CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 8 h, 75%; (d) triethylamine trihydrofluoride, MeOH, room temp, 16 h, 67–75%; (e) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 35–49%; (f) H<sub>2</sub>O<sub>2</sub>, 1,1,1,3,3,3-hexfluoropropan-2-ol, room temp, 0.5 h, 70%; (g) PTSA, MeOH, 60 °C, 3 h, 50–62%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alongside the essential characteristics of a successful drug, such as efficacy and safety, inhalation as a route of delivery requires a compound to have certain other attributes to increase the likelihood of success. These include (1) high potency to achieve a low inhaled dose (≤1 mg of drug product), (2) duration of action (DoA) for therapeutically relevant period, (3) high clearance and low oral absorption of any swallowed dose to mimimize systemic exposure and therefore potential for adverse events, (4) multiple routes of clearance to minimize drug–drug interactions (DDIs), and (5) physical form characteristics suitable for a dry powder inhaler including high crystallinity and compatibility with lactose which is the commonly used excipient. These requirements suggest that designing compounds at the edge of or outside the “rule-of-five” (Ro5) would potentially increase the likelihood of achieving the pharmacokinetic profile mentioned above.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Non-Ro5 physicochemical space could potentially deliver a compound with relatively higher clearance, through high lipophilicity, and a slower rate of absorption of drug from the lung to the systemic circulation through a reduction in permeability and solubility. The latter concept could conceivably lead to increasing the duration of action (DoA) of the inhibitor at the site of action by retaining the compound in the lung.</div><div class="NLM_p">In addition to achieving a DoA by physical means, we hypothesized that a slow <i>k</i><sub>off</sub> from the enzyme itself could extend the DoA. The discovery of the oral p38 inhibitor BIRB-796 and its unique enzyme kinetics suggested that potent and selective p38α inhibitors could be designed with the potential for a longer duration of action (DoA).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The slow <i>k</i><sub>on</sub> and slow <i>k</i><sub>off</sub> rates observed with the inhibitor were rationalized on the basis of X-ray crystallographic observations. For BIRB-796 to bind to p38α, it was reported that the activation loop (consisting of the conserved residues Asp168-Phe169-Gly170) must undergo a movement of about 10 Å, creating a lipophilic pocket that was then filled by the arylpyrazole moiety. High affinity binding to the so-called DFG-out conformation was reported to deliver the long <i>k</i><sub>off</sub> rates. For this reason we decided to target the DFG-out conformation.</div><div class="NLM_p">At the time we were aware of a triazolopyridine series of DFG-in binding inhibitors of p38 that were highly selective because of a unique ability to act as a dihydrogen bond acceptor at the hinge region of the kinase due to an induced flip of Gly110.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A similar series containing a triazolopyridine, as exemplified by <b>41</b> (Chart <a class="ref internalNav" href="#cht4" aria-label="4">4</a>), had also been published that contained a urea, similar to that in BIRB-796.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>41</b> has been cocrystallized in p38α and was found to bind in the DFG-in conformation and as expected had relatively fast <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> rates, as determined by surface plasmon resonace (SPR) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This prompted us to consider hydridizing <b>41</b> and BIRB-796 to see if a potent DFG-out binding compound could be achieved with enzyme kinetics similar to those of BIRB-796 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). As can be seen from the overlay of <b>41</b> onto the cocrystal structure of BIRB-796 in p38α, the N-3 of the triazolopyridine in <b>41</b> overlays well with the oxygen of the morpholino group in BIRB-796. These are the key hydrogen bond acceptors that make an interaction with Met109 at the hinge region of the kinase. The phenyl ring of <b>41</b> interacts with the gatekeeper residue (Thr106) and overlays well with the naphthalene ring system of BIRB-796, and finally the ureas of <b>41</b> and BIRB-796 are also suitably aligned. With these structural similarities in mind <b>1a</b> (Chart <a class="ref internalNav" href="#cht4" aria-label="4">4</a>) was designed and synthesized and gratifyingly proved to be a potent p38 inhibitor with enzyme kinetics akin to those of BIRB-796 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="cht4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0023.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0024.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of <b>41</b> (carbon atoms colored green, derived from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yix">2yix</a>) in the protein DFG-out cocrystal structure of BIRB-796 (carbon atoms colored purple) in p38α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0025.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of <b>1a</b> (carbon atoms colored orange, derived from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw">2yiw</a>) in the protein DFG-out cocrystal structure of BIRB-796 (carbon atoms colored purple) in p38α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. p38α Potency and Enzyme Kinetics</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>on</sub> (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>off</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>D</sub> (nM)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">4.3 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">0.014</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1 × 10<sup>5</sup></td><td class="colsep0 rowsep0" align="left">4 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="left">4.81</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIRB-796<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">5 × 10<sup>4</sup></td><td class="colsep0 rowsep0" align="left">5 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="left">3.85</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Enzyme kinetics and <i>K</i><sub>D</sub> were determined by surface plasmon resonance using a Biacore instrument, on the inactive form of the kinase.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Compounds were routinely profiled by assessing their ability to inhibit TNF-α production from lipopolysaccharide (LPS) stimulated human isolated peripheral blood mononuclear cells (PBMCs), following a 1 h preincubation of PBMCs and test compound.</p></div></div></div><div class="NLM_p">The slow <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> rates presented a screening challenge at the outset of this program. We decided to use a cell based assay to routinely assess the potency of target compounds. Compounds were tested for their ability to inhibit TNF-α production from LPS stimulated human isolated peripheral blood mononuclear cells (PBMCs). First we needed to establish how long our whole cell PBMC assay would need in terms of preincubation time to ensure that the experiment was at equilibrium. <b>1a</b>, for example, had an IC<sub>50</sub> in the whole cell assay of 5 nM after a 10 min preincubation time, whereas if the preincubation time was increased to 1 h, the IC<sub>50</sub> decreased to 0.3 nM. It did not decrease further with longer preincubation times. Therefore, a preincubation time of 1 h was used for future screening. This suggests that the slow <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> were clearly impacting the time to equilibrium in this experiment. With <b>1a</b> being potent in a cell based assay and having the desired enzyme kinetics, we were keen to investigate the selectivity profile against wider kinases. Through binding to the DFG-out region of the kinase it was hypothesized<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> that a good selectivity profile could be achieved, as many kinases in the kinome are potentially unable to adopt a DFG-out conformation. Interestingly, <b>41</b> being a DFG-in binding mode was more selective than the DFG-out binding mode observed with compound <b>1a</b>, which is contrary to the hypothesis above. It is possible that the kinases with significant inhibition at 10 μM (shown in red) are capable of binding in the DFG-out binding mode in a similar way to p38 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0026.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selectivity profiles of <b>41</b> and <b>1a</b> against a panel 45 kinases at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With a promising lead in <b>1a</b> we sought to investigate and optimize the pharmacokinetic and pharmaceutical properties for inhalation while maintaining the high levels of potency and selectivity. As mentioned above, targeting high hepatic clearance was important for minimizing systemic exposure following absorption from the lung or absorption from the gut from any swallowed dose. In the targeting of liver metabolism, it was also key to ensure that the metabolites were inactive or had reduced activity and therefore could not contribute to any systemic p38 activity. With these considerations in mind we examined the cocrystal structure of <b>1a</b> in p38α which pointed to several opportunities to tune the pharmacokinetic properties of this series (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0027.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding site surface of <b>1a</b> in p38α cocrystal structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw">2yiw</a>). The region of <b>1a</b> highlighted in purple is binding into the pocket created by the DFG loop movement. Binding surface illustrates lipophilic surface (green/yellow), surface made up of hydrogen accepting oxygen atoms (red) and hydrogen donating atoms (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The <i>tert</i>-butyl group of <b>1a</b> resides in a lipophilic pocket created by activation loop movement. Introduction of a “soft” metabolic group within this pocket may render the molecule to site directed metabolism leading to a more polar metabolite having reduced binding affinity for p38. Alternatively the isopropyl group on the triazolopyridine of <b>1a</b> could be replaced with soft metabolic groups that may also lead to a less potent metabolite. These modifications would lead to phase I cytochrome P450 (CYP) mediated metabolism; therefore, to mitigate any CYP mediated DDI potential, we were interested in introducing the potential for phase II mediated metabolic pathways. Glucuronidation is a phase II metabolic pathway that has high capacity and is a major route of drug inactivation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Phenol groups are well documented to undergo glucuronidation, and so we intended to explore the possibility of their introduction into synthetically accessible regions of the molecule that were also likely to be tolerated from a potency standpoint. The <i>N</i>-phenyl ring of the arylpyrazole moiety of <b>1a</b> was binding into a relatively hydrated pocket and therefore seemed a sensible site for the introduction of a phenolic group (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">As can be seen from compounds <b>1b</b>–<b>f</b>,<b>h</b>,<b>i</b>, generally good levels of potency could be achieved relative to the starting point <b>1a</b>. Introduction of a thiomethyl group at R<sup>2</sup>, in <b>1b</b>, led to a slight drop-off in potency while a methylenethiomethyl, in <b>1c</b>, group led to a further drop-off in potency, suggesting that we were pushing the boundaries of the lipophilic pocket. It was gratifying to note that introduction of phenols in the meta and para positions of R<sup>1</sup> with <b>1d</b> and <b>1e</b>, respectively, did not lead to a significant drop-off in potency. Moreover, the combination of a thiomethyl group at R<sup>2</sup> with a <i>m</i>-phenol at R<sup>1</sup> retained good potency in <b>1f</b> alongside high intrinsic clearance. It was also pleasing to see some level of glucuronidation with this compound, although probably not enough to mitigate a CYP DDI. Interestingly, the corresponding proposed sulfoxide metabolite of this compound <b>1g</b> led to a significant drop-off in potency, thereby validating the hypothesis above. Introduction of a chlorine atom adjacent to the phenol in <b>1h</b> and <b>1i</b> resulted in potency akin to the starting point <b>1a</b> and displayed good levels of glucuronidation alongside high CYP mediated metabolism.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. p38 Potency, clogP, HLM, and HLM UGT Data for <b>1a</b>–<b>i</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0028.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0001.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compounds were routinely profiled by assessing their ability to inhibit TNF-α production from LPS stimulated human isolated PBMCs.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Compounds were routinely assessed for metabolic stability in human liver microsomes (HLM).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Compounds were assessed for phase II glucuronidation in HLM by including the cofactor uridine diphosphate glucuronic acid (UDPGA) and excluding the cytochrome P450 dependent cofactor NADPH.</p></div></div><div></div></div><div class="NLM_p">In parallel to the changes we were making on the arylpyrazole moiety we were interested in understanding if modifications of the isopropyl group on the triazolopyridine may also be useful. The cocrystal structure of <b>1a</b> suggested there was space to replace the isopropyl group with larger groups and in particular with a phenyl ring. To this end, we designed and synthesized <b>1j</b>–<b>s</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. p38 Potency, clogP, HLM, and HLM UGT Data for <b>1j</b>–<b>s</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0002.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0003.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compounds were routinely profiled by assessing their ability to inhibit TNF-α production from LPS stimulated human isolated PBMCs.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Compounds were routinely assess for metabolic stability in HLM.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Compounds were assessed for phase II glucuronidation in HLM by including the cofactor UDPGA, excluding the cytochrome P450 dependent cofactor NADPH.</p></div></div><div></div></div><div class="NLM_p">It was pleasing to note that <b>1j</b> retained good cellular potency after inclusion of a 2-hydroxyphenyl ring on the ATP binding portion of the molecule. <b>1k</b>, while also potent, demonstrated some level of glucuronidation, albeit low. Interestingly <b>1l</b> was more potent than <b>1c</b> seen previously, suggesting that on this scaffold the thiomethylmethylene group could be accommodated in the active site. Moreover, the sulfoxide metabolite <b>1m</b> of this compound led to a more than 100-fold drop-off in potency, which was encouraging from a metabolite activity perspective. The phenolic hydroxyl group could be moved around the phenyl ring in combination with a chloride substituent, in <b>1n</b> and <b>1o</b>, without loss of cellular potency. Alternatively the 2-hydroxyphenol could be replaced with a thiomethyl group in <b>1p</b>, again maintaining good cellular potency. The sulfoxide metabolite <b>1q</b> this time retained good potency with only a modest drop-off from its parent <b>1p</b>. <b>1p</b> and others above highlight that this region of the kinase binding site was very tolerant of functional groups of varying polarities and size and several different positions and hence represent a good opporunity to tune the physicochemical properites and in particular the properties required for inhalation. Finally introduction of a flexible hydroxyethylene group either on the phenyl ring at the DFG-out binding site, in <b>1r</b>, or at the ATP binding site, in <b>1s</b>, maintained good cellular potency despite being a relatively large group.</div><div class="NLM_p">At this stage of the project we were interested to know whether the optimization of in vitro properties would translate into high clearance in vivo. To understand this, we investigated the intravenous and oral pharmacokinetic properties in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The rat liver microsome (RLM) intrinsic clearance was high for <b>1f</b>, which translated into near liver blood flow clearance in the in vivo experiment and very high unbound clearance of >9600 (mL/min)/kg also. The high clearance and low volume of distribution of <b>1f</b> lead to a very short half-life in rat. The oral pharmacokinetics of <b>1f</b> suggests negligable oral bioavailability. This, of course, was exactly the pharmacokinetic profile we were targeting to minimize systemic exposure either through a lung absorbed fraction or an orally absorbed fraction following a swallowed dose.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo ADME Properties for <b>1f</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">iv clearance<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> ((mL/min)/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">oral bioavailability<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">PPB (%)</th><th class="colsep0 rowsep0" align="center">RLM ((μL/min)/mg protein)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1f</b></td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">>99</td><td class="colsep0 rowsep0" align="left">200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Intravenous (iv) pharmacokinetics were determined in rats from a 1 mg/kg dose.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Oral pharmacokinetics were determined from a 3 mg/kg dose.</p></div></div></div><div class="NLM_p">Alongside favorable pharmacokinetic properties we were interested to know if the selectivity profile of <b>1f</b> was maintained from that of the original lead in <b>1a</b>. Indeed this was the case, with <b>1f</b> being only a potent inhibitor of isoforms of p38 (α, β, and γ) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0004.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selectivity profile of <b>1f</b> against a panel of 29 kinases, showing % inhibition at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The favorable pharmacokinetic properties led us to evaluate some of the pharmaceutical properties of <b>1f</b> to see if the crystallinity, solid form properties, and solubility were commensurate with those required for inhalation. The powder X-ray diffraction pattern of the crystalline <b>1f</b> suggested a good level of crystallinity, with a melting point of 220 °C, but the compound had no detectable solubility in water or in our simulated lung fluid (SLF) preparation. This was of great concern not only because dissolved material is required for a pharmacological response but also because this series of compounds appeared to have slow <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> rates, necessitating a relatively high local concentration to drive binding to the kinase. This prompted us to focus on looking for an inhibitor with an improved solubility profile. As a benchmark, we considered the marketed inhaled corticosteroid drug fluticasone as a good indicator of the required solubility we should be targeting in our SLF preparation (SLF ≈ 0.5 μg/mL).</div><div class="NLM_p">In order to improve the solubility, we sought to disrupt the crystal packing of the molecule to a large enough extent such that the compound became more soluble but not so much that the compound became an amorphous solid. From our SAR studies we knew that the ATP binding site could tolerate groups such as hydroxyethylene in <b>1r</b> and <b>1s</b>, and we hypothesized that introduction of such flexible groups might disrupt the crystal packing enough to improve solubility to some extent. To this end, we crystallized compound <b>1r</b> and measured its SLF solubility, and we were pleased to see that we could now detect some dissolved material (SLF 1.0 μg/mL), which was above that of the benchmark fluticasone. As a result, <b>1r</b> became an attractive lead with good cellular potency, high intrinsic clearance, but unfortunately low levels of glucuronidation in the HLM UGT in vitro assay. In fact modeling of the DDI potential of <b>1r</b> did suggest that the lack of multiple routes of clearance for this compound could lead to it becoming a victim of a DDI. This led us to target higher rates of glucuronidation, alongside the other favorable characteristics observed in compound <b>1r</b>. <b>1t</b>–<b>ac</b> were designed and synthesized to address the above issues (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. p38 Potency, clogP, HLM, and HLM UGT Data for <b>1t</b>–<b>ac</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0005.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0006.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Compounds were routinely profiled by assessing their ability to inhibit TNF-α production from LPS stimulated human isolated PBMCs.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Compounds were routinely assess for metabolic stability in HLM.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">Compounds were assessed for phase II glucuronidation in HLM by including the cofactor UDPGA, excluding the cytochrome P450 dependent cofactor NADPH.</p></div></div><div></div></div><div class="NLM_p"><b>1t</b> and <b>1u</b> showed encouraging increases in glucuronidation rate relative to <b>1r</b>. However, significant improvement in glucuronidation rate came through the addition of 2-chlorophenol ring systems in <b>1v</b>–<b>x</b>. Interestingly <b>1v</b> and <b>1w</b> had differing rates of glucuronidation, suggesting that a <i>p</i>-phenol was preferred to maximize the rate of phase II metabolism. <b>1x</b> in particular was an interesting lead, as it had one of the highest rates of gluronidation observed and also had very high cytochrome P450 driven metabolism, but unfortunately the addition of the methylenethiomethyl group at R<sup>2</sup> led to a significant drop-off in potency. Interestingly, the addition of a 2-fluorophenol in <b>1y</b> also led to a reduction in potency relative to the chloro analogue <b>1v</b>. It is interesting to note not only that the rates of glucuronidation appear dependent on the p<i>K</i><sub>a</sub> of phenol being glucuronidated but also that the compounds have SAR. This is probably not a surprise, as the enzyme responsible for transferring the glucuronide to the xenobiotic compound will have a specific recognition element and therefore display SAR.</div><div class="NLM_p">Several of the methylenethiomethyl analogues (R<sup>2</sup> = CH<sub>2</sub>SMe), such as <b>1x</b>, were less potent than the <i>tert</i>-butyl analogue (R<sup>2</sup> = Me) <b>1v</b>, and so we sought to incorporate a soft metabolic group in another part of the inhibitor to increase the chances of producing a significantly less active metabolite. <b>1p</b> had previously suggested that a thiomethyl group on the ATP binding side of the molecule was tolerated from a potency perspective but also that the metabolite <b>1q</b> only led to a modest drop-off in potency. This led us to design <b>1z</b> which incorporates both a soft metabolic handle and the flexible solubilizing hydroxyethyl chain. To improve on the glucuronidation rate of <b>1z</b>, we incorporated the more acidic phenol in <b>1aa</b> and <b>1ab</b> (PF-03715455), with <b>1ab</b> having the best balance of potency, HLM intrinsic clearance, and glucuronidation rate. The sulfoxide metabolite <b>1ac</b> also showed an approximate 25-fold drop-off in potency.</div><div class="NLM_p">At this stage <b>1ab</b> was a very attractive lead, and so we set about characterizing it further. In the PBMC cell assay, with a preincubation time of 1 h the potency was determined to be 1.7 nM. Determining the potency of <b>1ab</b> against the human p38α enzyme proved to be complex as a result of the slow dissociation kinetics observed with this compound. The interaction of <b>1ab</b> with p38α was quantified by monitoring the IC<sub>50</sub> as a function of the preincubation time. In the presence of nonsaturating levels of ATP (10-fold below <i>K</i><sub>m</sub>, 5 μM ATP) a decrease in the IC<sub>50</sub> for <b>1ab</b> was observed from 9 nM (no preincubation) to 0.88 nM (40 min of preincubation).</div><div class="NLM_p">The binding kinetics of <b>1ab</b> was determined for the inactive/nonphosphorylated form of human p38α using SPR. Fast <i>k</i><sub>on</sub> and slow <i>k</i><sub>off</sub> kinetics were observed with <b>1ab</b> for p38α, resulting in a half-life of approximately 80 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Clearly the enzyme kinetics for <b>1ab</b> is significantly different from that determined for <b>1a</b>, with a faster association rate and a slower dissociation rate, leading to a much greater affinity of <b>1ab</b> for the p38α enzyme, and a much slower half-life. The origin of this difference could not be rationalized easily from a structural perspective but could perhaps be due to the larger group at the 2-position of the triazolopyridine (2-hydroxyethylthiophenyl versus isopropyl) leading to improved affinity. The mismatch between <i>K</i><sub>D</sub> generated on <b>1ab</b> from binding kinetic constants and enzymatic IC<sub>50</sub> is attributed to the enzyme assay not being at equilibrium within a time frame suitable for enzymatic assays (maximum of 40 min). The relatively fast <i>k</i><sub>on</sub> of <b>1ab</b> coupled with the slow <i>k</i><sub>off</sub> rate provides the optimal binding kinetics to overcome competition with high cellular levels of ATP. The potency and dissociation <i>t</i><sub>1/2</sub> of <b>1ab</b> for inhibiting rat p38α kinase were similar to the results observed for the human enzyme.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. p38α Affinity and Enzyme Kinetics of <b>1ab</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>on</sub> (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>off</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>D</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1ab</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">3.1 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="left">2.4 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0.001</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Enzyme kinetics were determined by surface plasmon resonance on the inactive form of the kinase using a Biacore instrument.</p></div></div></div><div class="NLM_p"><b>1a</b> was shown to bind in the DFG-out binding mode which translated into slow dissociation kinetics, and so we were keen to confirm that the DFG-out binding mode was also apparent with <b>1ab</b>. Indeed, a protein cocrystal structure confirmed this to be the case (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0007.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding site surface of <b>1ab</b> in p38α cocrystal structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yis">2yis</a>). The region of <b>1ab</b> highlighted in purple is binding into the pocket created by the DFG loop movement. Binding surface illustrates lipophilic surface (green/yellow), surface made up of hydrogen accepting oxygen atoms (red) and hydrogen donating atoms (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The previous leads <b>1a</b> and <b>1f</b> displayed good selectivity profiles, and so we were keen to confirm that <b>1ab</b> was also selective over other kinases. <b>1ab</b> has an IC<sub>50</sub> at enzyme <i>K</i><sub>m</sub> for ATP of <1 μM for 15 enzymes of the 205 recombinant kinases screened. Scaling to the p38α IC<sub>50</sub> of 0.88 nM, five kinases have a selectivity ratio of ≤100×. Whole cell assays were established that demonstrated that recombinant enzyme activity does not translate to the whole cell for three of these kinases, leaving p38β (enzyme IC<sub>50</sub> = 23nM) and misshapen NIK related kinase 1 (MINK) (enzyme IC<sub>50</sub> 6nM) as potential cross over targets for <b>1ab</b>. Selectivity over p38β was not thought to represent a toxicity liability or be required for efficacy. The low systemic exposure expected for <b>1ab</b> coupled with the seemingly fast <i>k</i><sub>on</sub> and slow <i>k</i><sub>off</sub> kinetics for p38 suggested that inhibition of MINK is unlikely to represent a toxicity risk. Moreover, <b>1ab</b> did not inhibit LPS induced JNK phosphorylation (MINK signals through JNK) in the human monocytic cell line U937 at 1 μM, suggesting that <b>1ab</b> only inhibited p38 dependent end points.</div><div class="NLM_p">In terms of physicochemical properties, <b>1ab</b> is a non-Ro5 compliant, high molecular weight (700 Da), highly lipophilic (clogP = 7.3, log <i>D</i> > 4.1), and weakly acidic molecule exhibiting an acidic p<i>K</i><sub>a</sub> of 7.45 (chlorinated phenol group). It therefore has low aqueous solubility (<0.1 mg/mL) but with measurable SLF solubility (3.0 μg/mL) when determined on a crystalline form. The pharmaceutical properties for <b>1ab</b> including crystallinity, stability on lactose, and solubility were considered suitable for dry powder inhalation.</div><div class="NLM_p">The pharmacokinetics of <b>1ab</b> was then assessed in vitro and in vivo. <b>1ab</b> was rapidly metabolized in rat, dog, and human liver microsomes. The HLM glururonidation experiment suggested that glucuronidation will significantly contribute to the human clearance of <b>1ab</b>. In fact the metabolite profile from human hepatocytes suggested that the glucuronide resulting from transfer to the chlorophenol is the major metabolite and presumably will be devoid or have greatly reduced p38 activity. In human hepatocytes, coadministration of 2 μM ketoconazole (CYP3A4 inhibitor) did not lead to any significant reduction in intrinsic clearance of <b>1ab</b> over the control incubations, suggesting that enzymes other than CYP3A4 contributed to the hepatocyte clearance of <b>1ab</b> with glucuronidation being a likely alternative pathway. These data suggest that <b>1ab</b> should not be a victim of a DDI. <b>1ab</b> is a moderate inhibitor of CYP1A2, CYP2C19, and CYP2D6 and a potent inhibitor of CYP’s 2C9 and CYP3A4. However, on the basis of the very low projected unbound plasma <i>C</i><sub>max</sub> of <b>1ab</b>, the potential for the compound acting as a perpetrator of a DDI is low.</div><div class="NLM_p">Demonstrating intrinsic cell permeability was difficult to achieve with <b>1ab</b> because of its low solubility. However, as we were observing good levels of potency (<10nM) in our whole cell PBMC experiments, it is assumed that <b>1ab</b> has some level of intrinsic cellular permeability, although it is suggested to be low based on its physicochemistry. <b>1ab</b> is a high affinity substrate for P-glycoprotein (P-gp) (<i>K</i><sub>m</sub>= 0.12 μM). This, coupled with low solubility, and presumed low intrinsic permeability translated into neglibible oral absorption in the rat (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Moderate total clearance was observed in rat and dog with <b>1ab</b>, but when corrected for high protein binding, this translates into extremely high unbound clearance values of 33 000 and 15 000 (mL/min)/kg, respectively. Human clearance predictions from preclinical data suggest low oral bioavailability and high clearance, resulting in a short half-life. Therefore, any drug reaching the systemic circulation, through absorption from either the gut or the lung, will be rapidly metabolized to relatively inactive metabolites.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Intravenous (iv) and Oral Rat and Dog Blood Pharmacokinetics of <b>1ab</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">iv clearance ((mL/min)/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">oral absorption (%)</th><th class="colsep0 rowsep0" align="center" char=".">PPB (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat iv<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">33.8</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat po<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char=".">99.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog iv<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">13.1</td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Intravenous pharmacokinetics were determined in rats from a 1 mg/kg dose.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Oral pharmacokinetics were determined from a 0.5 mg/kg dose.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Intravenous pharmacokinetics were determined in dogs from a 0.5 mg/kg dose.</p></div></div></div><div class="NLM_p">With suitable pharmacokinetic properties demonstrated with <b>1ab</b>, we were then keen to assess if the overall properties of the molecule would translate into a desirable in vivo efficacy profile. LPS challenge to the lungs of rats results in lung neutrophilia, a characteristic of COPD, in addition to induction of both exhaled nitric oxide and inflammatory mediator expression. When <b>1ab</b> was dosed as a micelle solution intratracheally (IT) 2 h prior to stimulus, it dose-dependently inhibited LPS induced lung neutrophilia with an efficacious dose (ED<sub>50</sub>) of 30 μg. The maximum inhibition was similar to that of a solution dosed corticosteroid (fluticasone, dose 100 μg, 64% inhibition) of approximately 50–70%. To investigate the in vivo DoA of <b>1ab</b>, the compound was predosed for increasing times prior to LPS challenge. <b>1ab</b> showed significant inhibition of neutrophilia on 4 h of predosing but did not significantly inhibit lung neutrophilia on 24 h of predosing. To confirm that the apparent DoA of <b>1ab</b> was not due to systemic exposure, systemic anti-inflammatory activity was assessed in an ex vivo whole blood LPS induced TNFα assay. While a significant inhibition of ex vivo LPS induced TNFα production was observed 1 h after IT solution dosing, there was no significant inhibition in blood collected 4 h after dosing. These data suggest that the DoA observed in the LPS neutrophilia model was driven by sustained p38α inhibition in the lung and was not due to systemic exposure (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). It is possible that this observed DoA is made possible by a combination of physical retention of the compound in the lung, as well as the slow dissociation kinetics from the p38α enzyme.</div><figure id="fig7" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0008.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Dose dependent inhibition of LPS induced neutrophilia at 2 h predosing with <b>1ab</b> and (B) demonstration of in vivo duration of action of greater than 4 h based on predosing studies: ∗, <i>p</i> < 0.05; NS, not statistically significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>1ab</b> was subjected to wide ligand profiling (CEREP) at 10 μM which revealed <50% inhibition against 66 of the 68 targets assayed. IC<sub>50</sub> values were therefore obtained for <b>1ab</b> at the N-type calcium channel (12 μM) and the human VEGFR1-tyrosine kinase (0.89 μM, consistent with findings in the kinase selectivity section). These affinities were all >1000× the primary pharmacology of <b>1ab</b> and therefore not considered a significant risk. Furthermore, <b>1ab</b> demonstrated little effect on the hERG current amplitude in the patch-clamp assay (46 ± 8.8% inhibition at 10 μM (<i>n</i> = 6)) and no in vitro genetic toxicity was observed. Intravenous and oral in vivo toleration studies in the rat with <b>1ab</b> for 4 days did not induce any relevant clinical signs, clinical pathology, or histopathological evidence of toxicity at doses up to 2 and 2.8 (mg/kg)/day, respectively. Overall <b>1ab</b> had a preclinical safety profile suggesting it would be tolerated in humans at clinically relevant inhaled doses.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38585" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38585" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have described our approaches toward the identification of a novel DFG-out binding lead series, beginning with <b>1a</b>, followed by subsequent optimization of various properties to ultimately identify <b>1ab</b>. Much of the design philosophy is similar to that described as “inhalation by design”, which was outlined in a previous publication.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><b>1ab</b> is a very potent and selective inhibitor for the p38α enzyme, which translates into potent inhibition of proinflammatory cytokine release in whole cells that are relevant to COPD. Moreover, the enzyme kinetics of the inactivated form of the p38α enzyme suggest fast association and slow dissociation, which should provide optimal binding kinetics to overcome competition with high cellular levels of ATP. In vivo experiments in rat suggest that <b>1ab</b> has a a DoA greater than 4 h, which could be explained by slow dissociation kinetics in combination with physical retention of compound in the lung. The in vitro and in vivo pharmacokinetic profile suggests that the compound will display low oral bioavailability in humans following any swallowed dose, coupled with very high intrinsic clearance such that any lung absorbed drug will be rapidly metabolized to relatively inactive metabolites. Data suggest that <b>1ab</b> is metabolized by both phase I and phase II pathways and therefore should not be a victim or a perpetrator of any DDIs. The pharmaceutical properties of <b>1ab</b> are suitable for combination with lactose in a dry powder inhaler, with good stability, crystallinity, and solubility being key features. Finally the compound has demonstrated a good preclinical safety profile and may offer an improved safety profile relative to oral p38 inhibitors. This promising overall profile has led to the nomination of compound <b>1ab</b> as a development candidate for the treatment of COPD. Further information relating to the research and development of compound <b>1ab</b> will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Biology. In Vitro Pharmacological Activity. IC<sub>50</sub> Determination of Inhibition of TNF-α Release from Isolated Human Peripheral Blood Mononuclear Cells (PBMCs) after LPS Stimulation</h3><div class="NLM_p last">Peripheral venous blood from healthy, nonmedicated donors was collected using ethylenediaminetetraacetic acid (EDTA) as the anticoagulant. For PBMC preparation, samples of blood were diluted 1:1 with sterile phosphate buffered saline and then separated using ACCUSPIN System-Histopaque-1077 tubes (Sigma-Aldrich, St. Louis, MO), centrifuged at 400<i>g</i> for 35 min. Buffy coat cells were removed into PBS, centrifuged at 200<i>g</i> for 10 min, and resuspended in PBMC assay buffer (Hanks balanced salt solution, 0.28% [w/v] 4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid [HEPES], 0.01% [w/v] low-endotoxin bovine serum albumin [BSA]). A differential white cell count was performed, and PBMCs were diluted to 1 × 10<sup>6</sup> lymphocytes per mL in PBMC assay buffer. Test compounds were dissolved in DMSO and diluted in PBMC assay buffer (final DMSO concentration 1%) to cover an appropriate concentration range, e.g., 0.001–10000 nM. Samples of test compound solution or vehicle (20 μL) were added into 96-well tissue culture treated plates (Corning), and PBMC (160 μL) added to each well. The assay mixtures were incubated at 37 °C for 1 h in a humidified incubator containing an atmosphere of air supplemented with 5% CO<sub>2</sub> before adding LPS (20 μL of 100 ng/mL). Plates were returned to the incubator for a further 18 h and then centrifuged before recovery of samples of supernatant. TNF-α in the samples was determined using an enzyme-linked immunosorbent assay (ELISA) (Invitrogen kit no. CHC-1754; Invitrogen Carlsbad, CA) and following the manufacturer's instructions. Dose response curves were constructed from which IC<sub>50</sub> values were calculated. At least <i>n</i> = 2 determinations were made from a single donor of PBMCs. For compounds such as <b>1ab</b>, <i>n</i> = 6 determinations were conducted from six different donors, with IC<sub>50</sub> values ranging from 1.39 to 2.02 nM.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Pharmacological Activity. ED<sub>50</sub> Determination of Inhibtion of LPS-Induced Lung Neutrophilia in Rats</h3><div class="NLM_p last">The primary objective of this procedure was to determine the anti-inflammatory activity of the compounds of formula 1, when administered directly into the lungs via the trachea, and also to determine the duration of effect. Test compounds were dissolved, or prepared as fine suspensions, in phosphate buffered saline containing 0.5% (w/v) Tween-80 to provide a range of dose levels. Male CD Sprague–Dawley rats (300–450 g) were randomized to study groups of <i>n</i> = 6 and then briefly anesthetized in an anesthetic chamber with 5% isoflurane in 3 L/min O<sub>2</sub>. One of the test compound formulations or dose vehicle (100 μL) was injected directly into the trachea of each anesthetized rat using a Hamilton syringe. The animals were then allowed to recover from the anesthetic. Dependent on the study design, animals were predosed 2, 4, or 24 h prior to inflammatory challenge. The rats were placed into a chamber (300 mm × 300 mm × 450 mm), connected to an ultrasonic nebulizer and a small animal rodent ventilator set to the maximum tidal volume and rate (5 mL, 160 strokes/min). An amount of 10 mL of 1 mg/mL LPS (Sigma-Aldrich, L2630) dissolved in saline, prewarmed to 37 °C, was nebulized into the chamber. After 15 min the ventilator and nebulizer were turned off, and the animals remained in the chamber to breathe the mist for a further 15 min before being returned to the home cage. Four hours after the end of the LPS treatment the animals were terminally anesthetised with 1 mL/kg Pentoject ip. The trachea was cannulated. The lungs were lavaged with 4 × 2.5 mL of PBS containing 2.6 mM EDTA, and the lavage fluid was collected. An amount of 1 mL of bronchioalveolar lavage (BAL) was added to 125 μL of 40% bovine serum albumen (BSA) and the cellular count determined using an Advia 120 hematology system (Siemens). Also, a terminal blood sample was collected from each rat, and IC<sub>50</sub> was determined for inhibition of LPS induced TNFα release from whole blood. Dose response curves were constructed for inhibition of LPS-induced lung neutrophils, and half-maximal effect doses (ED<sub>50</sub>) were estimated from the fitted curves.</div></div><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> p38α Enzyme Kinetics (<i>k</i><sub>on</sub> and <i>k</i><sub>off</sub>) for PF-03715444 (<b>1ab</b>), As Determined by Surface Plasmon Resonance Using a Biacore Instrument, on the Inactive (Nonphosphorylated) Form of the Kinase</h3><div class="NLM_p last">Biacore uses a technique based upon surface plasmon resonance to follow the real-time binding of compounds in a liquid milieu to immobilized proteins on a carboxymethyl dextran surface. The compounds flow across the protein surface, and as they bind, there is an increase in signal (RU). Then, as the compounds dissociate from the surface, the signal decreases and returns to baseline. These binding studies were performed at 25 °C using a running buffer of 10 mM HEPES, 150 mM NaCl, 0.005% P20 with a flow rate of 20 μL/min. For immobilization, a CM5 chip (Biacore, Piscataway, NJ) was preconditioned and then streptavidin immobilized (13000–14000 RU) using amine coupling with <i>N</i>-hydroxysuccinimide and <i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide according to Biacore methods. Nonphosphorylated BirA-MK2 (control flow cell) or BirA-p38α were then captured to a level of 10000–11000 RU. These particular binding experiments were done slightly differently from typical Biacore studies. To the immobilized, nonphosphorylated, and biotinylated p38α was added SC-71830 (200 nM) which was first allowed to bind (three times) to achieve a maximal control response. SC-71830 is a proprietry ATP competitive p38α inhibitor that displays fast on and fast off p38α enzyme kinetics. In theory any fast on and fast off inhibitor that is ATP competitive could be used. Following dissociation of the final pass of SC-71830, <b>1ab</b> (1000 nM) was injected for 5 min. At various times after the injection of <b>1ab</b>, SC-71830 (200 nM) was injected and the binding response measured. As <b>1ab</b> dissociated from the immobilized p38α, the binding of SC-71830 increased. The increase in binding response of SC-71830 over time was used to measure the dissociation of <b>1ab</b>, and these data were used to calculate the <i>k</i><sub>on</sub> and <i>k</i><sub>off</sub> for <b>1ab</b>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">Unless otherwise indicated, all reactions were carried out under a nitrogen atmosphere, using commercially available anhydrous solvents. “Ammonia” refers to commercially available aqueous ammonia solution of 0.880 specific gravity. Thin-layer chromatography was performed on glass-backed precoated Merck silica gel (60 F254) plates, and compounds were visualized using UV light, 5% aqueous potassium permanganate, or chloroplatinic acid/potassium iodide solution. Silica gel column chromatography was carried out using 40–63 μm silica gel (Merck silica gel 60). Proton NMR spectra were measured on a Varian Inova 400 or Varian Mercury 400 spectrometer in the solvents specified. In these NMR spectra, exchangeable protons that appeared distinct from solvent peaks are also reported. Low resolution mass spectra were recorded on either a Fisons Trio 1000, using thermospray positive ionization, or a Finnigan Navigator, using electrospray positive or negative ionization. High resolution mass spectra were recorded on a Bruker Apex II FT-MS using electrospray positive ionization. Test compound purity of ≥95% was determined using combustion analysis conducted by Exeter Analytical U.K. Ltd., Uxbridge, Middlesex, U.K. In the absence of test compound purity data determined by combustion analyis, all target compounds were purified until at least ≥95% purity as judged by HPLC utilizing an ELSD detection system.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methyl 2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]benzoate (<b>22</b>)</h3><div class="NLM_p last">Sodium hydride (60% in oil, 1.70 g, 29.9 mmol) was washed with heptane and subsequently suspended in <i>N</i>,<i>N</i>-dimethylformamide (25 mL). To this was added methyl thiosalicylate (5.0 g, 29.9 mmol), and the mixture was allowed to stir for 1 h. A solution of (2-bromoethoxy)-<i>tert</i>-butyldimethylsilane (7.16 g, 29.9 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (5 mL) was added dropwise, and the mixture was allowed to stir overnight at room temperature. The mixture was diluted with ethyl acetate (100 mL), and the organics were washed with brine (100 mL) and dried (MgSO<sub>4</sub>). Concentration in vacuo gave a colorless oil (7.90 g, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (dd, 1H), 7.32–7.39 (m, 2H), 7.97 (dt, 1H), 3.85 (s, 3H), 3.78 (t, 2H), 3.03 (t, 2H), 0.83 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 327 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> {2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}methanol (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>22</b> (7.90 g, 24.37 mmol) in tetrahydrofuran (50 mL) at 0 °C was added lithium aluminum hydride (1 M in tetrahydrofuran, 24.37 mL, 24.37 mmol), and the mixture was allowed to warm to room temperature with stirring overnight. Water (1 mL) was added dropwise to the mixture, followed by sodium hydroxide (1M, 3 mL). The mixture was then stirred for 30 min at room temperature. The mixture was filtered through Celite, and the Celite was then washed with ethyl acetate. The organics were then concentrated in vacuo to give a clear oil (5.90 g, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.45 (m, 1H), 7.32–7.35 (m, 1H), 7.16–1.26 (m, 2H), 4.74 (s, 2H), 3.71 (t, 2H), 2.99 (t, 2H), 2.25 (br, 1H), 0.84 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 299 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]benzaldehyde (<b>21b</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (5.90 g, 19.87 mmol) in dichloromethane (100 mL) was added barium permanganate (25.32 g, 99.27 mmol), and the mixture was stirred at room temperature for 24 h. The mixture was filtered through Celite and concentrated in vacuo. Crude analysis indicated that significant starting material remained. The residue was then diluted with dichloromethane (100 mL), and manganese dioxide (25 g, 288 mmol) was added. The mixture was heated to reflux overnight. The mixture was allowed to cool to room temperature and then filtered through Celite. The residue was concentrated in vacuo to give a purple oil (3.66 g, 62%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.39 (s, 1H), 7.78 (d, 1H), 7.46 (d, 1H), 7.24–7.28 (m, 1H), 3.78 (t, 2H), 3.05 (t, 2H), 0.84 (s, 9H), 0.00 (s, 6H). LRMS: <i>m</i>/<i>z</i> 297 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]benzaldehyde (5-bromopyridin-2-yl)hydrazone (<b>15a</b>)</h3><div class="NLM_p last">To a solution of <b>21b</b> (3.61 g, 12.24 mmol) in ethanol (10 mL) was added (5-bromopyridin-2-yl)hydrazine (2.30 g, 12.24 mmol), and the mixture was heated to reflux for 3 h. The solvent was then removed in vacuo to give the product as a pink solid (5.63 g, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.20 (br, 1H), 8.39 (s, 1H), 8.13 (d, 1H), 7.88–7.91 (m, 1H), 7.66 (dd, 1H), 7.43–7.45 (m, 1H), 7.31 (d, 1H), 7.21–7.28 (m, 1H), 3.73 (t, 2H), 2.98 (t, 2H), 2.74–2.96 (br, 1H), 0.84 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 466–468 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 6-Bromo-3-{2-[(2-{[<i>tert</i>-butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>16a</b>)</h3><div class="NLM_p last">To a solution of <b>15a</b> (5.63 g, 12.08 mmol) in dichloromethane (50 mL) and methanol (15 mL) was added iodobenzene diacetate (4.67 g, 14.50 mmol), and the mixture was stirred at room temperature overnight. The mixture was then diluted with dichloromethane (50 mL), and the mixture was washed with sodium hydroxide solution (1M, 100 mL), brine (100 mL), and subsequently dried (MgSO<sub>4</sub>). The organics were then concentrated in vacuo and purified by column chromatography on silica gel, eluting with a gradient of ethyl acetate in heptane from 0% to 100%. Fractions containing product were concentrated in vacuo to leave a pink oil (4.30 g, 77%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (dd, 1H), 7.76 (dd, 1H), 7.65 (dd, 1H), 7.57–7.58 (m, 2H), 7.36–7.43 (m, 2H), 3.69 (t, 2H), 2.93 (t, 2H), 0.84 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 464–466 [M + H]<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> {2-[(3-{2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}[1,2,4]triazolo[4,3-<i>a</i>]pyridin-6-yl)thio]phenyl}methanol (<b>17a</b>)</h3><div class="NLM_p last">A solution of <b>16a</b> (2.0 g, 4.31 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (70 mL) was degassed with argon. 2-Mercaptobenzyl alcohol (724 mg, 5.17 mmol), cesium carbonate (2.81 g, 8.62 mmol), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (169 mg, 431 μmols) were then added, and the mixture was degassed an additional time. The mixture was then heated to 90 °C for 4 h. The mixture was concentrated in vacuo, and the residue was partitioned between ethyl acetate (50 mL) and water (100 mL). The aqueous phase was then re-extracted with ethyl acetate (50 mL). The combined organics were washed with brine (100 mL), dried (MgSO<sub>4</sub>), and concentrated in vacuo. The residue was purified by column chromatography on silica gel, eluting with ethyl acetate in heptane in a gradient from 0% to 100%. Fractions containing product were concentrated in vacuo to leave a brown gum (1.32 g, 59%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (d, 1H), 7.24 (d, 1H), 7.52–7.64 (m, 4H), 7.38 (dd, 1H), 7.33 (dd, 1H), 7.27–7.30 (m, 2H), 7.17 (dd, 1H), 4.85 (s, 2H), 3.67 (t, 2H), 2.90 (t, 2H), 0.84 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 524 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-{2-[(3-{2-[(2-{[<i>tert</i>-Butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}[1,2,4]triazolo[4,3-<i>a</i>]pyridin-6-yl)thio]phenyl}methanamine (<b>2a</b>)</h3><div class="NLM_p last">To a solution of <b>17a</b> (1.32 g, 2.52 mmol) in dichloromethane (20 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.88 mL, 5.05 mmol) followed by methanesulfonic anhydride (666 mg, 3.79 mmol), and the mixture was stirred for 2 h at room temperature. The solution was then poured into a solution of methanolic ammonia (7 M, 36 mL, 252.2 mmol), and the mixture was stirred for 4 h. The solvent was removed in vacuo, and the residue was partitioned between ethyl acetate (50 mL) and ammonium hydroxide (20 mL). The organics were then washed with brine (50 mL), dried (MgSO<sub>4</sub>), and concentrated in vacuo. Purification was effected using column chromatography on silica gel, eluting from 0% to 10% methanol in (99:1) ethyl acetate with ammonia. Fractions containing product were concentrated in vacuo to leave a brown oil (904 mg, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82–7.83 (m, 1H), 7.76 (dd, 1H), 7.63 (dd, 1H), 7.58 (dd, 1H), 7.52 (dd, 1H), 7.45 (d, 1H), 7.39 (dd, 1H), 7.27–7.32 (m, 1H), 7.21–7.23 (m, 2H), 7.16 (dd, 1H), 4.07 (s, 2H), 3.66 (t, 2H), 2.90 (t, 2H), 0.85 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 523 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Chloro-4-hydrazinophenol (<b>4b</b>)</h3><div class="NLM_p last">To a suspension of 4-amino-2-chlorophenol (25 g, 174 mmol) in water (40 mL) was added concentrated hydrochloric acid (63 mL, 783 mmol). The mixture was cooled to −10 °C under nitrogen. A solution of sodium nitrite (12.0 g, 174 mmol) in water (35 mL) was added dropwise. After addition was complete the mixture was stirred for an additional 30 min at −10 °C. Tin(II) chloride dehydrate (98.1 g, 435 mmol) was dissolved in 6 M hydrochloric acid (100 mL), and the diazotization mixture was poured into this solution. The mixture was stirred for 3.5 h at −10 °C. The solids were then filtered off and dried overnight. The material was not purified further but carried over into the next step. LRMS: <i>m</i>/<i>z</i> 159 [M + H]<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(5-Amino-3-<i>tert</i>-butyl-1<i>H</i>-pyrazol-1-yl)-2-chlorophenol (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>4b</b> (174 mmol) (carried over from the previous step) in ethanol (250 mL) was added 4,4-dimethyl-3-oxopentanenitrile (21.9 g, 174 mmol), and the mixture was heated to reflux overnight. The solvent was removed in vacuo. The residue was then triturated using diethyl ether (125 mL) and heptane (250 mL). After the mixture was stirred vigorously for 2 h a fine powder was obtained. The powder was filtered off and resuspended in diethyl ether (100 mL) and heptane (200 mL), and the mixture was stirred for an additional 2 h. The solid was filtered off and dried in a vacuum oven (40 °C) to afford the desired compound as a brown solid (22 g, 48% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.10 (br, 1H), 7.10–7.67 (m, 3H), 5.61 (s, 1H), 1.28 (s, 9H) ppm. LRMS: <i>m</i>/<i>z</i> 266–268 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-<i>tert</i>-Butyl-1-(4-{[<i>tert</i>-butyl(dimethyl)silyl]oxy}-3-chlorophenyl)-1<i>H</i>-pyrazol-5-amine (<b>3f</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (40 g, 0.15 mol) in <i>N</i>,<i>N</i>-dimethylformamide (100 mL) were added <i>tert</i>-butyl(dimethyl)silyl chloride (23.8 g, 0.16 mol) and imidazole (11.2 g, 0.17 mol). The mixture was then stirred at room temperature overnight. The reaction was quenched by addition of methanol (40 mL), and subsequently the mixture was concentrated in vacuo. The residue was partitioned between ethyl acetate (300 mL) and aqueous saturated sodium bicarbonate solution (100 mL). The aqueous was then re-extracted with ethyl acetate (2 × 300 mL). The organic washes were then combined and dried (Na<sub>2</sub>SO<sub>4</sub>). After concentration in vacuo, the residue was purified by column chromatography on silica gel, eluting with ethyl acetate in hexane (1:6). Fractions containing product were concentrated in vacuo and then crystallized from ethyl acetate and hexane, giving fine white needle crystals (9.6 g, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.64 (d, 1H), 7.48 (dd, 2H), 7.10 (d, 1H), 5.41 (s, 1H), 5.22 (br, 2H), 1.24 (s, 9H), 1.05 (s, 9H), 0.29 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 380–382 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Phenyl [3-<i>tert</i>-Butyl-1-(4-{[<i>tert</i>-butyl(dimethyl)silyl]oxy}-3-chlorophenyl)-1<i>H</i>-pyrazol-5-yl]carbamate (<b>31c</b>)</h3><div class="NLM_p last">To a 0 °C cooled solution of <b>3f</b> (4.0 g, 10.5 mmol) in tetrahydrofuran (30 mL) was added pyridine (1.20 mL, 14.7 mmol) followed by dropwise addition of phenyl chloroformate (1.46 mL, 11.6 mmol). After addition was complete the mixture was allowed to warm to room temperature for 3 h. The mixture was then partitioned between ethyl acetate (100 mL) and water (100 mL). The organics were separated, washed with brine (40 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to yield an orange oil. The oil was triturated with heptane (60 mL) and the triturate stirred for 1 h. The desired product was then filtered off as a white solid (4.5 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (d, 1H), 7.37–7.42 (m, 2H), 7.27–7.32 (m, 2H), 7.23–7.26 (m, 1H), 7.10–7.18 (m, 2H), 7.02 (d, 1H), 6.46 (br, 1H), 1.36 (s, 9H), 1.07 (s, 9H), 0.28 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 500 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-[3-<i>tert</i>-Butyl-1-(3-chloro-4-hydroxyphenyl)-1<i>H</i>-pyrazol-5-yl]-3-{2-[(3-{2-[(2-{[<i>tert</i>-butyl(dimethyl)silyl]oxy}ethyl)thio]phenyl}[1,2,4]triazolo[4,3-<i>a</i>]pyridin-6-yl)thio]benzyl}urea (<b>36</b>)</h3><div class="NLM_p last">To a solution of <b>31c</b> (100 mg, 0.2 mmol) in dimethylsulfoxide (2 mL) was added <b>2a</b> (105 mg, 0.2 mmol), and the mixture was stirred overnight at room temperature. The mixture was diluted with ethyl acetate (30 mL) and water (30 mL). The organics were separated, washed with brine (20 mL), dried over (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was purified using column chromatography on silica gel, eluting with ethyl acetate in cyclohexane, 0–100%. Product containing fractions were combined and concentrated in vacuo to give the desired product as a white solid (110 mg, 68%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.78–7.82 (m, 1H), 7.72–7.76 (m, 2H), 7.62–7.67 (m, 1H), 7.58 (dd, 1H), 7.29–7.49 (m, 7H), 7.21–7.24 (m, 1H), 7.02 (d, 1H), 6.28 (s, 1H), 4.51 (s, 1H), 3.73 (t, 2H), 3.00 (t, 2H), 1.34 (s, 9H), 0.84 (s, 9H), 0.00 (s, 6H) ppm. LRMS: <i>m</i>/<i>z</i> 814 [M + H]<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-[3-<i>tert</i>-Butyl-1-(3-chloro-4-hydroxyphenyl)-1<i>H</i>-pyrazol-5-yl]-3-{2-[(3-{2-[(2-hydroxyethyl)thio]phenyl}[1,2,4]triazolo[4,3-<i>a</i>]pyridin-6-yl)thio]benzyl}urea (<b>1ab</b>)</h3><div class="NLM_p last">To a solution of <b>36</b> (90 mg, 0.1 mmol) in methanol (10 mL) was added triethylamine trihydrofluoride (18 μL, 0.1 mmol), and the mixture was stirred at room temperature overnight. The mixture was concentrated in vacuo. Then 7 M methanolic ammonia (20 mL) was added, and the reaction mixture was concentrated again in vacuo. The residue was preabsorbed onto silica gel and purified using column chromatography, eluting with a gradient of ammonia in dichloromethane (0.3:99.7) to a mixture of dichloromethane, methanol, and ammonia (94.5:5:0.5). Product containing fractions were combined and concentrated in vacuo to give the desired product as a white solid (51 mg, 73%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.72–7.76 (m, 1H), 7.64–7.68 (m, 2H), 7.58–7.63 (m, 1H), 7.53 (d, 1H), 7.37–7.44 (m, 3H), 7.23–7.36 (m, 4H), 7.17 (d, 1H), 6.97 (d, 1H), 6.23 (s, 1H), 4.46 (s, 2H), 3.56 (d, 2H), 2.94 (d, 2H), 1.29 (s, 9H) ppm. LRMS: <i>m</i>/<i>z</i> 700 [M + H]<sup>+</sup>. Anal. (C<sub>35</sub>H<sub>34</sub>ClN<sub>7</sub>O<sub>3</sub>S<sub>2</sub>) C, H, N.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/jm200677b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures and analytical data for intermediates and final compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200677b/suppl_file/jm200677b_si_001.pdf">jm200677b_si_001.pdf (311.75 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200677b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Millan</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#056164736c612b686c6969646b456268646c692b666a68"><span class="__cf_email__" data-cfemail="5e3a3f28373a70333732323f301e39333f3732703d3133">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark E. Bunnage</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane L. Burrows</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth J. Butcher</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter G. Dodd</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy J. Evans</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Fairman</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha J. Hughes</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iain C. Kilty</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arnaud Lemaitre</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell A. Lewthwaite</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Axel Mahnke</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Mathias</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Philip</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Smith</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark H. Stefaniak</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Yeadon</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Phillips</span> - <span class="hlFld-Affiliation affiliation">§Worldwide Medicinal Chemistry, ∥Allergy and Respiratory Research Unit, ⊥Department of Pharmacokinetics, Dynamics, and Metabolism, #Department of Drug Safety, and ∞Department of Pharmaceutical Sciences, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent, CT13 9NJ, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jonathan Duckworth for assistance with ADME experiments. Deborah Bruce, Iva Navratilova, and Klaus Rumpel are thanked for assistance with Biacore generated data. Suengil Han, Eric Marr, Marie Anderson, and Stephen Irving are thanked for assistance with X-ray crystallographic data. William Hood is thanked for help with progression curve experiments and analysis. Joe Monahan is also thanked for useful advice and guidance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> Abbreviations Used</h2><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CRP</td><td class="NLM_def"><p class="first last">C-reactive protein</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DDI</td><td class="NLM_def"><p class="first last">drug–drug interaction</p></td></tr><tr><td class="NLM_term">DoA</td><td class="NLM_def"><p class="first last">duration of action</p></td></tr><tr><td class="NLM_term">FEV<sub>1</sub></td><td class="NLM_def"><p class="first last">forced expiratory volume in 1 s</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin 1β</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">MMP-9</td><td class="NLM_def"><p class="first last">matrix metalloprotease 9</p></td></tr><tr><td class="NLM_term">MINK</td><td class="NLM_def"><p class="first last">misshapen NIK related kinase 1</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">mitogen activated kinase</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PDE4</td><td class="NLM_def"><p class="first last">phosphodiesterase 4</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">Ro5</td><td class="NLM_def"><p class="first last">rule-of-five</p></td></tr><tr><td class="NLM_term">SLF</td><td class="NLM_def"><p class="first last">simulated lung fluid</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TBDMS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran-2-yl</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">VEGFR1</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor 1</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: interleukin-1 and tumour necrosis factor as effector molecules in autoimmune diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+interleukin-1+and+tumour+necrosis+factor+as+effector+molecules+in+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0lgwEYFUorNQtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520interleukin-1%2520and%2520tumour%2520necrosis%2520factor%2520as%2520effector%2520molecules%2520in%2520autoimmune%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A. A.</span><span> </span><span class="NLM_article-title">Pharmalogical treatment of established rheumatoid arthritis</span> <span class="citation_source-journal">Best Pract. Res., Clim. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS1521-6942%2803%2900048-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=12915159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1WqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=811-829&author=S.+J.+Leeauthor=A.+A.+Kavanaugh&title=Pharmalogical+treatment+of+established+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of established rheumatoid arthritis</span></div><div class="casAuthors">Lee, Susan Jung-Ah; Kavanaugh, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Rheumatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">811-829</span>CODEN:
                <span class="NLM_cas:coden">BPRCC7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA) is a chronic, inflammatory condition of unknown etiol. that affects about 1% of the general population.  Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone of treatment for established RA.  The current therapeutic model encourages a step-up approach that safely incorporates several currently available classes of agents: non-steroidal anti-inflammatory drugs, selective cyclo-oxygenase-2 inhibitors, glucocorticoids, disease-modifying anti-rheumatic drugs, and biol. agents (tumor necrosis factor-α inhibitors and interleukin-1 receptor antagonist).  Non-steroidal anti-inflammatory drugs, selective cyclo-oxygenase-2 inhibitors and glucocorticoids, which offer a quick onset of symptom relief, are used mainly as adjunctive therapies.  Disease-modifying anti-rheumatic drugs and biologicals have been successful in altering disease outcome and slowing radiog. progression.  The indications, efficacy and safety of these agents in clin. trials and practice are reviewed in this chapter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPDcHHX2kOFbVg90H21EOLACvtfcHk0lgC65Ds9iQksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1WqsLY%253D&md5=e7d624cded2632bab54904753d35f4b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1521-6942%2803%2900048-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1521-6942%252803%252900048-2%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKavanaugh%26aufirst%3DA.%2BA.%26atitle%3DPharmalogical%2520treatment%2520of%2520established%2520rheumatoid%2520arthritis%26jtitle%3DBest%2520Pract.%2520Res.%252C%2520Clim.%2520Rheumatol.%26date%3D2003%26volume%3D17%26spage%3D811%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Weisman, M.; Furst, D.; Schiff, M.</span>; <span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A Double-Blind, Placebo Controlled Trial of VX-745, an Oral p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor in Patients with Rheumatoid Arthritis (RA)</span>. Presented at the Annual Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0018.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Weisman&author=D.+Furst&author=M.+Schiff&title=A+Double-Blind%2C+Placebo+Controlled+Trial+of+VX-745%2C+an+Oral+p38+Mitogen-Activated+Protein+Kinase+%28MAPK%29+Inhibitor+in+Patients+with+Rheumatoid+Arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWeisman%26aufirst%3DM.%26atitle%3DA%2520Double-Blind%252C%2520Placebo%2520Controlled%2520Trial%2520of%2520VX-745%252C%2520an%2520Oral%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%2528MAPK%2529%2520Inhibitor%2520in%2520Patients%2520with%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Haens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geboes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurcov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golovenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2Fj.cgh.2005.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=16527696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=325-334&author=S.+Schreiberauthor=B.+Feaganauthor=G.+D%E2%80%99Haensauthor=J.-F.+Colombelauthor=K.+Geboesauthor=M.+Yurcovauthor=V.+Isakovauthor=O.+Golovenkoauthor=C.+N.+Bernsteinauthor=D.+Ludwigauthor=T.+Winterauthor=U.+Meierauthor=C.+Yongauthor=J.+Steffgen&title=Oral+p38+mitogen-activated+protein+kinase+inhibition+with+BIRB+796+for+active+Crohn%E2%80%99s+disease%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double- blind, placebo- controlled trial</span></div><div class="casAuthors">Schreiber, Stefan; Feagan, Brian; D'Haens, Geert; Colombel, Jean-Frederic; Geboes, Karel; Yurcov, Mikhail; Isakov, Vasily; Golovenko, Oleg; Bernstein, Charles N.; Ludwig, Diether; Winter, Trevor; Meier, Ulrich; Yong, Chan; Steffgen, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) regulates the expression of proinflammatory cytokines, which play a crit. role in the pathophysiol. of Crohn's disease (CD).  This study investigated the efficacy and safety of BIRB 796, a highly potent inhibitor of p38 MAPK, in chronic active CD.  In a multicenter, multinational trial, 284 patients with moderate to severe CD were randomized to receive placebo, or 10, 20, 30, or 60 mg of BIRB 796 twice daily for 8 wk.  Clin. endpoints were based on std. safety assessments, CD Activity Index, C-reactive protein levels, and quality of life (Inflammatory Bowel Disease Questionnaire).  In a substudy, the Crohn's Disease Endoscopic Index of Severity and histol. results of biopsy specimens were assessed.  No clin. efficacy (primary end point, clin. remission; secondary end point, clin. response; Inflammatory Bowel Disease Questionnaire; Crohn's Disease Endoscopic Index of Severity) was seen for BIRB 796 in comparison with placebo.  A significant, dose-dependent decrease of C-reactive protein level was obsd. transiently after BIRB 796 after 1 wk with a return to baseline level over time.  The incidence of adverse events was comparable between all treatment groups, with the exception of a mild increase of transaminase levels that was seen more frequently in the BIRB 796 groups.  Geog. center effects were obsd. with Russian centers producing distinctly higher remission and response rates and lower adverse event rates than in other countries in both placebo and active treatment groups.  There was no evidence for clin. efficacy of BIRB 796 in CD.  A remarkable difference in the course of CD exists between Russia and non-Russian centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPlk4HFJbHhrVg90H21EOLACvtfcHk0lgC65Ds9iQksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D&md5=f99fbaeea2b16c7e5fa11069b99518f1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2005.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2005.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Haens%26aufirst%3DG.%26aulast%3DColombel%26aufirst%3DJ.-F.%26aulast%3DGeboes%26aufirst%3DK.%26aulast%3DYurcov%26aufirst%3DM.%26aulast%3DIsakov%26aufirst%3DV.%26aulast%3DGolovenko%26aufirst%3DO.%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DWinter%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DYong%26aufirst%3DC.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DOral%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibition%2520with%2520BIRB%2520796%2520for%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D4%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M. J.</span><span> </span><span class="NLM_article-title">Selective p38α inhibitors clinically evaluated for the treatment of chronic inflammatory disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2345-2353&author=D.+M.+Goldsteinauthor=A.+Kuglstatterauthor=Y.+Louauthor=M.+J.+Soth&title=Selective+p38%CE%B1+inhibitors+clinically+evaluated+for+the+treatment+of+chronic+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012906%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DSoth%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520p38%25CE%25B1%2520inhibitors%2520clinically%2520evaluated%2520for%2520the%2520treatment%2520of%2520chronic%2520inflammatory%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2345%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Vertex Pharmaceuticals Inc</span><span class="NLM_x">: Vertex moves to re-allocate resources from VX-745 in p38 MAP kinase program to accelerate development of second generation drug candidates VX-702 and VX-850. Press Release, September 24, </span><span class="NLM_x"> (</span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vertex+Pharmaceuticals+Inc%3A+Vertex+moves+to+re-allocate+resources+from+VX-745+in+p38+MAP+kinase+program+to+accelerate+development+of+second+generation+drug+candidates+VX-702+and+VX-850.+Press+Release%2C+September+24%2C+%282001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wood</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics and pharmacodynamics of an oral p38 MAP kinase inhibitor (BIRB 796 BS), administered once daily for 7 days</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">) </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1067%2Fmai.2002.124889" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=993&author=+Woodauthor=+Yongauthor=+Madwedauthor=A.+Gupta&title=Safety%2C+pharmacokinetics+and+pharmacodynamics+of+an+oral+p38+MAP+kinase+inhibitor+%28BIRB+796+BS%29%2C+administered+once+daily+for+7+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1067%2Fmai.2002.124889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2002.124889%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aulast%3DYong%26aulast%3DMadwed%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520an%2520oral%2520p38%2520MAP%2520kinase%2520inhibitor%2520%2528BIRB%2520796%2520BS%2529%252C%2520administered%2520once%2520daily%2520for%25207%2520days%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2002%26volume%3D109%26spage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span>Boehringer Ingelheim. <a href="http://www.boehringer-ingelheim.com" class="extLink">http://www.boehringer-ingelheim.com</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boehringer+Ingelheim.+http%3A%2F%2Fwww.boehringer-ingelheim.com+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mannino, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buist, A. S.</span><span> </span><span class="NLM_article-title">Global burden of COPD: risk factors, prevalence, and future trends</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0140-6736%2807%2961380-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=17765526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A280%3ADC%252BD2srhs1SisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=765-773&author=D.+M.+Manninoauthor=A.+S.+Buist&title=Global+burden+of+COPD%3A+risk+factors%2C+prevalence%2C+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Global burden of COPD: risk factors, prevalence, and future trends</span></div><div class="casAuthors">Mannino David M; Buist A Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">9589</span>),
    <span class="NLM_cas:pages">765-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) continues to be an important cause of morbidity, mortality, and health-care costs worldwide.  It is a global health issue, with cigarette smoking being an important risk factor universally; other factors, such as exposure to indoor and outdoor air pollution, occupational hazards, and infections, are also important.  As the global population ages, the burden of COPD will increase in years to come.  Prevalence estimates of the disorder show considerable variability across populations, suggesting that risk factors can affect populations differently.  Other advances in our understanding of COPD are increased recognition of the importance of comorbid disease, identification of different COPD phenotypes, and understanding how factors other than lung function affect outcome in our patients.  The challenge we will all face in the next few years will be implementation of cost-effective prevention and management strategies to stem the tide of this disease and its cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTAJAVB43A0isZ1x6zOs0vfW6udTcc2eZn56NlijQ1u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srhs1SisQ%253D%253D&md5=0a73050bcb4fe9e7a2bf7bda4a699192</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961380-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961380-4%26sid%3Dliteratum%253Aachs%26aulast%3DMannino%26aufirst%3DD.%2BM.%26aulast%3DBuist%26aufirst%3DA.%2BS.%26atitle%3DGlobal%2520burden%2520of%2520COPD%253A%2520risk%2520factors%252C%2520prevalence%252C%2520and%2520future%2520trends%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D765%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Glucocorticoid resistance in inflammatory diseases</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1905</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=1905-1917&author=P.+J.+Barnesauthor=I.+M.+Adcock&title=Glucocorticoid+resistance+in+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DGlucocorticoid%2520resistance%2520in%2520inflammatory%2520diseases%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D1905%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Renda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestrelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maselli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsico, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saetta, M.</span><span> </span><span class="NLM_article-title">Increased activation of p38 MAPK in COPD</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1183%2F09031936.00036707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=17959643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVCgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=62-69&author=T.+Rendaauthor=S.+Baraldoauthor=G.+Pelaiaauthor=E.+Bazzanauthor=G.+Turatoauthor=A.+Papiauthor=P.+Maestrelliauthor=R.+Maselliauthor=A.+Vatrellaauthor=L.+M.+Fabbriauthor=R.+Zuinauthor=S.+A.+Marsicoauthor=M.+Saetta&title=Increased+activation+of+p38+MAPK+in+COPD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Increased activation of p38 MAPK in COPD</span></div><div class="casAuthors">Renda, T.; Baraldo, S.; Pelaia, G.; Bazzan, E.; Turato, G.; Papi, A.; Maestrelli, P.; Maselli, R.; Vatrella, A.; Fabbri, L. M.; Zuin, R.; Marsico, S. A.; Saetta, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Inflammation, oxidative stress and apoptosis, which are involved in chronic obstructive pulmonary disease (COPD) pathogenesis, may activate the p38 subgroup of mitogen-activated protein kinases (MAPKs).  Therefore, the aim of the present study was to evaluate the expression of the phosphorylated, active form of p38 MAPK (phospho-p38) in the lungs of COPD patients.  Surgical specimens were obtained from 18 smokers with COPD at different stages of disease severity, plus nine smoking and eight nonsmoking subjects with normal lung function.  Phospho-p38+ cells were quantified by immunohistochem. in both alveolar spaces and alveolar walls.  Moreover, a Western blot anal. of phospho-p38 and total p38α isoform expressed by alveolar macrophages was performed.  Phospho-p38+ alveolar macrophages and phospho-p38+ cells in alveolar walls were increased in patients with severe and mild/moderate COPD, compared with smoking and nonsmoking controls.  Moreover, they were inversely correlated to values of forced expiratory vol. in one second (FEV1) and FEV1/forced vital capacity.  Western blot anal. showed that phosphorylated p38, but not the total p38α isoform, was specifically increased in alveolar macrophages from COPD patients.  Activation of the p38 mitogen-activated protein kinase pathway appears to be involved in the pathogenesis of chronic obstructive pulmonary disease.  The present findings suggest that this protein may be a suitable pharmacol. target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtAB3KTmtt7bVg90H21EOLACvtfcHk0lhq2xkaTOg5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVCgs7g%253D&md5=39f304338b1fab6a54221a1ed305d220</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1183%2F09031936.00036707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00036707%26sid%3Dliteratum%253Aachs%26aulast%3DRenda%26aufirst%3DT.%26aulast%3DBaraldo%26aufirst%3DS.%26aulast%3DPelaia%26aufirst%3DG.%26aulast%3DBazzan%26aufirst%3DE.%26aulast%3DTurato%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DMaestrelli%26aufirst%3DP.%26aulast%3DMaselli%26aufirst%3DR.%26aulast%3DVatrella%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DL.%2BM.%26aulast%3DZuin%26aufirst%3DR.%26aulast%3DMarsico%26aufirst%3DS.%2BA.%26aulast%3DSaetta%26aufirst%3DM.%26atitle%3DIncreased%2520activation%2520of%2520p38%2520MAPK%2520in%2520COPD%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2008%26volume%3D31%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Underwood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochnowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, D. E.</span><span> </span><span class="NLM_article-title">SB 217063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=10734180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFGhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=281-288&author=D.+C.+Underwoodauthor=R.+R.+Osbornauthor=C.+J.+Kotzerauthor=J.+L.+Adamsauthor=J.+C.+Leeauthor=E.+F.+Webbauthor=D.+C.+Carpenterauthor=S.+Bochnowiczauthor=H.+C.+Thomasauthor=D.+W.+P.+Hayauthor=D.+E.+Griswold&title=SB+217063%2C+a+potent+p38+MAP+kinase+inhibitor%2C+reduces+inflammatory+cytokine+production%2C+airways+eosinophil+infiltration%2C+and+persistence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence</span></div><div class="casAuthors">Underwood, David C.; Osborn, Ruth R.; Kotzer, Charles J.; Adams, Jerry L.; Lee, John C.; Webb, Edward F.; Carpenter, Donald C.; Bochnowicz, Steven; Thomas, Heath C.; Hay, Douglas W. P.; Griswold, Don E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-288</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The anti-inflammatory/antiallergic activity of a novel second-generation p38 mitogen-activated protein kinase inhibitor, SB 239063 [trans-1-(4-hydroxycyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyridim idin-4-yl)imidazole], was investigated in vivo and in vitro.  SB 239063 had an IC50 of 44 nM for inhibition of recombinant purified human p38α.  In lipopolysaccharide-stimulated human peripheral blood monocytes, SB 239063 inhibited interleukin-1 and tumor necrosis factor-α prodn. (IC50 values = 0.12 and 0.35 μM, resp.).  A role for p38 kinase in cytokine-assocd. inflammation in the mouse was shown by p38 activation in the lung and inhibition of lipopolysaccharide-induced tumor necrosis factor-α prodn. by SB 239063 (ED50 = 5.8 mg/kg p.o.).  Antiallergic activity was demonstrated by essential abolition (∼93% inhibition) of inhaled ovalbumin (OA)-induced airway eosinophilia by SB 239063 (12 mg/kg p.o.), measured by bronchoalveolar lavage (BAL) in OA-sensitized mice.  In addn., p38 kinase was found by Western anal. to be activated in guinea pig lung.  Administration of SB 239063 (10 or 30 mg/kg p.o.) in conscious guinea pigs markedly reduced (∼50% inhibition) OA-induced pulmonary eosinophil influx, measured by BAL 24 h after antigen.  SB 239063 (10 mg/kg b.i.d. p.o.) administered after leukotriene D4 inhalation, reduced by 60% the persistent airway eosinophilia seen at 4 days.  Apoptosis of cultured eosinophils isolated from guinea pig BAL was increased by SB 239063 (1-10 μM) in the presence of interleukin-5.  These results indicate that SB 239063 is a potent inhibitor of inflammatory cytokine prodn., inhibits eosinophil recruitment, in addn. to enhancing apoptosis of these cells.  Collectively, the results support the potential utility of p38 kinase inhibitors, such as SB 239063 for the treatment of asthma and other inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLFMXLD74MwLVg90H21EOLACvtfcHk0lhq2xkaTOg5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFGhuro%253D&md5=3a09fb3f2b3c67d8b359cea1d73ef27b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DD.%2BC.%26aulast%3DOsborn%26aufirst%3DR.%2BR.%26aulast%3DKotzer%26aufirst%3DC.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DWebb%26aufirst%3DE.%2BF.%26aulast%3DCarpenter%26aufirst%3DD.%2BC.%26aulast%3DBochnowicz%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DH.%2BC.%26aulast%3DHay%26aufirst%3DD.%2BW.%2BP.%26aulast%3DGriswold%26aufirst%3DD.%2BE.%26atitle%3DSB%2520217063%252C%2520a%2520potent%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520reduces%2520inflammatory%2520cytokine%2520production%252C%2520airways%2520eosinophil%2520infiltration%252C%2520and%2520persistence%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">p38α selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1124%2Fjpet.107.127092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=18056868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=921-929&author=S.+Medicherlaauthor=M.+Fitzgeraldauthor=D.+Spicerauthor=P.+Woodmanauthor=J.+Y.+Maauthor=A.+M.+Kapounauthor=S.+Chakravartyauthor=S.+Dugarauthor=A.+A.+Protterauthor=L.+S.+Higgins&title=p38%CE%B1+selective+MAP+kinase+inhibitor%2C+SD-282%2C+reduces+inflammation+in+a+sub-chronic+model+of+tobacco+smoke-induced+airway+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">p38α-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model to tobacco smoke-induced airway inflammation</span></div><div class="casAuthors">Medicherla, Satyanarayana; Fitzgerald, Mary F.; Spicer, Dianne; Woodman, Paul; Ma, Jing Y.; Kapoun, Ann M.; Chakravarty, Sarvajit; Dugar, Sundeep; Protter, Andrew A.; Higgins, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation, which is relatively insensitive to inhaled corticosteroids.  The extent of the pulmonary inflammation in COPD correlates with disease severity, and it is thought to play a significant role in disease progression.  We have evaluated a selective p38α-selective mitogen-activated protein kinase (MAPK) inhibitor, indole-5-carboxamide (ATP-competitive inhibitor of p38 kinase) (SD-282), in an 11-day model of tobacco smoke (TS)-induced pulmonary inflammation in A/J mice, by using dexamethasone as a ref. steroid.  Two oral treatment paradigms were evaluated in this TS model: prophylactic with daily pretreatment before each daily exposure, and therapeutic with daily treatment for 6 days commencing after 5 days of smoke exposure.  Bronchoalveolar lavage and histol. evaluation of lung sections taken after exposure to TS revealed an inflammatory response composed of increased nos. of macrophages and neutrophils and enhanced mucin staining.  Phospho-p38 staining in macrophages and type II epithelial cells after TS exposure was also obsd.  Given prophylactically or therapeutically, dexamethasone failed to inhibit any of the TS-induced inflammatory changes.  By contrast, SD-282 inhibited TS-induced increases in macrophages and neutrophils.  Furthermore, SD 282 reduced TS-induced increases in cyclooxygenase-2 and interleukin-6 levels, and phospho-p38 expression in the lungs.  In conclusion, SD-282 markedly reduced TS-induced inflammatory responses when given prophylactically or therapeutically whereas dexamethasone was ineffective.  This is the first evidence that a p38α-selective MAPK inhibitor can exert pulmonary anti-inflammatory activity in a TS exposure model when given in a therapeutic mode, establishing the potential of p38 MAPK inhibitors as a therapy for COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1iU4ffng8NLVg90H21EOLACvtfcHk0lhq2xkaTOg5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajsrk%253D&md5=0f80c6c05438e104a8ef5adc0985cc94</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127092%26sid%3Dliteratum%253Aachs%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DSpicer%26aufirst%3DD.%26aulast%3DWoodman%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3Dp38%25CE%25B1%2520selective%2520MAP%2520kinase%2520inhibitor%252C%2520SD-282%252C%2520reduces%2520inflammation%2520in%2520a%2520sub-chronic%2520model%2520of%2520tobacco%2520smoke-induced%2520airway%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. S. F.</span><span> </span><span class="NLM_article-title">Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1164%2Frccm.200408-1006OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=15557129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A280%3ADC%252BD2M7itFKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=571-578&author=W.+Duanauthor=J.+H.+Chanauthor=K.+McKayauthor=J.+R.+Crosbyauthor=H.+H.+Chooauthor=B.+P.+Leungauthor=J.+G.+Karrasauthor=W.+S.+F.+Wong&title=Inhaled+p38alpha+mitogen-activated+protein+kinase+antisense+oligonucleotide+attenuates+asthma+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice</span></div><div class="casAuthors">Duan Wei; Chan Jasmine H P; McKay Kelly; Crosby Jeffrey R; Choo Hui Hwa; Leung Bernard P; Karras James G; Wong W S Fred</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">571-8</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) plays a critical role in the activation of inflammatory cells.  Therefore, we investigated the antiinflammatory effects of a respirable p38alpha MAPK antisense oligonucleotide (p38alpha-ASO) in a mouse asthma model.  A potent and selective p38alpha-ASO was characterized in vitro.  Inhalation of aerosolized p38alpha-ASO using an aerosol chamber dosing system produced measurable lung deposition of ASO and significant reduction of ovalbumin (OVA-)-induced increases in total cells, eosinophils, and interleukin 4 (IL-4), IL-5, and IL-13 levels in bronchoalveolar lavage fluid, and dose-dependent inhibition of airway hyperresponsiveness in allergen-challenged mice.  Furthermore, inhaled p38alpha-ASO markedly inhibited OVA-induced lung tissue eosinophilia and airway mucus hypersecretion.  Quantitative polymerase chain reaction analysis of bronchoalveolar lavage fluid cells and peribronchial lymph node cells showed that p38alpha-ASO significantly reduced p38alpha MAPK mRNA expression.  Nose-only aerosol exposure of mice verified the p38alpha-ASO-induced inhibition of OVA-induced pulmonary eosinophilia, mucus hypersecretion, and airway hyperresponsiveness.  None of the effects of the p38alpha-ASO were produced by a six-base mismatched control oligonucleotide.  These findings demonstrate antisense pharmacodynamic activity in the airways after aerosol delivery and suggest that a p38alpha MAPK ASO approach may have therapeutic potential for asthma and other inflammatory lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCM3oekSwyXr5oR8RchjrrfW6udTcc2eaLjIqKO0fW4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7itFKitA%253D%253D&md5=6d7ad445958db3a8c4eab9f0b459c535</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1164%2Frccm.200408-1006OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200408-1006OC%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DJ.%2BH.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DCrosby%26aufirst%3DJ.%2BR.%26aulast%3DChoo%26aufirst%3DH.%2BH.%26aulast%3DLeung%26aufirst%3DB.%2BP.%26aulast%3DKarras%26aufirst%3DJ.%2BG.%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26atitle%3DInhaled%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520antisense%2520oligonucleotide%2520attenuates%2520asthma%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2005%26volume%3D171%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Array Biopharm. <a href="http://www.arraybiopharma.com" class="extLink">http://www.arraybiopharma.com</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Biopharm.+http%3A%2F%2Fwww.arraybiopharma.com+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>ClinicalTrials.gov. <a href="http://www.clinicaltrials.gov" class="extLink">http://www.clinicaltrials.gov</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+http%3A%2F%2Fwww.clinicaltrials.gov+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_contrib-group">MacNee, W.; Allan, R.; Jones, I.; De Salvo, M. C.; Tan, L.</span><span> </span><span class="NLM_article-title">A Randomised, Placebo Controlled Trial of 6 Weeks’ Treatment with a Novel Oral p38 Inhibitor in Patients with COPD</span>. Presented at the European Respiratory Society Meeting, Barcelona, Spain,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=W.+MacNee&author=R.+Allan&author=I.+Jones&author=M.+C.+De+Salvo&author=L.+Tan&title=A+Randomised%2C+Placebo+Controlled+Trial+of+6+Weeks%E2%80%99+Treatment+with+a+Novel+Oral+p38+Inhibitor+in+Patients+with+COPD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMacNee%26aufirst%3DW.%26atitle%3DA%2520Randomised%252C%2520Placebo%2520Controlled%2520Trial%2520of%25206%2520Weeks%25E2%2580%2599%2520Treatment%2520with%2520a%2520Novel%2520Oral%2520p38%2520Inhibitor%2520in%2520Patients%2520with%2520COPD%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalamanchili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonder Embse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4066</span><span class="NLM_x">–</span> <span class="NLM_lpage">4071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2Fj.bmcl.2011.04.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=21641211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4066-4071&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=B.+Devadasauthor=J.+K.+Walkerauthor=T.+L.+Boehmauthor=R.+C.+Durleyauthor=H.+Shiehauthor=L.+Xingauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Balauthor=D.+Messingauthor=J.+Yangauthor=M.+K.+Maoauthor=G.+Yalamanchiliauthor=R.+Vonder+Embseauthor=J.+Hirschauthor=M.+Saabyeauthor=S.+Bonarauthor=E.+Webbauthor=G.+Andersonauthor=J.+B.+Monahan&title=Discovery+of+PH-797804%2C+a+highly+selective+and+potent+inhibitor+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span></div><div class="casAuthors">Selness, Shaun R.; Devraj, Rajesh V.; Devadas, Balekudru; Walker, John K.; Boehm, Terri L.; Durley, Richard C.; Shieh, Huey; Xing, Li; Rucker, Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen, Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo, Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal, Radhika; Messing, Dean; Yang, Jerry; Mao, Michael K.; Yalamanchili, Gopi; Vonder Embse, Richard; Hirsch, Jeffrey; Saabye, Matthew; Bonar, Sheri; Webb, Elizabeth; Anderson, Gary; Monahan, Joseph B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4066-4071</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of a novel N-arylpyridinone class of p38 kinase inhibitors are described.  Systematic structural modifications to the HTS lead led to the identification of a clin. candidate (phase II clin. studies) for the treatment of inflammatory diseases.  Addnl., the chiral synthesis and properties of said clin. candidate are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL54FATgVMdbVg90H21EOLACvtfcHk0ljiCA7z35Kjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLk%253D&md5=eb900d70d0c84f642e3b09ecbeb0cf91</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.121%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DM.%2BK.%26aulast%3DYalamanchili%26aufirst%3DG.%26aulast%3DVonder%2BEmbse%26aufirst%3DR.%26aulast%3DHirsch%26aufirst%3DJ.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DBonar%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520PH-797804%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4066%26epage%3D4071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanoje, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semwal, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1411-1425&author=P.+Chopraauthor=V.+Kanojeauthor=A+Semwalauthor=A.+Ray&title=Therapeutic+potential+of+inhaled+p38+mitogen-activated+protein+kinase+inhibitors+for+inflammatory+pulmonary+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DKanoje%26aufirst%3DV.%26aulast%3DSemwal%26aufirst%3DA%26aulast%3DRay%26aufirst%3DA.%26atitle%3DTherapeutic%2520potential%2520of%2520inhaled%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%2520for%2520inflammatory%2520pulmonary%2520diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1411%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Millan, D. S.</span><span> </span><span class="NLM_article-title">What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.4155%2Ffmc.11.96" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=21942253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1635-1645&author=D.+S.+Millan&title=What+is+the+potential+for+inhaled+p38+inhibitors+in+the+treatment+of+chronic+obstructive+pulmonary+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?</span></div><div class="casAuthors">Millan, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1635-1645</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 has been an intensely studied therapeutic target in the pharmaceutical industry.  With more than 20 compds. entering human trials, none have progressed beyond Phase II to the best of our knowledge.  The transient efficacy seen in many of the Phase II trials has raised some concerns for the future potential of this target, particularly in rheumatoid arthritis.  With this caveat, there is good evidence for p38 inhibition to be efficacious in chronic obstructive pulmonary disease and there are now several oral compds. currently in development for this disease, with encouraging data beginning to emerge.  With an inhaled agent likely to improve the therapeutic window between efficacy and some of the common adverse events obsd. with oral p38 inhibitors it would seem a sensible approach to take for a disease of the lung.  This review will highlight the potential for an inhaled p38 inhibitor in chronic obstructive pulmonary disease, as well as some of the design principles that are important to consider when developing an inhaled kinase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4waRvOu6S_LVg90H21EOLACvtfcHk0ljcdc9mQdFICQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvK&md5=81104fda424ad56be567693b9207b4f3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.96%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26atitle%3DWhat%2520is%2520the%2520potential%2520for%2520inhaled%2520p38%2520inhibitors%2520in%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1635%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Glossop, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, C. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros-Huguet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, F. J.</span><span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6640</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0ljcdc9mQdFICQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capolino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of the p38α MAP kinase inhibitor 1-(5-<i>tert</i>-butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)napthalen-1-yl]urea (BIRB 796)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4676</span><span class="NLM_x">–</span> <span class="NLM_lpage">4686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030121k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4676-4686&author=J.+Reganauthor=A.+Capolinoauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=R.+R.+Kroeauthor=M.+Madwedauthor=M.+Moriakauthor=R.+Nelsonauthor=C.+A.+Pargellisauthor=A.+Swinamerauthor=C.+Torcelliniauthor=M.+Tsangauthor=N.+Moss&title=Structure%E2%80%93activity+relationships+of+the+p38%CE%B1+MAP+kinase+inhibitor+1-%285-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl%29-3-%5B4-%282-morpholin-4-yl-ethoxy%29napthalen-1-yl%5Durea+%28BIRB+796%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm030121k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030121k%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DCapolino%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DMadwed%26aufirst%3DM.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTsang%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520the%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%25201-%25285-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl%2529-3-%255B4-%25282-morpholin-4-yl-ethoxy%2529napthalen-1-yl%255Durea%2520%2528BIRB%2520796%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4676%26epage%3D4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paregllis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">The kinetics of binding to p38 MAP kinase by analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Reganauthor=C.+A.+Paregllisauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=E.+R.+Hickeyauthor=G.+W.+Peetauthor=A.+Protoauthor=A.+Swinamerauthor=N.+Moss&title=The+kinetics+of+binding+to+p38+MAP+kinase+by+analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0ljUv1HmcNO3Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DParegllis%26aufirst%3DC.%2BA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DThe%2520kinetics%2520of%2520binding%2520to%2520p38%2520MAP%2520kinase%2520by%2520analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipesa, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMotte, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Y.</span><span> </span><span class="NLM_article-title">Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5728</span><span class="NLM_x">–</span> <span class="NLM_lpage">5737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050346q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVChsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5728-5737&author=K.+F.+McClureauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=J.+T.+Barberiaauthor=W.+Caiauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=D.+E.+Danleyauthor=A.+J.+Dipesaauthor=K.+M.+Donahueauthor=M.+A.+Dombroskiauthor=N.+C.+Elliottauthor=C.+A.+Gabelauthor=S.+Hanauthor=T.+R.+Hynesauthor=P.+K.+LeMotteauthor=M.+N.+Mansourauthor=E.+S.+Marrauthor=M.+A.+Letavicauthor=J.+Panditauthor=D.+B.+Ripinauthor=F.+J.+Sweeneyauthor=D.+Tanauthor=Y.+Tao&title=Theoretical+and+experimental+design+of+atypical+kinase+inhibitors%3A+application+to+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical and Experimental Design of Atypical Kinase Inhibitors: Application to p38 MAP Kinase</span></div><div class="casAuthors">McClure, Kim F.; Abramov, Yuriy A.; Laird, Ellen R.; Barberia, John T.; Cai, Weiling; Carty, Thomas J.; Cortina, Santo R.; Danley, Dennis E.; Dipesa, Alan J.; Donahue, Kathleen M.; Dombroski, Mark A.; Elliott, Nancy C.; Gabel, Christopher A.; Han, Seungil; Hynes, Thomas R.; LeMotte, Peter K.; Mansour, Mahmoud N.; Marr, Eric S.; Letavic, Michael A.; Pandit, Jayvardhan; Ripin, David B.; Sweeney, Francis J.; Tan, Douglas; Tao, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mimics of the benzimidazolone nucleus found in inhibitors of p38 kinase are proposed, and their theor. potential as bioisosteres is described.  A set of calcd. descriptors relevant to the anticipated binding interaction for the fragments 1-methyl-1H-benzotriazole, 3-methylbenzo[d]isoxazole, and 3-methyl[1,2,4]triazolo[4,3-a]pyridine, pyridine, and 1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one are reported.  The design considerations and synthesis of p38 inhibitors based on these H-bond acceptor fragments is detailed.  Comparative evaluation of the pyridine-, benzimidazolone-, benzotriazole-, and triazolopyridine-based inhibitors shows the triazoles I and II to be significantly more potent exptl. than the benzimidazolone after which they were modeled.  An X-ray crystal structure of II bound to the active site shows that the triazole group serves as the H-bond acceptor but unexpectedly as a dual acceptor, inducing movement of the crossover connection of p38α.  The computed descriptors for the hydrophobic and π-π interaction capacities were the most useful in ranking potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozbRRIfTs-bbVg90H21EOLACvtfcHk0ljUv1HmcNO3Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVChsLw%253D&md5=d53877752524d77f6e5f3b04d8e8e8ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050346q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050346q%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DDipesa%26aufirst%3DA.%2BJ.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DT.%2BR.%26aulast%3DLeMotte%26aufirst%3DP.%2BK.%26aulast%3DMansour%26aufirst%3DM.%2BN.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRipin%26aufirst%3DD.%2BB.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DTan%26aufirst%3DD.%26aulast%3DTao%26aufirst%3DY.%26atitle%3DTheoretical%2520and%2520experimental%2520design%2520of%2520atypical%2520kinase%2520inhibitors%253A%2520application%2520to%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5728%26epage%3D5737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Braganza, J. F.; Letavic, M. A.; McClure, K. F.</span><span> </span><span class="NLM_article-title">Preparation of Triazolo[4,3-<i>a</i>]pyridines as MAP Kinases, in Particular p38 Kinase Inhibitors, and Their Use as Antiinflammatory Agents</span>. WO2004072072,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+F.+Braganza&author=M.+A.+Letavic&author=K.+F.+McClure&title=Preparation+of+Triazolo%5B4%2C3-a%5Dpyridines+as+MAP+Kinases%2C+in+Particular+p38+Kinase+Inhibitors%2C+and+Their+Use+as+Antiinflammatory+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26atitle%3DPreparation%2520of%2520Triazolo%255B4%252C3-a%255Dpyridines%2520as%2520MAP%2520Kinases%252C%2520in%2520Particular%2520p38%2520Kinase%2520Inhibitors%252C%2520and%2520Their%2520Use%2520as%2520Antiinflammatory%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmirski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Enhanced selectivity profile of pyrazole-urea based DFG-out p38α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4885</span><span class="NLM_x">–</span> <span class="NLM_lpage">4891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4885-4891&author=H.+Liuauthor=C.+Kuhnauthor=F.+Feruauthor=S.+L.+Jacquesauthor=G.+D.+Deshmukhauthor=P.+Yeauthor=G.+R.+Rennieauthor=T.+Johnsonauthor=S.+Kazmirskiauthor=S.+Lowauthor=R.+Coliauthor=Y.-H.+Dingauthor=A.+C.+Chengauthor=H.+Tecleauthor=J.+M.+Englishauthor=R.+Stantonauthor=J.+C.+Wu&title=Enhanced+selectivity+profile+of+pyrazole-urea+based+DFG-out+p38%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DY.-H.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DEnhanced%2520selectivity%2520profile%2520of%2520pyrazole-urea%2520based%2520DFG-out%2520p38%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4885%26epage%3D4891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1081%2FDMR-120000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=11768770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=273-297&author=M.+B.+Fisherauthor=M.+F.+Paineauthor=T.+J.+Strelevitzauthor=S.+A.+Wrighton&title=The+role+of+hepatic+and+extrahepatic+UDP-glucuronosyltransferases+in+human+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span></div><div class="casAuthors">Fisher, Michael B.; Paine, Mary F.; Strelevitz, Timothy J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">273-297</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  At present, the methods and enzymol. of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P 450 (CYPs).  About 15 human UGTs have been identified, and knowledge about their regulation, substrate selectivity, and tissue distribution has progressed recently.  Alamethicin has been characterized as a treatment to remove the latency of microsomal glucuronidations.  Most UGT isoforms appear to have a distinct hepatic and/or extrahepatic expression, resulting in significant expression in kidney, intestine, and steroid target tissues.  The gastrointestinal tract possesses a complex expression pattern largely contg. members of the UGT1A subfamily.  Thus, these forms are poised to participate in the first pass metab. of oral drugs.  The authors and others have identified a significant expression of UGT1A1 in human small intestine, an enzyme possessing considerable allelic variability and a polymorphic expression pattern in intestine.  Intestinal glucuronidation therefore plays a major role not only in first pass metab., but also in the degree of interindividual variation in overall oral bioavailability.  Due to issues such as significant genetic variability and tissue localization in first-pass organs, clearance due to UGT1A1 should be minimized for new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThMjjbeI-nbVg90H21EOLACvtfcHk0lgm2Xa_F3YFfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D&md5=7a35a3d8dcba636ac4bcac54a13f47b1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000653%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520of%2520hepatic%2520and%2520extrahepatic%2520UDP-glucuronosyltransferases%2520in%2520human%2520drug%2520metabolism%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D273%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 68 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ariane Nunes-Alves, Fabian Ormersbach, <span class="NLM_string-name hlFld-ContribAuthor">Rebecca C. Wade</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of the Drug–Target Binding Kinetics for Flexible Proteins by Comparative Binding Energy Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (7)
                                     , 3708-3721. <a href="https://doi.org/10.1021/acs.jcim.1c00639" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00639%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrediction%252Bof%252Bthe%252BDrug%2525E2%252580%252593Target%252BBinding%252BKinetics%252Bfor%252BFlexible%252BProteins%252Bby%252BComparative%252BBinding%252BEnergy%252BAnalysis%26aulast%3DNunes-Alves%26aufirst%3DAriane%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04062021%26date%3D01072021%26volume%3D61%26issue%3D7%26spage%3D3708%26epage%3D3721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gavin W. Collie, Iacovos N. Michaelides, Kevin Embrey, Christopher J. Stubbs, Ulf Börjesson, Ian L. Dale, Arjan Snijder, Louise Barlind, Kun Song, Puneet Khurana, Christopher Phillips, <span class="NLM_string-name hlFld-ContribAuthor">R. Ian Storer</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Basis for Targeting the Folded P-Loop Conformation of c-MET. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 162-167. <a href="https://doi.org/10.1021/acsmedchemlett.0c00392" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00392%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252BBasis%252Bfor%252BTargeting%252Bthe%252BFolded%252BP-Loop%252BConformation%252Bof%252Bc-MET%26aulast%3DCollie%26aufirst%3DGavin%2BW.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D13072020%26date%3D30112020%26date%3D08122020%26volume%3D12%26issue%3D1%26spage%3D162%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Megan Egbert, Adrian Whitty, György M. Keserű, <span class="NLM_string-name hlFld-ContribAuthor">Sandor Vajda</span>. </span><span class="cited-content_cbyCitation_article-title">Why Some Targets Benefit from beyond Rule of Five Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10005-10025. <a href="https://doi.org/10.1021/acs.jmedchem.8b01732" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01732</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01732%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhy%252BSome%252BTargets%252BBenefit%252Bfrom%252Bbeyond%252BRule%252Bof%252BFive%252BDrugs%26aulast%3DEgbert%26aufirst%3DMegan%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13112018%26date%3D26062019%26date%3D12062019%26volume%3D62%26issue%3D22%26spage%3D10005%26epage%3D10025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christine E. Bowman, Rafael G. da Silva, Amber Pham, <span class="NLM_string-name hlFld-ContribAuthor">Stephen W. Young</span>. </span><span class="cited-content_cbyCitation_article-title">An Exceptionally Potent Inhibitor of Human CD73. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (31)
                                     , 3331-3334. <a href="https://doi.org/10.1021/acs.biochem.9b00448" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00448%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DAn%252BExceptionally%252BPotent%252BInhibitor%252Bof%252BHuman%252BCD73%26aulast%3DBowman%26aufirst%3DChristine%2BE.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21052019%26date%3D10072019%26date%3D23072019%26volume%3D58%26issue%3D31%26spage%3D3331%26epage%3D3334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanjeev Kumar, Jesse P. Waldo, Firoz A. Jaipuri, Agnieszka Marcinowicz, Clarissa Van Allen, James Adams, Tanay Kesharwani, Xiaoxia Zhang, Richard Metz, Angela J. Oh, Seth F. Harris, <span class="NLM_string-name hlFld-ContribAuthor">Mario R. Mautino</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6705-6733. <a href="https://doi.org/10.1021/acs.jmedchem.9b00662" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00662%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252B%2525281R%25252C4r%252529-4-%252528%252528R%252529-2-%252528%252528S%252529-6-Fluoro-5H-imidazo%25255B5%25252C1-a%25255Disoindol-5-yl%252529-1-hydroxyethyl%252529cyclohexan-1-ol%252B%252528Navoximod%252529%25252C%252Ba%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BIndoleamine%252B2%25252C3-Dioxygenase%252B1%26aulast%3DKumar%26aufirst%3DSanjeev%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D02072019%26date%3D18062019%26volume%3D62%26issue%3D14%26spage%3D6705%26epage%3D6733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yingchun Cai, Hongbin Yang, Weihua Li, Guixia Liu, Philip W. Lee, <span class="NLM_string-name hlFld-ContribAuthor">Yun Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Prediction of Site of Metabolism for UGT-Catalyzed Reactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (3)
                                     , 1085-1095. <a href="https://doi.org/10.1021/acs.jcim.8b00851" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00851%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BPrediction%252Bof%252BSite%252Bof%252BMetabolism%252Bfor%252BUGT-Catalyzed%252BReactions%26aulast%3DCai%26aufirst%3DYingchun%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D24112018%26date%3D10012019%26date%3D26122018%26volume%3D59%26issue%3D3%26spage%3D1085%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, <span class="NLM_string-name hlFld-ContribAuthor">Naomi S. Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9030-9058. <a href="https://doi.org/10.1021/acs.jmedchem.8b00667" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%25253A%252BRecent%252BAdvances%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D15062018%26date%3D05062018%26volume%3D61%26issue%3D20%26spage%3D9030%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Hemmerling</span>, <span class="hlFld-ContribAuthor ">Stinabritt  Nilsson</span>, <span class="hlFld-ContribAuthor ">Karl  Edman</span>, <span class="hlFld-ContribAuthor ">Stefan  Eirefelt</span>, <span class="hlFld-ContribAuthor ">Wayne  Russell</span>, <span class="hlFld-ContribAuthor ">Ramon  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Eskil  Johnsson</span>, <span class="hlFld-ContribAuthor ">Carina  Kärrman Mårdh</span>, <span class="hlFld-ContribAuthor ">Markus  Berger</span>, <span class="hlFld-ContribAuthor ">Hartmut  Rehwinkel</span>, <span class="hlFld-ContribAuthor ">Anna  Abrahamsson</span>, <span class="hlFld-ContribAuthor ">Jan  Dahmén</span>, <span class="hlFld-ContribAuthor ">Anders R.  Eriksson</span>, <span class="hlFld-ContribAuthor ">Balint  Gabos</span>, <span class="hlFld-ContribAuthor ">Krister  Henriksson</span>, <span class="hlFld-ContribAuthor ">Nafizal  Hossain</span>, <span class="hlFld-ContribAuthor ">Svetlana  Ivanova</span>, <span class="hlFld-ContribAuthor ">Anne-Helene  Jansson</span>, <span class="hlFld-ContribAuthor ">Tina J.  Jensen</span>, <span class="hlFld-ContribAuthor ">Anders  Jerre</span>, <span class="hlFld-ContribAuthor ">Henrik  Johansson</span>, <span class="hlFld-ContribAuthor ">Tomas  Klingstedt</span>, <span class="hlFld-ContribAuthor ">Matti  Lepistö</span>, <span class="hlFld-ContribAuthor ">Martin  Lindsjö</span>, <span class="hlFld-ContribAuthor ">Irene  Mile</span>, <span class="hlFld-ContribAuthor ">Grigorios  Nikitidis</span>, <span class="hlFld-ContribAuthor ">John  Steele</span>, <span class="hlFld-ContribAuthor ">Ulrika  Tehler</span>, <span class="hlFld-ContribAuthor ">Lisa  Wissler</span>, and <span class="hlFld-ContribAuthor ">Thomas  Hansson</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8591-8605. <a href="https://doi.org/10.1021/acs.jmedchem.7b01215" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BNonsteroidal%252BGlucocorticoid%252BReceptor%252BModulators%252Bfor%252Bthe%252BInhaled%252BTreatment%252Bof%252BPulmonary%252BDiseases%26aulast%3DHemmerling%26aufirst%3DMartin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18082017%26date%3D12102017%26date%3D26102017%26date%3D22092017%26volume%3D60%26issue%3D20%26spage%3D8591%26epage%3D8605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Komala  Pandurangan</span>, <span class="hlFld-ContribAuthor ">Anna B.  Aletti</span>, <span class="hlFld-ContribAuthor ">Devis  Montroni</span>, <span class="hlFld-ContribAuthor ">Jonathan. A.  Kitchen</span>, <span class="hlFld-ContribAuthor ">Miguel  Martínez-Calvo</span>, <span class="hlFld-ContribAuthor ">Salvador  Blasco</span>, <span class="hlFld-ContribAuthor ">Thorfinnur  Gunnlaugsson</span>, and <span class="hlFld-ContribAuthor ">Eoin M.  Scanlan</span>  . </span><span class="cited-content_cbyCitation_article-title">Supramolecular Anion Recognition Mediates One-Pot Synthesis of 3-Amino-[1,2,4]-triazolo Pyridines from Thiosemicarbazides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 1068-1071. <a href="https://doi.org/10.1021/acs.orglett.6b03645" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03645%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSupramolecular%252BAnion%252BRecognition%252BMediates%252BOne-Pot%252BSynthesis%252Bof%252B3-Amino-%25255B1%25252C2%25252C4%25255D-triazolo%252BPyridines%252Bfrom%252BThiosemicarbazides%26aulast%3DPandurangan%26aufirst%3DKomala%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10012017%26date%3D21022017%26date%3D03032017%26volume%3D19%26issue%3D5%26spage%3D1068%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Jones</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Yogesh A.  Sabnis</span>, <span class="hlFld-ContribAuthor ">Florian M.  Wakenhut</span>, <span class="hlFld-ContribAuthor ">Gavin A.  Whitlock</span>, <span class="hlFld-ContribAuthor ">Katherine S.  England</span>, <span class="hlFld-ContribAuthor ">Takasuke  Mukaiyama</span>, <span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Jotham W.  Coe</span>, <span class="hlFld-ContribAuthor ">Steve W.  Kortum</span>, <span class="hlFld-ContribAuthor ">Jill E.  Chrencik</span>, <span class="hlFld-ContribAuthor ">David G.  Brown</span>, <span class="hlFld-ContribAuthor ">Rhys M.  Jones</span>, <span class="hlFld-ContribAuthor ">John R.  Murphy</span>, <span class="hlFld-ContribAuthor ">Thean  Yeoh</span>, <span class="hlFld-ContribAuthor ">Paul  Morgan</span>, and <span class="hlFld-ContribAuthor ">Iain  Kilty</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 767-786. <a href="https://doi.org/10.1021/acs.jmedchem.6b01634" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BPan-Janus%252BKinase%252BInhibitor%252BClinical%252BCandidate%252B%252528PF-06263276%252529%252BSuitable%252Bfor%252BInhaled%252Band%252BTopical%252BDelivery%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDiseases%252Bof%252Bthe%252BLungs%252Band%252BSkin%26aulast%3DJones%26aufirst%3DPeter%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D08112016%26date%3D04012017%26date%3D26012017%26date%3D16122016%26volume%3D60%26issue%3D2%26spage%3D767%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart T.  Onions</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Ito</span>, <span class="hlFld-ContribAuthor ">Catherine E.  Charron</span>, <span class="hlFld-ContribAuthor ">Richard J.  Brown</span>, <span class="hlFld-ContribAuthor ">Marie  Colucci</span>, <span class="hlFld-ContribAuthor ">Fritz  Frickel</span>, <span class="hlFld-ContribAuthor ">George  Hardy</span>, <span class="hlFld-ContribAuthor ">Kevin  Joly</span>, <span class="hlFld-ContribAuthor ">John  King-Underwood</span>, <span class="hlFld-ContribAuthor ">Yasuo  Kizawa</span>, <span class="hlFld-ContribAuthor ">Ian  Knowles</span>, <span class="hlFld-ContribAuthor ">P. John  Murray</span>, <span class="hlFld-ContribAuthor ">Andrew  Novak</span>, <span class="hlFld-ContribAuthor ">Anjna  Rani</span>, <span class="hlFld-ContribAuthor ">Garth  Rapeport</span>, <span class="hlFld-ContribAuthor ">Alun  Smith</span>, <span class="hlFld-ContribAuthor ">Peter  Strong</span>, <span class="hlFld-ContribAuthor ">David M.  Taddei</span>, and <span class="hlFld-ContribAuthor ">Jonathan G.  Williams</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 1727-1746. <a href="https://doi.org/10.1021/acs.jmedchem.5b01029" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNarrow%252BSpectrum%252BKinase%252BInhibitors%25253A%252BNew%252BTherapeutic%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BCOPD%252Band%252BSteroid-Resistant%252BAsthma%26aulast%3DOnions%26aufirst%3DStuart%2BT.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D01072015%26date%3D04022016%26date%3D10032016%26date%3D22012016%26volume%3D59%26issue%3D5%26spage%3D1727%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Rudolph</span>, <span class="hlFld-ContribAuthor ">Yao  Xiao</span>, <span class="hlFld-ContribAuthor ">Arthur  Pardi</span>, and <span class="hlFld-ContribAuthor ">Natalie G.  Ahn</span>  . </span><span class="cited-content_cbyCitation_article-title">Slow Inhibition and Conformation Selective Properties of Extracellular Signal-Regulated Kinase 1 and 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2015,</strong> <em>54 </em>
                                    (1)
                                     , 22-31. <a href="https://doi.org/10.1021/bi501101v" title="DOI URL">https://doi.org/10.1021/bi501101v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi501101v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi501101v%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DSlow%252BInhibition%252Band%252BConformation%252BSelective%252BProperties%252Bof%252BExtracellular%252BSignal-Regulated%252BKinase%252B1%252Band%252B2%252BInhibitors%26aulast%3DRudolph%26aufirst%3DJohannes%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01092014%26date%3D23102014%26date%3D04122014%26date%3D13012015%26date%3D28102014%26volume%3D54%26issue%3D1%26spage%3D22%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary K.  Newton</span>, <span class="hlFld-ContribAuthor ">Trevor R.  Perrior</span>, <span class="hlFld-ContribAuthor ">Kerry  Jenkins</span>, <span class="hlFld-ContribAuthor ">Meriel R.  Major</span>, <span class="hlFld-ContribAuthor ">Rebekah E.  Key</span>, <span class="hlFld-ContribAuthor ">Mark R.  Stewart</span>, <span class="hlFld-ContribAuthor ">Stuart  Firth-Clark</span>, <span class="hlFld-ContribAuthor ">Steven M.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Jihui  Zhang</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Francis-Newton</span>, <span class="hlFld-ContribAuthor ">Jonathan P.  Richardson</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Pei  Lai</span>, <span class="hlFld-ContribAuthor ">David R.  Garrod</span>, and <span class="hlFld-ContribAuthor ">Clive  Robinson</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Potent, Selective, and Reversible Inhibitors of the House Dust Mite Peptidase Allergen Der p 1: An Innovative Approach to the Treatment of Allergic Asthma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9447-9462. <a href="https://doi.org/10.1021/jm501102h" title="DOI URL">https://doi.org/10.1021/jm501102h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501102h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501102h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BReversible%252BInhibitors%252Bof%252Bthe%252BHouse%252BDust%252BMite%252BPeptidase%252BAllergen%252BDer%252Bp%252B1%25253A%252BAn%252BInnovative%252BApproach%252Bto%252Bthe%252BTreatment%252Bof%252BAllergic%252BAsthma%26aulast%3DNewton%26aufirst%3DGary%2BK.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D15072014%26date%3D17112014%26date%3D26112014%26date%3D03112014%26volume%3D57%26issue%3D22%26spage%3D9447%26epage%3D9462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa M.  Madkour</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>. </span><span class="cited-content_cbyCitation_article-title">Current status and future prospects of p38α/MAPK14 kinase and its inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113216. <a href="https://doi.org/10.1016/j.ejmech.2021.113216" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113216%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bstatus%252Band%252Bfuture%252Bprospects%252Bof%252Bp38%2525CE%2525B1%25252FMAPK14%252Bkinase%252Band%252Bits%252Binhibitors%26aulast%3DMadkour%26aufirst%3DMoustafa%2BM.%26date%3D2021%26volume%3D213%26spage%3D113216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corrado  Pelaia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Vatrella</span>, <span class="hlFld-ContribAuthor ">Luca  Gallelli</span>, <span class="hlFld-ContribAuthor ">Nicola  Lombardo</span>, <span class="hlFld-ContribAuthor ">Angela  Sciacqua</span>, <span class="hlFld-ContribAuthor ">Rocco  Savino</span>, <span class="hlFld-ContribAuthor ">Girolamo  Pelaia</span>. </span><span class="cited-content_cbyCitation_article-title">Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2021,</strong> <em>Volume 15 </em>, 1275-1284. <a href="https://doi.org/10.2147/DDDT.S300988" title="DOI URL">https://doi.org/10.2147/DDDT.S300988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S300988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S300988%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3DRole%252Bof%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252Bin%252BAsthma%252Band%252BCOPD%25253A%252BPathogenic%252BAspects%252Band%252BPotential%252BTargeted%252BTherapies%26aulast%3DPelaia%26aufirst%3DCorrado%26date%3D2021%26date%3D2021%26volume%3DVolume%252015%26spage%3D1275%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Raubo</span>, <span class="hlFld-ContribAuthor ">Richard  Evans</span>, <span class="hlFld-ContribAuthor ">Paul  Willis</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (18)
                                     , 127412. <a href="https://doi.org/10.1016/j.bmcl.2020.127412" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127412%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Bevaluation%252Bof%252B3-amino-2%2525281H%252529-pyrazinones%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252Bselective%252Bp38%2525CE%2525B1%252BMAP%252Bkinase%252Binhibitors%26aulast%3DRaubo%26aufirst%3DPiotr%26date%3D2020%26volume%3D30%26issue%3D18%26spage%3D127412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Özal  MUTLU</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesiosis and theileriosis. </span><span class="cited-content_cbyCitation_journal-name">TURKISH JOURNAL OF VETERINARY AND ANIMAL SCIENCES</span><span> <strong>2020,</strong> <em>44 </em>
                                    (3)
                                     , 702-713. <a href="https://doi.org/10.3906/vet-2002-20" title="DOI URL">https://doi.org/10.3906/vet-2002-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3906/vet-2002-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3906%2Fvet-2002-20%26sid%3Dliteratum%253Aachs%26jtitle%3DTURKISH%2520JOURNAL%2520OF%2520VETERINARY%2520AND%2520ANIMAL%2520SCIENCES%26atitle%3DAssessment%252Bof%252Bmitogen-activated%252Bprotein%252Bkinases%252Bas%252Btherapeutic%252Btargets%252Bfor%252Bthe%252Btreatment%252Bof%252Bbabesiosis%252Band%252Btheileriosis%26aulast%3DMUTLU%26aufirst%3D%25C3%2596zal%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D3%26spage%3D702%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Marenghi</span>, <span class="hlFld-ContribAuthor ">Adryana Rocha  Clementino</span>, <span class="hlFld-ContribAuthor ">Alessandro  Fioni</span>, <span class="hlFld-ContribAuthor ">Francesca  Buttini</span>, <span class="hlFld-ContribAuthor ">Fabio  Sonvico</span>. </span><span class="cited-content_cbyCitation_article-title">Pulmonary delivery of a p38 α/β MAP kinase inhibitor: bioanalytical method validation and biodistribution in rat plasma and respiratory tissues. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>149 </em>, 105341. <a href="https://doi.org/10.1016/j.ejps.2020.105341" title="DOI URL">https://doi.org/10.1016/j.ejps.2020.105341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2020.105341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2020.105341%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPulmonary%252Bdelivery%252Bof%252Ba%252Bp38%252B%2525CE%2525B1%25252F%2525CE%2525B2%252BMAP%252Bkinase%252Binhibitor%25253A%252Bbioanalytical%252Bmethod%252Bvalidation%252Band%252Bbiodistribution%252Bin%252Brat%252Bplasma%252Band%252Brespiratory%252Btissues%26aulast%3DMarenghi%26aufirst%3DGiulia%26date%3D2020%26volume%3D149%26spage%3D105341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Yaoyao  Wang</span>, <span class="hlFld-ContribAuthor ">Minggui  Shen</span>, <span class="hlFld-ContribAuthor ">Shubai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Photocatalyzed synthesis of unsymmetrical ureas via the oxidative decarboxylation of oxamic acids with PANI-g-C3N4-TiO2 composite under visible light. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (23)
                                     , 151962. <a href="https://doi.org/10.1016/j.tetlet.2020.151962" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151962%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPhotocatalyzed%252Bsynthesis%252Bof%252Bunsymmetrical%252Bureas%252Bvia%252Bthe%252Boxidative%252Bdecarboxylation%252Bof%252Boxamic%252Bacids%252Bwith%252BPANI-g-C3N4-TiO2%252Bcomposite%252Bunder%252Bvisible%252Blight%26aulast%3DWang%26aufirst%3DLiang%26date%3D2020%26volume%3D61%26issue%3D23%26spage%3D151962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corrado  Pelaia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Vatrella</span>, <span class="hlFld-ContribAuthor ">Angela  Sciacqua</span>, <span class="hlFld-ContribAuthor ">Rosa  Terracciano</span>, <span class="hlFld-ContribAuthor ">Girolamo  Pelaia</span>. </span><span class="cited-content_cbyCitation_article-title">Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Respiratory Medicine</span><span> <strong>2020,</strong> <em>14 </em>
                                    (5)
                                     , 485-491. <a href="https://doi.org/10.1080/17476348.2020.1732821" title="DOI URL">https://doi.org/10.1080/17476348.2020.1732821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17476348.2020.1732821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17476348.2020.1732821%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Respiratory%2520Medicine%26atitle%3DRole%252Bof%252Bp38-mitogen-activated%252Bprotein%252Bkinase%252Bin%252BCOPD%25253A%252Bpathobiological%252Bimplications%252Band%252Btherapeutic%252Bperspectives%26aulast%3DPelaia%26aufirst%3DCorrado%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D5%26spage%3D485%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuheng  Huang</span>, <span class="hlFld-ContribAuthor ">Linxin  Chen</span>, <span class="hlFld-ContribAuthor ">Hu  Mei</span>, <span class="hlFld-ContribAuthor ">Duo  Zhang</span>, <span class="hlFld-ContribAuthor ">Tingting  Shi</span>, <span class="hlFld-ContribAuthor ">Zuyin  Kuang</span>, <span class="hlFld-ContribAuthor ">Yu  Heng</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Xianchao  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Prediction of the Dissociation Rate Constants of Small Chemical Ligands by 3D-Grid-Based VolSurf Method. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (7)
                                     , 2456. <a href="https://doi.org/10.3390/ijms21072456" title="DOI URL">https://doi.org/10.3390/ijms21072456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21072456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21072456%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIn%252BSilico%252BPrediction%252Bof%252Bthe%252BDissociation%252BRate%252BConstants%252Bof%252BSmall%252BChemical%252BLigands%252Bby%252B3D-Grid-Based%252BVolSurf%252BMethod%26aulast%3DHuang%26aufirst%3DShuheng%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D7%26spage%3D2456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Christopher  Phillips</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Structural, Thermodynamic, and Kinetic Information to Drive Hit‐to‐Lead Progression. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 99-124. <a href="https://doi.org/10.1002/9781118681121.ch5" title="DOI URL">https://doi.org/10.1002/9781118681121.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118681121.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118681121.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DCombining%252BStructural%25252C%252BThermodynamic%25252C%252Band%252BKinetic%252BInformation%252Bto%252BDrive%252BHit%2525E2%252580%252590to%2525E2%252580%252590Lead%252BProgression%26aulast%3DHoldgate%26aufirst%3DGeoffrey%2BA.%26date%3D2020%26date%3D2020%26spage%3D99%26epage%3D124%26pub%3DWiley%26atitle%3DStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DRenaud%26aufirst%3DJean%25E2%2580%2590Paul%26date%3D2020%26date%3D2020%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Naomi S.  Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Inhaled Janus Kinase (JAK) inhibitors for the treatment of asthma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126658. <a href="https://doi.org/10.1016/j.bmcl.2019.126658" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126658%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhaled%252BJanus%252BKinase%252B%252528JAK%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Cornelis E.C.A.  Hop</span>, <span class="hlFld-ContribAuthor ">Gabriela  Patilea-Vrana</span>, <span class="hlFld-ContribAuthor ">Gautham  Gampa</span>, <span class="hlFld-ContribAuthor ">Herana Kamal  Seneviratne</span>, <span class="hlFld-ContribAuthor ">Jashvant D.  Unadkat</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Karthik  Nagapudi</span>, <span class="hlFld-ContribAuthor ">Li  Di</span>, <span class="hlFld-ContribAuthor ">Lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Wright</span>, <span class="hlFld-ContribAuthor ">Namandjé N.  Bumpus</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Yurong  Lai</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule–Related Therapeutic Modalities. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2019,</strong> <em>47 </em>
                                    (10)
                                     , 1122-1135. <a href="https://doi.org/10.1124/dmd.119.086744" title="DOI URL">https://doi.org/10.1124/dmd.119.086744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.119.086744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.119.086744%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DDrug%252BConcentration%252BAsymmetry%252Bin%252BTissues%252Band%252BPlasma%252Bfor%252BSmall%252BMolecule%2525E2%252580%252593Related%252BTherapeutic%252BModalities%26aulast%3DZhang%26aufirst%3DDonglu%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D10%26spage%3D1122%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy C.  Burton</span>, <span class="hlFld-ContribAuthor ">Neil J.  Grimsey</span>. </span><span class="cited-content_cbyCitation_article-title">Ubiquitination as a Key Regulator of Endosomal Signaling by GPCRs. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2019,</strong> <em>7 </em><a href="https://doi.org/10.3389/fcell.2019.00043" title="DOI URL">https://doi.org/10.3389/fcell.2019.00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2019.00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2019.00043%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DUbiquitination%252Bas%252Ba%252BKey%252BRegulator%252Bof%252BEndosomal%252BSignaling%252Bby%252BGPCRs%26aulast%3DBurton%26aufirst%3DJeremy%2BC.%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duo  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuheng  Huang</span>, <span class="hlFld-ContribAuthor ">Hu  Mei</span>, <span class="hlFld-ContribAuthor ">MuliadiYeremia  Kevin</span>, <span class="hlFld-ContribAuthor ">Tingting  Shi</span>, <span class="hlFld-ContribAuthor ">Linxin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Protein–ligand interaction fingerprints for accurate prediction of dissociation rates of p38 MAPK Type II inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Integrative Biology</span><span> <strong>2019,</strong> <em>11 </em>
                                    (2)
                                     , 53-60. <a href="https://doi.org/10.1093/intbio/zyz004" title="DOI URL">https://doi.org/10.1093/intbio/zyz004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/intbio/zyz004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fintbio%2Fzyz004%26sid%3Dliteratum%253Aachs%26jtitle%3DIntegrative%2520Biology%26atitle%3DProtein%2525E2%252580%252593ligand%252Binteraction%252Bfingerprints%252Bfor%252Baccurate%252Bprediction%252Bof%252Bdissociation%252Brates%252Bof%252Bp38%252BMAPK%252BType%252BII%252Binhibitors%26aulast%3DZhang%26aufirst%3DDuo%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D2%26spage%3D53%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Guiqing  Li</span>, <span class="hlFld-ContribAuthor ">Shuliang  Min</span>, <span class="hlFld-ContribAuthor ">Fangyuan  Xiang</span>, <span class="hlFld-ContribAuthor ">Shiqi  Liu</span>, <span class="hlFld-ContribAuthor ">Waigang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Pd/C-Catalyzed Domino Synthesis of Urea Derivatives Using Chloroform as the Carbon Monoxide Source in Water. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (23)
                                     , 4585-4593. <a href="https://doi.org/10.1002/adsc.201800954" title="DOI URL">https://doi.org/10.1002/adsc.201800954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800954%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DPd%25252FC-Catalyzed%252BDomino%252BSynthesis%252Bof%252BUrea%252BDerivatives%252BUsing%252BChloroform%252Bas%252Bthe%252BCarbon%252BMonoxide%252BSource%252Bin%252BWater%26aulast%3DWang%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D23%26spage%3D4585%26epage%3D4593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ju Hee  Lee</span>, <span class="hlFld-ContribAuthor ">Dong Suk  Min</span>, <span class="hlFld-ContribAuthor ">Chan Woo  Lee</span>, <span class="hlFld-ContribAuthor ">Kwang Ho  Song</span>, <span class="hlFld-ContribAuthor ">Yeong Shik  Kim</span>, <span class="hlFld-ContribAuthor ">Hyun Pyo  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Ginsenosides from Korean Red Ginseng ameliorate lung inflammatory responses: inhibition of the MAPKs/NF-κB/c-Fos pathways. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ginseng Research</span><span> <strong>2018,</strong> <em>42 </em>
                                    (4)
                                     , 476-484. <a href="https://doi.org/10.1016/j.jgr.2017.05.005" title="DOI URL">https://doi.org/10.1016/j.jgr.2017.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jgr.2017.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jgr.2017.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ginseng%2520Research%26atitle%3DGinsenosides%252Bfrom%252BKorean%252BRed%252BGinseng%252Bameliorate%252Blung%252Binflammatory%252Bresponses%25253A%252Binhibition%252Bof%252Bthe%252BMAPKs%25252FNF-%2525CE%2525BAB%25252Fc-Fos%252Bpathways%26aulast%3DLee%26aufirst%3DJu%2BHee%26date%3D2018%26volume%3D42%26issue%3D4%26spage%3D476%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shufeng  Jiao</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Qiongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of fused 3-amino-1,2,4-triazoles via sequential addition of aryl hydrazines to isothiocyanates and I 2 -mediated cyclodesulfurization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (24)
                                     , 3069-3073. <a href="https://doi.org/10.1016/j.tet.2018.05.009" title="DOI URL">https://doi.org/10.1016/j.tet.2018.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bfused%252B3-amino-1%25252C2%25252C4-triazoles%252Bvia%252Bsequential%252Baddition%252Bof%252Baryl%252Bhydrazines%252Bto%252Bisothiocyanates%252Band%252BI%252B2%252B-mediated%252Bcyclodesulfurization%26aulast%3DJiao%26aufirst%3DShufeng%26date%3D2018%26volume%3D74%26issue%3D24%26spage%3D3069%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">So Ri  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic Therapies for Severe Asthma. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 99-122. <a href="https://doi.org/10.1007/978-981-10-1998-2_6" title="DOI URL">https://doi.org/10.1007/978-981-10-1998-2_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-1998-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-1998-2_6%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacologic%252BTherapies%252Bfor%252BSevere%252BAsthma%26aulast%3DKim%26aufirst%3DSo%2BRi%26date%3D2018%26date%3D2017%26spage%3D99%26epage%3D122%26pub%3DSpringer%2520Singapore%26atitle%3DSevere%252BAsthma%26aulast%3DLee%26aufirst%3DYong%2BChul%26date%3D2018%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Bistrović</span>, <span class="hlFld-ContribAuthor ">Luka  Krstulović</span>, <span class="hlFld-ContribAuthor ">Anja  Harej</span>, <span class="hlFld-ContribAuthor ">Petra  Grbčić</span>, <span class="hlFld-ContribAuthor ">Mirela  Sedić</span>, <span class="hlFld-ContribAuthor ">Sanja  Koštrun</span>, <span class="hlFld-ContribAuthor ">Sandra Kraljević  Pavelić</span>, <span class="hlFld-ContribAuthor ">Miroslav  Bajić</span>, <span class="hlFld-ContribAuthor ">Silvana  Raić-Malić</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1616-1634. <a href="https://doi.org/10.1016/j.ejmech.2017.10.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzimidazole%252Bamidines%252Bas%252Bpotent%252Bmulti-target%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DBistrovi%25C4%2587%26aufirst%3DAndrea%26date%3D2018%26volume%3D143%26spage%3D1616%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MirHojjat  Khorasanizadeh</span>, <span class="hlFld-ContribAuthor ">Mahsa  Eskian</span>, <span class="hlFld-ContribAuthor ">Erwin W.  Gelfand</span>, <span class="hlFld-ContribAuthor ">Nima  Rezaei</span>. </span><span class="cited-content_cbyCitation_article-title">Mitogen-activated protein kinases as therapeutic targets for asthma. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2017,</strong> <em>174 </em>, 112-126. <a href="https://doi.org/10.1016/j.pharmthera.2017.02.024" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.02.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.02.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.02.024%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DMitogen-activated%252Bprotein%252Bkinases%252Bas%252Btherapeutic%252Btargets%252Bfor%252Basthma%26aulast%3DKhorasanizadeh%26aufirst%3DMirHojjat%26date%3D2017%26volume%3D174%26spage%3D112%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Mark E.  Bunnage</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of chemogenomic library screening in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2017,</strong> <em>16 </em>
                                    (4)
                                     , 285-296. <a href="https://doi.org/10.1038/nrd.2016.244" title="DOI URL">https://doi.org/10.1038/nrd.2016.244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2016.244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2016.244%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DApplications%252Bof%252Bchemogenomic%252Blibrary%252Bscreening%252Bin%252Bdrug%252Bdiscovery%26aulast%3DJones%26aufirst%3DLyn%2BH.%26date%3D2017%26date%3D2017%26volume%3D16%26issue%3D4%26spage%3D285%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasuhiro  Yamauchi</span>, <span class="hlFld-ContribAuthor ">Takahide  Nagase</span>. </span><span class="cited-content_cbyCitation_article-title">New Anti-inflammatory Drugs for COPD: Is There a Possibility of Developing Drugs That Can Fundamentally Suppress Inflammation?. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 267-278. <a href="https://doi.org/10.1007/978-981-10-0839-9_14" title="DOI URL">https://doi.org/10.1007/978-981-10-0839-9_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-0839-9_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-0839-9_14%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BAnti-inflammatory%252BDrugs%252Bfor%252BCOPD%25253A%252BIs%252BThere%252Ba%252BPossibility%252Bof%252BDeveloping%252BDrugs%252BThat%252BCan%252BFundamentally%252BSuppress%252BInflammation%25253F%26aulast%3DYamauchi%26aufirst%3DYasuhiro%26date%3D2017%26date%3D2016%26spage%3D267%26epage%3D278%26pub%3DSpringer%2520Singapore%26atitle%3DChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DNakamura%26aufirst%3DHiroyuki%26date%3D2017%26volume%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Xing</span>, <span class="hlFld-ContribAuthor ">J.  Mathias</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Case History: Structure-Based Drug Design of Oral and Inhaled p38 MAP Kinase Inhibitors as Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-430. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12458-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12458-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12458-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12458-8%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252BCase%252BHistory%25253A%252BStructure-Based%252BDrug%252BDesign%252Bof%252BOral%252Band%252BInhaled%252Bp38%252BMAP%252BKinase%252BInhibitors%252Bas%252BClinical%252BCandidates%26aulast%3DXing%26aufirst%3DL.%26date%3D2017%26spage%3D408%26epage%3D430%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeynep  Yurtsever</span>, <span class="hlFld-ContribAuthor ">Dhara A.  Patel</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Kober</span>, <span class="hlFld-ContribAuthor ">Alvin  Su</span>, <span class="hlFld-ContribAuthor ">Chantel A.  Miller</span>, <span class="hlFld-ContribAuthor ">Arthur G.  Romero</span>, <span class="hlFld-ContribAuthor ">Michael J.  Holtzman</span>, <span class="hlFld-ContribAuthor ">Tom J.  Brett</span>. </span><span class="cited-content_cbyCitation_article-title">First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2016,</strong> <em>1860 </em>
                                    (11)
                                     , 2335-2344. <a href="https://doi.org/10.1016/j.bbagen.2016.06.023" title="DOI URL">https://doi.org/10.1016/j.bbagen.2016.06.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2016.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2016.06.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DFirst%252Bcomprehensive%252Bstructural%252Band%252Bbiophysical%252Banalysis%252Bof%252BMAPK13%252Binhibitors%252Btargeting%252BDFG-in%252Band%252BDFG-out%252Bbinding%252Bmodes%26aulast%3DYurtsever%26aufirst%3DZeynep%26date%3D2016%26volume%3D1860%26issue%3D11%26spage%3D2335%26epage%3D2344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Ding</span>, <span class="hlFld-ContribAuthor ">Ye  Fang</span>, <span class="hlFld-ContribAuthor ">Juana  Moreno</span>, <span class="hlFld-ContribAuthor ">J.  Ramanujam</span>, <span class="hlFld-ContribAuthor ">Mark  Jarrell</span>, <span class="hlFld-ContribAuthor ">Michal  Brylinski</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the similarity of ligand binding conformations with the Contact Mode Score. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2016,</strong> <em>64 </em>, 403-413. <a href="https://doi.org/10.1016/j.compbiolchem.2016.08.007" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2016.08.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2016.08.007%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DAssessing%252Bthe%252Bsimilarity%252Bof%252Bligand%252Bbinding%252Bconformations%252Bwith%252Bthe%252BContact%252BMode%252BScore%26aulast%3DDing%26aufirst%3DYun%26date%3D2016%26volume%3D64%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Barnes</span>, . </span><span class="cited-content_cbyCitation_article-title">Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2016,</strong> <em>68 </em>
                                    (3)
                                     , 788-815. <a href="https://doi.org/10.1124/pr.116.012518" title="DOI URL">https://doi.org/10.1124/pr.116.012518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.116.012518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.116.012518%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DKinases%252Bas%252BNovel%252BTherapeutic%252BTargets%252Bin%252BAsthma%252Band%252BChronic%252BObstructive%252BPulmonary%252BDisease%26aulast%3DBarnes%26aufirst%3DPeter%2BJ.%26date%3D2016%26date%3D2016%26volume%3D68%26issue%3D3%26spage%3D788%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dianxi  Zhu</span>, <span class="hlFld-ContribAuthor ">Qifeng  Xing</span>, <span class="hlFld-ContribAuthor ">Ruiyuan  Cao</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and p38 Inhibitory Activity of Some Novel Substituted N,N′-Diarylurea Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (5)
                                     , 677. <a href="https://doi.org/10.3390/molecules21050677" title="DOI URL">https://doi.org/10.3390/molecules21050677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21050677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21050677%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252Bp38%252BInhibitory%252BActivity%252Bof%252BSome%252BNovel%252BSubstituted%252BN%25252CN%2525E2%252580%2525B2-Diarylurea%252BDerivatives%26aulast%3DZhu%26aufirst%3DDianxi%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D5%26spage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Yang</span>, <span class="hlFld-ContribAuthor ">Peng  Cao</span>, <span class="hlFld-ContribAuthor ">Yang  Gao</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Wen  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Differential expression of p38 MAPK α, β, γ, δ isoforms in nucleus pulposus modulates macrophage polarization in intervertebral disc degeneration. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep22182" title="DOI URL">https://doi.org/10.1038/srep22182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep22182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep22182%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDifferential%252Bexpression%252Bof%252Bp38%252BMAPK%252B%2525CE%2525B1%25252C%252B%2525CE%2525B2%25252C%252B%2525CE%2525B3%25252C%252B%2525CE%2525B4%252Bisoforms%252Bin%252Bnucleus%252Bpulposus%252Bmodulates%252Bmacrophage%252Bpolarization%252Bin%252Bintervertebral%252Bdisc%252Bdegeneration%26aulast%3DYang%26aufirst%3DChen%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Fallica</span>, <span class="hlFld-ContribAuthor ">Lidenys  Varela</span>, <span class="hlFld-ContribAuthor ">Laura  Johnston</span>, <span class="hlFld-ContribAuthor ">Bo  Kim</span>, <span class="hlFld-ContribAuthor ">Leonid  Serebreni</span>, <span class="hlFld-ContribAuthor ">Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Mahendra  Damarla</span>, <span class="hlFld-ContribAuthor ">Todd M.  Kolb</span>, <span class="hlFld-ContribAuthor ">Paul M.  Hassoun</span>, <span class="hlFld-ContribAuthor ">Rachel  Damico</span>. </span><span class="cited-content_cbyCitation_article-title">Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1–p38–Xanthine Oxidoreductase–Dependent Cigarette Smoke–Induced Apoptosis. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Respiratory Cell and Molecular Biology</span><span> <strong>2016,</strong> <em>54 </em>
                                    (4)
                                     , 504-514. <a href="https://doi.org/10.1165/rcmb.2014-0403OC" title="DOI URL">https://doi.org/10.1165/rcmb.2014-0403OC</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1165/rcmb.2014-0403OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1165%2Frcmb.2014-0403OC%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Respiratory%2520Cell%2520and%2520Molecular%2520Biology%26atitle%3DMacrophage%252BMigration%252BInhibitory%252BFactor%25253A%252BA%252BNovel%252BInhibitor%252Bof%252BApoptosis%252BSignal-Regulating%252BKinase%252B1%2525E2%252580%252593p38%2525E2%252580%252593Xanthine%252BOxidoreductase%2525E2%252580%252593Dependent%252BCigarette%252BSmoke%2525E2%252580%252593Induced%252BApoptosis%26aulast%3DFallica%26aufirst%3DJonathan%26date%3D2016%26volume%3D54%26issue%3D4%26spage%3D504%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.T.  Fyfe</span>. </span><span class="cited-content_cbyCitation_article-title">Non-systemic Intestine-Targeted Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-44. <a href="https://doi.org/10.1016/bs.pmch.2015.10.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2015.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DNon-systemic%252BIntestine-Targeted%252BDrugs%26aulast%3DFyfe%26aufirst%3DMatthew%2BC.T.%26date%3D2016%26spage%3D1%26epage%3D44%26pub%3DElsevier%26date%3D2016%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandria P.  Taylor</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Yvette M.  Fobian</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Olugbeminiyi  Fadeyi</span>. </span><span class="cited-content_cbyCitation_article-title">Modern advances in heterocyclic chemistry in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (28)
                                     , 6611-6637. <a href="https://doi.org/10.1039/C6OB00936K" title="DOI URL">https://doi.org/10.1039/C6OB00936K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00936K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00936K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DModern%252Badvances%252Bin%252Bheterocyclic%252Bchemistry%252Bin%252Bdrug%252Bdiscovery%26aulast%3DTaylor%26aufirst%3DAlexandria%2BP.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D28%26spage%3D6611%26epage%3D6637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Barnes</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Allergy and Clinical Immunology</span><span> <strong>2015,</strong> <em>136 </em>
                                    (3)
                                     , 531-545. <a href="https://doi.org/10.1016/j.jaci.2015.05.052" title="DOI URL">https://doi.org/10.1016/j.jaci.2015.05.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaci.2015.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaci.2015.05.052%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Allergy%2520and%2520Clinical%2520Immunology%26atitle%3DTherapeutic%252Bapproaches%252Bto%252Basthma%2525E2%252580%252593chronic%252Bobstructive%252Bpulmonary%252Bdisease%252Boverlap%252Bsyndromes%26aulast%3DBarnes%26aufirst%3DPeter%2BJ.%26date%3D2015%26volume%3D136%26issue%3D3%26spage%3D531%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dianxi  Zhu</span>, <span class="hlFld-ContribAuthor ">Xingzhou  Li</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel Substituted N,N′-Diaryl ureas as Potent p38 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (9)
                                     , 16604-16619. <a href="https://doi.org/10.3390/molecules200916604" title="DOI URL">https://doi.org/10.3390/molecules200916604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200916604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200916604%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BSubstituted%252BN%25252CN%2525E2%252580%2525B2-Diaryl%252Bureas%252Bas%252BPotent%252Bp38%252BInhibitors%26aulast%3DZhu%26aufirst%3DDianxi%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D9%26spage%3D16604%26epage%3D16619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Waring</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Duncan C.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the Medicinal Chemical Optimization of Binding Kinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 191-210. <a href="https://doi.org/10.1002/9783527673025.ch10" title="DOI URL">https://doi.org/10.1002/9783527673025.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527673025.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527673025.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DChallenges%252Bin%252Bthe%252BMedicinal%252BChemical%252BOptimization%252Bof%252BBinding%252BKinetics%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2015%26date%3D2015%26spage%3D191%26epage%3D210%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DThermodynamics%252Band%252BKinetics%252Bof%252BDrug%252BBinding%26aulast%3DKeser%25C3%25BC%26aufirst%3DGy%25C3%25B6rgy%2BM.%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grant K  Walkup</span>, <span class="hlFld-ContribAuthor ">Zhiping  You</span>, <span class="hlFld-ContribAuthor ">Philip L  Ross</span>, <span class="hlFld-ContribAuthor ">Eleanor K H  Allen</span>, <span class="hlFld-ContribAuthor ">Fereidoon  Daryaee</span>, <span class="hlFld-ContribAuthor ">Michael R  Hale</span>, <span class="hlFld-ContribAuthor ">John  O'Donnell</span>, <span class="hlFld-ContribAuthor ">David E  Ehmann</span>, <span class="hlFld-ContribAuthor ">Virna J A  Schuck</span>, <span class="hlFld-ContribAuthor ">Ed T  Buurman</span>, <span class="hlFld-ContribAuthor ">Allison L  Choy</span>, <span class="hlFld-ContribAuthor ">Laurel  Hajec</span>, <span class="hlFld-ContribAuthor ">Kerry  Murphy-Benenato</span>, <span class="hlFld-ContribAuthor ">Valerie  Marone</span>, <span class="hlFld-ContribAuthor ">Sara A  Patey</span>, <span class="hlFld-ContribAuthor ">Lena A  Grosser</span>, <span class="hlFld-ContribAuthor ">Michele  Johnstone</span>, <span class="hlFld-ContribAuthor ">Stephen G  Walker</span>, <span class="hlFld-ContribAuthor ">Peter J  Tonge</span>, <span class="hlFld-ContribAuthor ">Stewart L  Fisher</span>. </span><span class="cited-content_cbyCitation_article-title">Translating slow-binding inhibition kinetics into cellular and in vivo effects. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (6)
                                     , 416-423. <a href="https://doi.org/10.1038/nchembio.1796" title="DOI URL">https://doi.org/10.1038/nchembio.1796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.1796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.1796%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DTranslating%252Bslow-binding%252Binhibition%252Bkinetics%252Binto%252Bcellular%252Band%252Bin%252Bvivo%252Beffects%26aulast%3DWalkup%26aufirst%3DGrant%2BK%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D6%26spage%3D416%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2015,</strong> <em>24 </em>
                                    (3)
                                     , 383-392. <a href="https://doi.org/10.1517/13543784.2015.1006358" title="DOI URL">https://doi.org/10.1517/13543784.2015.1006358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2015.1006358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2015.1006358%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DInvestigational%252Bp38%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2015%26date%3D2015%26volume%3D24%26issue%3D3%26spage%3D383%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gino  Villetti</span>, <span class="hlFld-ContribAuthor ">Chiara  Carnini</span>, <span class="hlFld-ContribAuthor ">Loredana  Battipaglia</span>, <span class="hlFld-ContribAuthor ">Laurent  Preynat</span>, <span class="hlFld-ContribAuthor ">Pier Tonino  Bolzoni</span>, <span class="hlFld-ContribAuthor ">Franco  Bassani</span>, <span class="hlFld-ContribAuthor ">Paola  Caruso</span>, <span class="hlFld-ContribAuthor ">Marco  Bergamaschi</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Pisano</span>, <span class="hlFld-ContribAuthor ">Veronica  Puviani</span>, <span class="hlFld-ContribAuthor ">Fabio Franco  Stellari</span>, <span class="hlFld-ContribAuthor ">Valentina  Cenacchi</span>, <span class="hlFld-ContribAuthor ">Roberta  Volta</span>, <span class="hlFld-ContribAuthor ">Vittorio  Bertacche</span>, <span class="hlFld-ContribAuthor ">Valentina  Mileo</span>, <span class="hlFld-ContribAuthor ">Valentina  Bagnacani</span>, <span class="hlFld-ContribAuthor ">Elisa  Moretti</span>, <span class="hlFld-ContribAuthor ">Paola  Puccini</span>, <span class="hlFld-ContribAuthor ">Silvia  Catinella</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Facchinetti</span>, <span class="hlFld-ContribAuthor ">Angelo  Sala</span>, <span class="hlFld-ContribAuthor ">Maurizio  Civelli</span>. </span><span class="cited-content_cbyCitation_article-title">CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2015,</strong> <em>352 </em>
                                    (3)
                                     , 568-578. <a href="https://doi.org/10.1124/jpet.114.220558" title="DOI URL">https://doi.org/10.1124/jpet.114.220558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.220558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.220558%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCHF6001%252BII%25253A%252BA%252BNovel%252BPhosphodiesterase%252B4%252BInhibitor%25252C%252BSuitable%252Bfor%252BTopical%252BPulmonary%252BAdministration%2525E2%252580%252594In%252BVivo%252BPreclinical%252BPharmacology%252BProfile%252BDefines%252Ba%252BPotent%252BAnti-Inflammatory%252BCompound%252Bwith%252Ba%252BWide%252BTherapeutic%252BWindow%26aulast%3DVilletti%26aufirst%3DGino%26date%3D2015%26date%3D2015%26volume%3D352%26issue%3D3%26spage%3D568%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Di  Wang</span>, <span class="hlFld-ContribAuthor ">Nan  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Huang</span>, <span class="hlFld-ContribAuthor ">Jia-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-Mei  Jiang</span>, <span class="hlFld-ContribAuthor ">Ya-Zhou  He</span>, <span class="hlFld-ContribAuthor ">Yu-Lin  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of
              CYP1A1
              Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis. </span><span class="cited-content_cbyCitation_journal-name">BioMed Research International</span><span> <strong>2015,</strong> <em>2015 </em>, 1-9. <a href="https://doi.org/10.1155/2015/942958" title="DOI URL">https://doi.org/10.1155/2015/942958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/942958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F942958%26sid%3Dliteratum%253Aachs%26jtitle%3DBioMed%2520Research%2520International%26atitle%3DImpact%252Bof%252BCYP1A1%252BPolymorphisms%252Bon%252BSusceptibility%252Bto%252BChronic%252BObstructive%252BPulmonary%252BDisease%25253A%252BA%252BMeta-Analysis%26aulast%3DWang%26aufirst%3DCheng-Di%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iain  Kilty</span>, <span class="hlFld-ContribAuthor ">Lyn H  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1 selective inhibition: state of the art and future opportunities. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (1)
                                     , 23-33. <a href="https://doi.org/10.4155/fmc.14.138" title="DOI URL">https://doi.org/10.4155/fmc.14.138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.138%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTAK1%252Bselective%252Binhibition%25253A%252Bstate%252Bof%252Bthe%252Bart%252Band%252Bfuture%252Bopportunities%26aulast%3DKilty%26aufirst%3DIain%26date%3D2015%26volume%3D7%26issue%3D1%26spage%3D23%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katie E.  Baker</span>, <span class="hlFld-ContribAuthor ">Sara J.  Bonvini</span>, <span class="hlFld-ContribAuthor ">Chantal  Donovan</span>, <span class="hlFld-ContribAuthor ">Rachel E.  Foong</span>, <span class="hlFld-ContribAuthor ">Bing  Han</span>, <span class="hlFld-ContribAuthor ">Aruni  Jha</span>, <span class="hlFld-ContribAuthor ">Yasin  Shaifta</span>, <span class="hlFld-ContribAuthor ">Marieke  Smit</span>, <span class="hlFld-ContribAuthor ">Jill R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Lyn M.  Moir</span>. </span><span class="cited-content_cbyCitation_article-title">Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models. </span><span class="cited-content_cbyCitation_journal-name">Pulmonary Pharmacology & Therapeutics</span><span> <strong>2014,</strong> <em>29 </em>
                                    (2)
                                     , 181-198. <a href="https://doi.org/10.1016/j.pupt.2014.05.008" title="DOI URL">https://doi.org/10.1016/j.pupt.2014.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pupt.2014.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pupt.2014.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPulmonary%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DNovel%252Bdrug%252Btargets%252Bfor%252Basthma%252Band%252BCOPD%25253A%252BLessons%252Blearned%252Bfrom%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bmodels%26aulast%3DBaker%26aufirst%3DKatie%2BE.%26date%3D2014%26volume%3D29%26issue%3D2%26spage%3D181%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie A.  Tucker</span>, <span class="hlFld-ContribAuthor ">Tobias  Klein</span>, <span class="hlFld-ContribAuthor ">Jason  Breed</span>, <span class="hlFld-ContribAuthor ">Alexander L.  Breeze</span>, <span class="hlFld-ContribAuthor ">Ross  Overman</span>, <span class="hlFld-ContribAuthor ">Chris  Phillips</span>, <span class="hlFld-ContribAuthor ">Richard A.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights into FGFR Kinase Isoform Selectivity: Diverse Binding Modes of AZD4547 and Ponatinib in Complex with FGFR1 and FGFR4. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2014,</strong> <em>22 </em>
                                    (12)
                                     , 1764-1774. <a href="https://doi.org/10.1016/j.str.2014.09.019" title="DOI URL">https://doi.org/10.1016/j.str.2014.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2014.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2014.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DStructural%252BInsights%252Binto%252BFGFR%252BKinase%252BIsoform%252BSelectivity%25253A%252BDiverse%252BBinding%252BModes%252Bof%252BAZD4547%252Band%252BPonatinib%252Bin%252BComplex%252Bwith%252BFGFR1%252Band%252BFGFR4%26aulast%3DTucker%26aufirst%3DJulie%25C2%25A0A.%26date%3D2014%26volume%3D22%26issue%3D12%26spage%3D1764%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Respivert’s multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (12)
                                     , 1397-1407. <a href="https://doi.org/10.1517/13543776.2014.967213" title="DOI URL">https://doi.org/10.1517/13543776.2014.967213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.967213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.967213%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRespivert%2525E2%252580%252599s%252Bmultikinase%252Binhibitors%25252C%252Ban%252Bevaluation%252Bof%252BWO2014033446%252Bto%252BWO2014033449%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D12%26spage%3D1397%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Hasumi</span>, <span class="hlFld-ContribAuthor ">Shuichiro  Sato</span>, <span class="hlFld-ContribAuthor ">Takahisa  Saito</span>, <span class="hlFld-ContribAuthor ">Jun-ya  Kato</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Shirota</span>, <span class="hlFld-ContribAuthor ">Jun  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shuji  Ohta</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (15)
                                     , 4162-4176. <a href="https://doi.org/10.1016/j.bmc.2014.05.045" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B5-%25255B%2525282-chloro-6-fluorophenyl%252529acetylamino%25255D-3-%2525284-fluorophenyl%252529-4-%2525284-pyrimidinyl%252529isoxazole%252B%252528AKP-001%252529%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252Bp38%252BMAP%252Bkinase%252Bwith%252Breduced%252Bside%252Beffects%252Bbased%252Bon%252Bthe%252Bantedrug%252Bconcept%26aulast%3DHasumi%26aufirst%3DKoichi%26date%3D2014%26volume%3D22%26issue%3D15%26spage%3D4162%26epage%3D4176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Feng  He</span>, <span class="hlFld-ContribAuthor ">Georgianna G.  Sergakis</span>, <span class="hlFld-ContribAuthor ">Majid S.  Koozehchian</span>, <span class="hlFld-ContribAuthor ">Julia N.  Stimpfl</span>, <span class="hlFld-ContribAuthor ">Yi  Rong</span>, <span class="hlFld-ContribAuthor ">Philip T.  Diaz</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Best</span>. </span><span class="cited-content_cbyCitation_article-title">Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Lung Cellular and Molecular Physiology</span><span> <strong>2014,</strong> <em>307 </em>
                                    (3)
                                     , L205-L218. <a href="https://doi.org/10.1152/ajplung.00330.2013" title="DOI URL">https://doi.org/10.1152/ajplung.00330.2013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajplung.00330.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajplung.00330.2013%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Lung%2520Cellular%2520and%2520Molecular%2520Physiology%26atitle%3DInterrelated%252Brole%252Bof%252Bcigarette%252Bsmoking%25252C%252Boxidative%252Bstress%25252C%252Band%252Bimmune%252Bresponse%252Bin%252BCOPD%252Band%252Bcorresponding%252Btreatments%26aulast%3DZuo%26aufirst%3DLi%26date%3D2014%26volume%3D307%26issue%3D3%26spage%3DL205%26epage%3DL218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefanie  Bühler</span>, <span class="hlFld-ContribAuthor ">Stefan A  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">p38 MAPK inhibitors: a patent review (2012 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (5)
                                     , 535-554. <a href="https://doi.org/10.1517/13543776.2014.894977" title="DOI URL">https://doi.org/10.1517/13543776.2014.894977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.894977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.894977%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3Dp38%252BMAPK%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282012%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DB%25C3%25BChler%26aufirst%3DStefanie%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D5%26spage%3D535%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianlong  Peng</span>, <span class="hlFld-ContribAuthor ">Jing  Lu</span>, <span class="hlFld-ContribAuthor ">Qiancheng  Shen</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">In silico site of metabolism prediction for human UGT-catalyzed reactions. </span><span class="cited-content_cbyCitation_journal-name">Bioinformatics</span><span> <strong>2014,</strong> <em>30 </em>
                                    (3)
                                     , 398-405. <a href="https://doi.org/10.1093/bioinformatics/btt681" title="DOI URL">https://doi.org/10.1093/bioinformatics/btt681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bioinformatics/btt681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbioinformatics%2Fbtt681%26sid%3Dliteratum%253Aachs%26jtitle%3DBioinformatics%26atitle%3DIn%252Bsilico%252Bsite%252Bof%252Bmetabolism%252Bprediction%252Bfor%252Bhuman%252BUGT-catalyzed%252Breactions%26aulast%3DPeng%26aufirst%3DJianlong%26date%3D2014%26date%3D2013%26volume%3D30%26issue%3D3%26spage%3D398%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iain  Kilty</span>, <span class="hlFld-ContribAuthor ">Martin P.  Green</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Bell</span>, <span class="hlFld-ContribAuthor ">David G.  Brown</span>, <span class="hlFld-ContribAuthor ">Peter G.  Dodd</span>, <span class="hlFld-ContribAuthor ">Christopher  Hewson</span>, <span class="hlFld-ContribAuthor ">Samantha J.  Hughes</span>, <span class="hlFld-ContribAuthor ">Christopher  Phillips</span>, <span class="hlFld-ContribAuthor ">Thomas  Ryckmans</span>, <span class="hlFld-ContribAuthor ">Robert T.  Smith</span>, <span class="hlFld-ContribAuthor ">Willem P.  van Hoorn</span>, <span class="hlFld-ContribAuthor ">Philip  Cohen</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1 Inhibition in the DFG-Out Conformation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2013,</strong> <em>82 </em>
                                    (5)
                                     , 500-505. <a href="https://doi.org/10.1111/cbdd.12169" title="DOI URL">https://doi.org/10.1111/cbdd.12169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12169%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DTAK1%252BInhibition%252Bin%252Bthe%252BDFG-Out%252BConformation%26aulast%3DKilty%26aufirst%3DIain%26date%3D2013%26date%3D2013%26volume%3D82%26issue%3D5%26spage%3D500%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert C.  Pan</span>, <span class="hlFld-ContribAuthor ">David W.  Borhani</span>, <span class="hlFld-ContribAuthor ">Ron O.  Dror</span>, <span class="hlFld-ContribAuthor ">David E.  Shaw</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants of drug–receptor binding kinetics. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (13-14)
                                     , 667-673. <a href="https://doi.org/10.1016/j.drudis.2013.02.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DMolecular%252Bdeterminants%252Bof%252Bdrug%2525E2%252580%252593receptor%252Bbinding%252Bkinetics%26aulast%3DPan%26aufirst%3DAlbert%2BC.%26date%3D2013%26volume%3D18%26issue%3D13-14%26spage%3D667%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Barnes</span>. </span><span class="cited-content_cbyCitation_article-title">New anti-inflammatory targets for chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2013,</strong> <em>12 </em>
                                    (7)
                                     , 543-559. <a href="https://doi.org/10.1038/nrd4025" title="DOI URL">https://doi.org/10.1038/nrd4025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4025%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DNew%252Banti-inflammatory%252Btargets%252Bfor%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DBarnes%26aufirst%3DPeter%2BJ.%26date%3D2013%26date%3D2013%26volume%3D12%26issue%3D7%26spage%3D543%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurence  Josset</span>, <span class="hlFld-ContribAuthor ">Vineet D.  Menachery</span>, <span class="hlFld-ContribAuthor ">Lisa E.  Gralinski</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Agnihothram</span>, <span class="hlFld-ContribAuthor ">Pavel  Sova</span>, <span class="hlFld-ContribAuthor ">Victoria S.  Carter</span>, <span class="hlFld-ContribAuthor ">Boyd L.  Yount</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Graham</span>, <span class="hlFld-ContribAuthor ">Ralph S.  Baric</span>, <span class="hlFld-ContribAuthor ">Michael G.  Katze</span>, , . </span><span class="cited-content_cbyCitation_article-title">Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2013,</strong> <em>4 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/mBio.00165-13" title="DOI URL">https://doi.org/10.1128/mBio.00165-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.00165-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.00165-13%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DCell%252BHost%252BResponse%252Bto%252BInfection%252Bwith%252BNovel%252BHuman%252BCoronavirus%252BEMC%252BPredicts%252BPotential%252BAntivirals%252Band%252BImportant%252BDifferences%252Bwith%252BSARS%252BCoronavirus%26aulast%3DJosset%26aufirst%3DLaurence%26date%3D2013%26volume%3D4%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Chunlou  Sun</span>, <span class="hlFld-ContribAuthor ">Haixia  Shan</span>, <span class="hlFld-ContribAuthor ">Xiaoyuan  Zou</span>, <span class="hlFld-ContribAuthor ">Jianjiang  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">From Regioselective Condensation to Regioselective N-Alkylation: A Novel and Environmentally Benign Strategy for the Synthesis of
              N
              ,
              N
              ′-Alkyl Aryl Ureas and
              N
              ,
              N
              ′-Dialkyl Ureas. </span><span class="cited-content_cbyCitation_journal-name">ChemCatChem</span><span> <strong>2013,</strong> <em>5 </em>
                                    (6)
                                     , 1543-1552. <a href="https://doi.org/10.1002/cctc.201200648" title="DOI URL">https://doi.org/10.1002/cctc.201200648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cctc.201200648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcctc.201200648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemCatChem%26atitle%3DFrom%252BRegioselective%252BCondensation%252Bto%252BRegioselective%252BN-Alkylation%25253A%252BA%252BNovel%252Band%252BEnvironmentally%252BBenign%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-Alkyl%252BAryl%252BUreas%252Band%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-Dialkyl%252BUreas%26aulast%3DLi%26aufirst%3DFeng%26date%3D2013%26date%3D2013%26volume%3D5%26issue%3D6%26spage%3D1543%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anta  Ngkelo</span>, <span class="hlFld-ContribAuthor ">Ian M  Adcock</span>. </span><span class="cited-content_cbyCitation_article-title">New treatments for COPD. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2013,</strong> <em>13 </em>
                                    (3)
                                     , 362-369. <a href="https://doi.org/10.1016/j.coph.2013.03.014" title="DOI URL">https://doi.org/10.1016/j.coph.2013.03.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2013.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2013.03.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DNew%252Btreatments%252Bfor%252BCOPD%26aulast%3DNgkelo%26aufirst%3DAnta%26date%3D2013%26volume%3D13%26issue%3D3%26spage%3D362%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianne Jennifer  Ratcliffe</span>, <span class="hlFld-ContribAuthor ">Iain Gordon  Dougall</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages. </span><span class="cited-content_cbyCitation_journal-name">BMC Pharmacology and Toxicology</span><span> <strong>2012,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/2050-6511-13-15" title="DOI URL">https://doi.org/10.1186/2050-6511-13-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2050-6511-13-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2050-6511-13-15%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Pharmacology%2520and%2520Toxicology%26atitle%3DComparison%252Bof%252Bthe%252Banti-inflammatory%252Beffects%252Bof%252BCilomilast%25252C%252BBudesonide%252Band%252Ba%252Bp38%252BMitogen%252Bactivated%252Bprotein%252Bkinase%252Binhibitor%252Bin%252BCOPD%252Blung%252Btissue%252Bmacrophages%26aulast%3DRatcliffe%26aufirst%3DMarianne%2BJennifer%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katie  Ellard</span>, <span class="hlFld-ContribAuthor ">Mihiro  Sunose</span>, <span class="hlFld-ContribAuthor ">Kathryn  Bell</span>, <span class="hlFld-ContribAuthor ">Nigel  Ramsden</span>, <span class="hlFld-ContribAuthor ">Giovanna  Bergamini</span>, <span class="hlFld-ContribAuthor ">Gitte  Neubauer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (14)
                                     , 4546-4549. <a href="https://doi.org/10.1016/j.bmcl.2012.05.121" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BPI3K%2525CE%2525B3%25252F%2525CE%2525B4%252Binhibitors%252Bas%252Bpotential%252Bagents%252Bfor%252Binflammation%26aulast%3DEllard%26aufirst%3DKatie%26date%3D2012%26volume%3D22%26issue%3D14%26spage%3D4546%26epage%3D4549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Audreesh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Cynthia  Koziol-White</span>, <span class="hlFld-ContribAuthor ">Reynold  Panettieri</span>. </span><span class="cited-content_cbyCitation_article-title">p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2012,</strong> <em>12 </em>
                                    (3)
                                     , 287-292. <a href="https://doi.org/10.1016/j.coph.2012.01.016" title="DOI URL">https://doi.org/10.1016/j.coph.2012.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2012.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2012.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3Dp38%252BMAPK%252Binhibitors%25252C%252BIKK2%252Binhibitors%25252C%252Band%252BTNF%2525CE%2525B1%252Binhibitors%252Bin%252BCOPD%26aulast%3DBanerjee%26aufirst%3DAudreesh%26date%3D2012%26volume%3D12%26issue%3D3%26spage%3D287%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Gabriella  Matera</span>, <span class="hlFld-ContribAuthor ">Luigino  Calzetta</span>, <span class="hlFld-ContribAuthor ">Andrea  Segreti</span>, <span class="hlFld-ContribAuthor ">Mario  Cazzola</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging drugs for chronic obstructive pulmonary disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Emerging Drugs</span><span> <strong>2012,</strong> <em>17 </em>
                                    (1)
                                     , 61-82. <a href="https://doi.org/10.1517/14728214.2012.660917" title="DOI URL">https://doi.org/10.1517/14728214.2012.660917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728214.2012.660917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728214.2012.660917%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Emerging%2520Drugs%26atitle%3DEmerging%252Bdrugs%252Bfor%252Bchronic%252Bobstructive%252Bpulmonary%252Bdisease%26aulast%3DMatera%26aufirst%3DMaria%2BGabriella%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D1%26spage%3D61%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Retrosynthetic Strategy for Preparation of Target Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) <sup><i>i</i></sup>PrNEt<sub>2</sub>, MeSO<sub>2</sub>Cl, DCM, 0 °C, 2 h; (ii) MeSNa, MeOH, reflux, 17 h, 17%; (b) NaH, CH<sub>3</sub>CN, THF, reflux, 5 h, 58–81%; (c) arylhydrazine, conc HCl, EtOH, reflux, 6 h, 23–95%; (d) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 18–89%; (e) THPOCH<sub>2</sub>CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 4 h, 71%; (f) TBDMSCl, imidazole, DMF, room temp, 16 h, 17–93%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0016.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) <i>n</i>-BuLi, di-<i>tert</i>-butyl diazodicarboxylate, THF, −78 °C, 2 h, 50%; (b) 4 M HCl, 1,4-dioxane, room temp, 16 h, 60%; (c) (i) conc HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, −10 °C, 0.5 h, (ii) 6 N HCl, SnCl<sub>2</sub>, −10 °C, 3.5 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0017.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) EtOH, reflux, 1 h, 86–99%; (b) PhI(OAc)<sub>2</sub>, DCM, EtOH, room temp, 18 h, 68–88%; (c) 2-mercaptobenzyl alcohol, Pd(dppf)<sub>2</sub>Cl<sub>2</sub>, CsCO<sub>3</sub>, DMF, 90 °C, 2 h, 17–77%; (d) (i) (Ms)<sub>2</sub>O, DCM, room temp, 2 h, (ii) 7 N NH<sub>3</sub>/MeOH, room temp, 16 h, 38–98%; (e) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 51%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0018.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (BOC)<sub>2</sub>O, <sup><i>i</i></sup>PrNEt<sub>2</sub>, DMF, room temp, 72 h, 100%; (b) Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 70 °C, 16 h, 87%; (c) THPOCH<sub>2</sub>CH<sub>2</sub>Br, NaH, <i>N</i>-methylpyrrolidinone, 55 °C, 16 h, 55%; (d) 4 M HCl, 1,4-dioxane, room temp, 2 h, 95%.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0019.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, THF, reflux, 30 h, 92%.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0020.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) TBDMSOCH<sub>2</sub>CH<sub>2</sub>Br, NaH, DMF, room temp, 16 h, 81%; (b) (i) lithium aluminum hydride, THF, 0 °C → room temp, 16 h, 81%, (ii) Ba(MnO<sub>4</sub>)<sub>2</sub>, DCM, room temp, 24 h, (iii) MnO<sub>2</sub>, DCM, reflux, 16 h, 62%.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0021.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) CDI, DCM, room temp, 16 h, (ii) <b>2b</b>–<b>f</b>, <b>2h</b>, <sup><i>i</i></sup>PrNEt<sub>2</sub>, DCM, room temp, 1 h, 23–100%; (b) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 46–85%; (c) H<sub>2</sub>O<sub>2</sub>, 1,1,1,3,3,3-hexfluoropropan-2-ol, room temp, 0.5 h, 22–80%; (d) PTSA, MeOH, 60 °C, 3 h, 67%.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0022.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) PhO(CO)Cl, pyridine, THF, 0 °C → room temp, 1 h, 86–100%; (b) <sup><i>i</i></sup>PrNEt<sub>2</sub>, DMSO, room temp, 16 h, 23–96%; (c) THPOCH<sub>2</sub>CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 60 °C, 8 h, 75%; (d) triethylamine trihydrofluoride, MeOH, room temp, 16 h, 67–75%; (e) BBr<sub>3</sub>, DCM, 0 °C, 0.5 h, 35–49%; (f) H<sub>2</sub>O<sub>2</sub>, 1,1,1,3,3,3-hexfluoropropan-2-ol, room temp, 0.5 h, 70%; (g) PTSA, MeOH, 60 °C, 3 h, 50–62%.</p></p></figure><figure data-id="cht4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Chart 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0023.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=cht4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0024.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of <b>41</b> (carbon atoms colored green, derived from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yix">2yix</a>) in the protein DFG-out cocrystal structure of BIRB-796 (carbon atoms colored purple) in p38α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0025.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of <b>1a</b> (carbon atoms colored orange, derived from PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw">2yiw</a>) in the protein DFG-out cocrystal structure of BIRB-796 (carbon atoms colored purple) in p38α (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2">1kv2</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0026.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selectivity profiles of <b>41</b> and <b>1a</b> against a panel 45 kinases at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0027.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding site surface of <b>1a</b> in p38α cocrystal structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw">2yiw</a>). The region of <b>1a</b> highlighted in purple is binding into the pocket created by the DFG loop movement. Binding surface illustrates lipophilic surface (green/yellow), surface made up of hydrogen accepting oxygen atoms (red) and hydrogen donating atoms (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0004.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selectivity profile of <b>1f</b> against a panel of 29 kinases, showing % inhibition at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0007.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding site surface of <b>1ab</b> in p38α cocrystal structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yis">2yis</a>). The region of <b>1ab</b> highlighted in purple is binding into the pocket created by the DFG loop movement. Binding surface illustrates lipophilic surface (green/yellow), surface made up of hydrogen accepting oxygen atoms (red) and hydrogen donating atoms (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/medium/jm-2011-00677b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0008.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Dose dependent inhibition of LPS induced neutrophilia at 2 h predosing with <b>1ab</b> and (B) demonstration of in vivo duration of action of greater than 4 h based on predosing studies: ∗, <i>p</i> < 0.05; NS, not statistically significant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-22/jm200677b/production/images/large/jm-2011-00677b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200677b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Inflammatory cytokines: interleukin-1 and tumour necrosis factor as effector molecules in autoimmune diseases</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0952-7915%2805%2980018-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=1665333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=941-948&author=C.+A.+Dinarello&title=Inflammatory+cytokines%3A+interleukin-1+and+tumour+necrosis+factor+as+effector+molecules+in+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory cytokines:  interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</span></div><div class="casAuthors">Dinarello, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-8</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    </div><div class="casAbstract">The nature of the events that ppt. autoimmune diseases varies.  Interleukin-1 and tumor necrosis factor do not ppt. autoimmune diseases but rather act as effector mols.  They induce eicosanoid and NO synthesis, stimulate collagenases and collagen synthesis, and trigger the genes for other cytokines, namely interleukin-2, interleukin-6 and interleukin-8.  The ability to block interleukin-1 with the receptor antagonist, and tumor necrosis factor with sol. receptors, has given investigators specific tools to test the role of these two cytokines in the pathol. processes of autoimmune disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhF6Z-Gd_1RrVg90H21EOLACvtfcHk0lguZUm8ASNwyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1ChtLs%253D&md5=9124ac01336892ed242ed4583f14b4c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2805%2980018-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252805%252980018-4%26sid%3Dliteratum%253Aachs%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DInflammatory%2520cytokines%253A%2520interleukin-1%2520and%2520tumour%2520necrosis%2520factor%2520as%2520effector%2520molecules%2520in%2520autoimmune%2520diseases%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1991%26volume%3D3%26spage%3D941%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A. A.</span><span> </span><span class="NLM_article-title">Pharmalogical treatment of established rheumatoid arthritis</span> <span class="citation_source-journal">Best Pract. Res., Clim. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS1521-6942%2803%2900048-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=12915159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1WqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=811-829&author=S.+J.+Leeauthor=A.+A.+Kavanaugh&title=Pharmalogical+treatment+of+established+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological treatment of established rheumatoid arthritis</span></div><div class="casAuthors">Lee, Susan Jung-Ah; Kavanaugh, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Rheumatology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">811-829</span>CODEN:
                <span class="NLM_cas:coden">BPRCC7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA) is a chronic, inflammatory condition of unknown etiol. that affects about 1% of the general population.  Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone of treatment for established RA.  The current therapeutic model encourages a step-up approach that safely incorporates several currently available classes of agents: non-steroidal anti-inflammatory drugs, selective cyclo-oxygenase-2 inhibitors, glucocorticoids, disease-modifying anti-rheumatic drugs, and biol. agents (tumor necrosis factor-α inhibitors and interleukin-1 receptor antagonist).  Non-steroidal anti-inflammatory drugs, selective cyclo-oxygenase-2 inhibitors and glucocorticoids, which offer a quick onset of symptom relief, are used mainly as adjunctive therapies.  Disease-modifying anti-rheumatic drugs and biologicals have been successful in altering disease outcome and slowing radiog. progression.  The indications, efficacy and safety of these agents in clin. trials and practice are reviewed in this chapter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPDcHHX2kOFbVg90H21EOLACvtfcHk0lgSqyP5CMBANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1WqsLY%253D&md5=e7d624cded2632bab54904753d35f4b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1521-6942%2803%2900048-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1521-6942%252803%252900048-2%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKavanaugh%26aufirst%3DA.%2BA.%26atitle%3DPharmalogical%2520treatment%2520of%2520established%2520rheumatoid%2520arthritis%26jtitle%3DBest%2520Pract.%2520Res.%252C%2520Clim.%2520Rheumatol.%26date%3D2003%26volume%3D17%26spage%3D811%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Weisman, M.; Furst, D.; Schiff, M.</span>; <span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A Double-Blind, Placebo Controlled Trial of VX-745, an Oral p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor in Patients with Rheumatoid Arthritis (RA)</span>. Presented at the Annual Congress of the European League against Rheumatism, Stockholm, Sweden, Jun 12–15,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>FRI0018.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Weisman&author=D.+Furst&author=M.+Schiff&title=A+Double-Blind%2C+Placebo+Controlled+Trial+of+VX-745%2C+an+Oral+p38+Mitogen-Activated+Protein+Kinase+%28MAPK%29+Inhibitor+in+Patients+with+Rheumatoid+Arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWeisman%26aufirst%3DM.%26atitle%3DA%2520Double-Blind%252C%2520Placebo%2520Controlled%2520Trial%2520of%2520VX-745%252C%2520an%2520Oral%2520p38%2520Mitogen-Activated%2520Protein%2520Kinase%2520%2528MAPK%2529%2520Inhibitor%2520in%2520Patients%2520with%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feagan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Haens, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geboes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yurcov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golovenko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2Fj.cgh.2005.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=16527696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=325-334&author=S.+Schreiberauthor=B.+Feaganauthor=G.+D%E2%80%99Haensauthor=J.-F.+Colombelauthor=K.+Geboesauthor=M.+Yurcovauthor=V.+Isakovauthor=O.+Golovenkoauthor=C.+N.+Bernsteinauthor=D.+Ludwigauthor=T.+Winterauthor=U.+Meierauthor=C.+Yongauthor=J.+Steffgen&title=Oral+p38+mitogen-activated+protein+kinase+inhibition+with+BIRB+796+for+active+Crohn%E2%80%99s+disease%3A+a+randomized%2C+double-blind%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double- blind, placebo- controlled trial</span></div><div class="casAuthors">Schreiber, Stefan; Feagan, Brian; D'Haens, Geert; Colombel, Jean-Frederic; Geboes, Karel; Yurcov, Mikhail; Isakov, Vasily; Golovenko, Oleg; Bernstein, Charles N.; Ludwig, Diether; Winter, Trevor; Meier, Ulrich; Yong, Chan; Steffgen, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) regulates the expression of proinflammatory cytokines, which play a crit. role in the pathophysiol. of Crohn's disease (CD).  This study investigated the efficacy and safety of BIRB 796, a highly potent inhibitor of p38 MAPK, in chronic active CD.  In a multicenter, multinational trial, 284 patients with moderate to severe CD were randomized to receive placebo, or 10, 20, 30, or 60 mg of BIRB 796 twice daily for 8 wk.  Clin. endpoints were based on std. safety assessments, CD Activity Index, C-reactive protein levels, and quality of life (Inflammatory Bowel Disease Questionnaire).  In a substudy, the Crohn's Disease Endoscopic Index of Severity and histol. results of biopsy specimens were assessed.  No clin. efficacy (primary end point, clin. remission; secondary end point, clin. response; Inflammatory Bowel Disease Questionnaire; Crohn's Disease Endoscopic Index of Severity) was seen for BIRB 796 in comparison with placebo.  A significant, dose-dependent decrease of C-reactive protein level was obsd. transiently after BIRB 796 after 1 wk with a return to baseline level over time.  The incidence of adverse events was comparable between all treatment groups, with the exception of a mild increase of transaminase levels that was seen more frequently in the BIRB 796 groups.  Geog. center effects were obsd. with Russian centers producing distinctly higher remission and response rates and lower adverse event rates than in other countries in both placebo and active treatment groups.  There was no evidence for clin. efficacy of BIRB 796 in CD.  A remarkable difference in the course of CD exists between Russia and non-Russian centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPlk4HFJbHhrVg90H21EOLACvtfcHk0lgSqyP5CMBANA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOqsrs%253D&md5=f99fbaeea2b16c7e5fa11069b99518f1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cgh.2005.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cgh.2005.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DFeagan%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Haens%26aufirst%3DG.%26aulast%3DColombel%26aufirst%3DJ.-F.%26aulast%3DGeboes%26aufirst%3DK.%26aulast%3DYurcov%26aufirst%3DM.%26aulast%3DIsakov%26aufirst%3DV.%26aulast%3DGolovenko%26aufirst%3DO.%26aulast%3DBernstein%26aufirst%3DC.%2BN.%26aulast%3DLudwig%26aufirst%3DD.%26aulast%3DWinter%26aufirst%3DT.%26aulast%3DMeier%26aufirst%3DU.%26aulast%3DYong%26aufirst%3DC.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DOral%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibition%2520with%2520BIRB%2520796%2520for%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D4%26spage%3D325%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soth, M. J.</span><span> </span><span class="NLM_article-title">Selective p38α inhibitors clinically evaluated for the treatment of chronic inflammatory disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2345</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9012906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2345-2353&author=D.+M.+Goldsteinauthor=A.+Kuglstatterauthor=Y.+Louauthor=M.+J.+Soth&title=Selective+p38%CE%B1+inhibitors+clinically+evaluated+for+the+treatment+of+chronic+inflammatory+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm9012906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012906%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DSoth%26aufirst%3DM.%2BJ.%26atitle%3DSelective%2520p38%25CE%25B1%2520inhibitors%2520clinically%2520evaluated%2520for%2520the%2520treatment%2520of%2520chronic%2520inflammatory%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2345%26epage%3D2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Vertex Pharmaceuticals Inc</span><span class="NLM_x">: Vertex moves to re-allocate resources from VX-745 in p38 MAP kinase program to accelerate development of second generation drug candidates VX-702 and VX-850. Press Release, September 24, </span><span class="NLM_x"> (</span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vertex+Pharmaceuticals+Inc%3A+Vertex+moves+to+re-allocate+resources+from+VX-745+in+p38+MAP+kinase+program+to+accelerate+development+of+second+generation+drug+candidates+VX-702+and+VX-850.+Press+Release%2C+September+24%2C+%282001."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wood</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span> </span><span class="NLM_article-title">Safety, pharmacokinetics and pharmacodynamics of an oral p38 MAP kinase inhibitor (BIRB 796 BS), administered once daily for 7 days</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">) </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1067%2Fmai.2002.124889" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=993&author=+Woodauthor=+Yongauthor=+Madwedauthor=A.+Gupta&title=Safety%2C+pharmacokinetics+and+pharmacodynamics+of+an+oral+p38+MAP+kinase+inhibitor+%28BIRB+796+BS%29%2C+administered+once+daily+for+7+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1067%2Fmai.2002.124889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2002.124889%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aulast%3DYong%26aulast%3DMadwed%26aulast%3DGupta%26aufirst%3DA.%26atitle%3DSafety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520an%2520oral%2520p38%2520MAP%2520kinase%2520inhibitor%2520%2528BIRB%2520796%2520BS%2529%252C%2520administered%2520once%2520daily%2520for%25207%2520days%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2002%26volume%3D109%26spage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span>Boehringer Ingelheim. <a href="http://www.boehringer-ingelheim.com" class="extLink">http://www.boehringer-ingelheim.com</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boehringer+Ingelheim.+http%3A%2F%2Fwww.boehringer-ingelheim.com+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mannino, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buist, A. S.</span><span> </span><span class="NLM_article-title">Global burden of COPD: risk factors, prevalence, and future trends</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0140-6736%2807%2961380-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=17765526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A280%3ADC%252BD2srhs1SisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2007&pages=765-773&author=D.+M.+Manninoauthor=A.+S.+Buist&title=Global+burden+of+COPD%3A+risk+factors%2C+prevalence%2C+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Global burden of COPD: risk factors, prevalence, and future trends</span></div><div class="casAuthors">Mannino David M; Buist A Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">9589</span>),
    <span class="NLM_cas:pages">765-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) continues to be an important cause of morbidity, mortality, and health-care costs worldwide.  It is a global health issue, with cigarette smoking being an important risk factor universally; other factors, such as exposure to indoor and outdoor air pollution, occupational hazards, and infections, are also important.  As the global population ages, the burden of COPD will increase in years to come.  Prevalence estimates of the disorder show considerable variability across populations, suggesting that risk factors can affect populations differently.  Other advances in our understanding of COPD are increased recognition of the importance of comorbid disease, identification of different COPD phenotypes, and understanding how factors other than lung function affect outcome in our patients.  The challenge we will all face in the next few years will be implementation of cost-effective prevention and management strategies to stem the tide of this disease and its cost.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTAJAVB43A0isZ1x6zOs0vfW6udTcc2eaWE8M4sAQYTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srhs1SisQ%253D%253D&md5=0a73050bcb4fe9e7a2bf7bda4a699192</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2807%2961380-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252807%252961380-4%26sid%3Dliteratum%253Aachs%26aulast%3DMannino%26aufirst%3DD.%2BM.%26aulast%3DBuist%26aufirst%3DA.%2BS.%26atitle%3DGlobal%2520burden%2520of%2520COPD%253A%2520risk%2520factors%252C%2520prevalence%252C%2520and%2520future%2520trends%26jtitle%3DLancet%26date%3D2007%26volume%3D370%26spage%3D765%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Barnes, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adcock, I. M.</span><span> </span><span class="NLM_article-title">Glucocorticoid resistance in inflammatory diseases</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1905</span><span class="NLM_x">–</span> <span class="NLM_lpage">1917</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=1905-1917&author=P.+J.+Barnesauthor=I.+M.+Adcock&title=Glucocorticoid+resistance+in+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DAdcock%26aufirst%3DI.%2BM.%26atitle%3DGlucocorticoid%2520resistance%2520in%2520inflammatory%2520diseases%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D1905%26epage%3D1917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Renda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maestrelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maselli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsico, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saetta, M.</span><span> </span><span class="NLM_article-title">Increased activation of p38 MAPK in COPD</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1183%2F09031936.00036707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=17959643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvVCgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=62-69&author=T.+Rendaauthor=S.+Baraldoauthor=G.+Pelaiaauthor=E.+Bazzanauthor=G.+Turatoauthor=A.+Papiauthor=P.+Maestrelliauthor=R.+Maselliauthor=A.+Vatrellaauthor=L.+M.+Fabbriauthor=R.+Zuinauthor=S.+A.+Marsicoauthor=M.+Saetta&title=Increased+activation+of+p38+MAPK+in+COPD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Increased activation of p38 MAPK in COPD</span></div><div class="casAuthors">Renda, T.; Baraldo, S.; Pelaia, G.; Bazzan, E.; Turato, G.; Papi, A.; Maestrelli, P.; Maselli, R.; Vatrella, A.; Fabbri, L. M.; Zuin, R.; Marsico, S. A.; Saetta, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Respiratory Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-69</span>CODEN:
                <span class="NLM_cas:coden">ERJOEI</span>;
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    
            (<span class="NLM_cas:orgname">European Respiratory Society</span>)
        </div><div class="casAbstract">Inflammation, oxidative stress and apoptosis, which are involved in chronic obstructive pulmonary disease (COPD) pathogenesis, may activate the p38 subgroup of mitogen-activated protein kinases (MAPKs).  Therefore, the aim of the present study was to evaluate the expression of the phosphorylated, active form of p38 MAPK (phospho-p38) in the lungs of COPD patients.  Surgical specimens were obtained from 18 smokers with COPD at different stages of disease severity, plus nine smoking and eight nonsmoking subjects with normal lung function.  Phospho-p38+ cells were quantified by immunohistochem. in both alveolar spaces and alveolar walls.  Moreover, a Western blot anal. of phospho-p38 and total p38α isoform expressed by alveolar macrophages was performed.  Phospho-p38+ alveolar macrophages and phospho-p38+ cells in alveolar walls were increased in patients with severe and mild/moderate COPD, compared with smoking and nonsmoking controls.  Moreover, they were inversely correlated to values of forced expiratory vol. in one second (FEV1) and FEV1/forced vital capacity.  Western blot anal. showed that phosphorylated p38, but not the total p38α isoform, was specifically increased in alveolar macrophages from COPD patients.  Activation of the p38 mitogen-activated protein kinase pathway appears to be involved in the pathogenesis of chronic obstructive pulmonary disease.  The present findings suggest that this protein may be a suitable pharmacol. target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtAB3KTmtt7bVg90H21EOLACvtfcHk0lh-rbncZiGs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvVCgs7g%253D&md5=39f304338b1fab6a54221a1ed305d220</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1183%2F09031936.00036707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.00036707%26sid%3Dliteratum%253Aachs%26aulast%3DRenda%26aufirst%3DT.%26aulast%3DBaraldo%26aufirst%3DS.%26aulast%3DPelaia%26aufirst%3DG.%26aulast%3DBazzan%26aufirst%3DE.%26aulast%3DTurato%26aufirst%3DG.%26aulast%3DPapi%26aufirst%3DA.%26aulast%3DMaestrelli%26aufirst%3DP.%26aulast%3DMaselli%26aufirst%3DR.%26aulast%3DVatrella%26aufirst%3DA.%26aulast%3DFabbri%26aufirst%3DL.%2BM.%26aulast%3DZuin%26aufirst%3DR.%26aulast%3DMarsico%26aufirst%3DS.%2BA.%26aulast%3DSaetta%26aufirst%3DM.%26atitle%3DIncreased%2520activation%2520of%2520p38%2520MAPK%2520in%2520COPD%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D2008%26volume%3D31%26spage%3D62%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Underwood, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bochnowicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold, D. E.</span><span> </span><span class="NLM_article-title">SB 217063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=10734180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkvFGhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2000&pages=281-288&author=D.+C.+Underwoodauthor=R.+R.+Osbornauthor=C.+J.+Kotzerauthor=J.+L.+Adamsauthor=J.+C.+Leeauthor=E.+F.+Webbauthor=D.+C.+Carpenterauthor=S.+Bochnowiczauthor=H.+C.+Thomasauthor=D.+W.+P.+Hayauthor=D.+E.+Griswold&title=SB+217063%2C+a+potent+p38+MAP+kinase+inhibitor%2C+reduces+inflammatory+cytokine+production%2C+airways+eosinophil+infiltration%2C+and+persistence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence</span></div><div class="casAuthors">Underwood, David C.; Osborn, Ruth R.; Kotzer, Charles J.; Adams, Jerry L.; Lee, John C.; Webb, Edward F.; Carpenter, Donald C.; Bochnowicz, Steven; Thomas, Heath C.; Hay, Douglas W. P.; Griswold, Don E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-288</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The anti-inflammatory/antiallergic activity of a novel second-generation p38 mitogen-activated protein kinase inhibitor, SB 239063 [trans-1-(4-hydroxycyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyridim idin-4-yl)imidazole], was investigated in vivo and in vitro.  SB 239063 had an IC50 of 44 nM for inhibition of recombinant purified human p38α.  In lipopolysaccharide-stimulated human peripheral blood monocytes, SB 239063 inhibited interleukin-1 and tumor necrosis factor-α prodn. (IC50 values = 0.12 and 0.35 μM, resp.).  A role for p38 kinase in cytokine-assocd. inflammation in the mouse was shown by p38 activation in the lung and inhibition of lipopolysaccharide-induced tumor necrosis factor-α prodn. by SB 239063 (ED50 = 5.8 mg/kg p.o.).  Antiallergic activity was demonstrated by essential abolition (∼93% inhibition) of inhaled ovalbumin (OA)-induced airway eosinophilia by SB 239063 (12 mg/kg p.o.), measured by bronchoalveolar lavage (BAL) in OA-sensitized mice.  In addn., p38 kinase was found by Western anal. to be activated in guinea pig lung.  Administration of SB 239063 (10 or 30 mg/kg p.o.) in conscious guinea pigs markedly reduced (∼50% inhibition) OA-induced pulmonary eosinophil influx, measured by BAL 24 h after antigen.  SB 239063 (10 mg/kg b.i.d. p.o.) administered after leukotriene D4 inhalation, reduced by 60% the persistent airway eosinophilia seen at 4 days.  Apoptosis of cultured eosinophils isolated from guinea pig BAL was increased by SB 239063 (1-10 μM) in the presence of interleukin-5.  These results indicate that SB 239063 is a potent inhibitor of inflammatory cytokine prodn., inhibits eosinophil recruitment, in addn. to enhancing apoptosis of these cells.  Collectively, the results support the potential utility of p38 kinase inhibitors, such as SB 239063 for the treatment of asthma and other inflammatory disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLFMXLD74MwLVg90H21EOLACvtfcHk0lh-rbncZiGs2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkvFGhuro%253D&md5=3a09fb3f2b3c67d8b359cea1d73ef27b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnderwood%26aufirst%3DD.%2BC.%26aulast%3DOsborn%26aufirst%3DR.%2BR.%26aulast%3DKotzer%26aufirst%3DC.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DWebb%26aufirst%3DE.%2BF.%26aulast%3DCarpenter%26aufirst%3DD.%2BC.%26aulast%3DBochnowicz%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DH.%2BC.%26aulast%3DHay%26aufirst%3DD.%2BW.%2BP.%26aulast%3DGriswold%26aufirst%3DD.%2BE.%26atitle%3DSB%2520217063%252C%2520a%2520potent%2520p38%2520MAP%2520kinase%2520inhibitor%252C%2520reduces%2520inflammatory%2520cytokine%2520production%252C%2520airways%2520eosinophil%2520infiltration%252C%2520and%2520persistence%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D293%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spicer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">p38α selective MAP kinase inhibitor, SD-282, reduces inflammation in a sub-chronic model of tobacco smoke-induced airway inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">324</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1124%2Fjpet.107.127092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=18056868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVajsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2008&pages=921-929&author=S.+Medicherlaauthor=M.+Fitzgeraldauthor=D.+Spicerauthor=P.+Woodmanauthor=J.+Y.+Maauthor=A.+M.+Kapounauthor=S.+Chakravartyauthor=S.+Dugarauthor=A.+A.+Protterauthor=L.+S.+Higgins&title=p38%CE%B1+selective+MAP+kinase+inhibitor%2C+SD-282%2C+reduces+inflammation+in+a+sub-chronic+model+of+tobacco+smoke-induced+airway+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">p38α-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model to tobacco smoke-induced airway inflammation</span></div><div class="casAuthors">Medicherla, Satyanarayana; Fitzgerald, Mary F.; Spicer, Dianne; Woodman, Paul; Ma, Jing Y.; Kapoun, Ann M.; Chakravarty, Sarvajit; Dugar, Sundeep; Protter, Andrew A.; Higgins, Linda S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is characterized by pulmonary inflammation, which is relatively insensitive to inhaled corticosteroids.  The extent of the pulmonary inflammation in COPD correlates with disease severity, and it is thought to play a significant role in disease progression.  We have evaluated a selective p38α-selective mitogen-activated protein kinase (MAPK) inhibitor, indole-5-carboxamide (ATP-competitive inhibitor of p38 kinase) (SD-282), in an 11-day model of tobacco smoke (TS)-induced pulmonary inflammation in A/J mice, by using dexamethasone as a ref. steroid.  Two oral treatment paradigms were evaluated in this TS model: prophylactic with daily pretreatment before each daily exposure, and therapeutic with daily treatment for 6 days commencing after 5 days of smoke exposure.  Bronchoalveolar lavage and histol. evaluation of lung sections taken after exposure to TS revealed an inflammatory response composed of increased nos. of macrophages and neutrophils and enhanced mucin staining.  Phospho-p38 staining in macrophages and type II epithelial cells after TS exposure was also obsd.  Given prophylactically or therapeutically, dexamethasone failed to inhibit any of the TS-induced inflammatory changes.  By contrast, SD-282 inhibited TS-induced increases in macrophages and neutrophils.  Furthermore, SD 282 reduced TS-induced increases in cyclooxygenase-2 and interleukin-6 levels, and phospho-p38 expression in the lungs.  In conclusion, SD-282 markedly reduced TS-induced inflammatory responses when given prophylactically or therapeutically whereas dexamethasone was ineffective.  This is the first evidence that a p38α-selective MAPK inhibitor can exert pulmonary anti-inflammatory activity in a TS exposure model when given in a therapeutic mode, establishing the potential of p38 MAPK inhibitors as a therapy for COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1iU4ffng8NLVg90H21EOLACvtfcHk0lgWmxOXS_yaCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVajsrk%253D&md5=0f80c6c05438e104a8ef5adc0985cc94</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127092%26sid%3Dliteratum%253Aachs%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DFitzgerald%26aufirst%3DM.%26aulast%3DSpicer%26aufirst%3DD.%26aulast%3DWoodman%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3Dp38%25CE%25B1%2520selective%2520MAP%2520kinase%2520inhibitor%252C%2520SD-282%252C%2520reduces%2520inflammation%2520in%2520a%2520sub-chronic%2520model%2520of%2520tobacco%2520smoke-induced%2520airway%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D324%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choo, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. S. F.</span><span> </span><span class="NLM_article-title">Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1164%2Frccm.200408-1006OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=15557129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A280%3ADC%252BD2M7itFKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2005&pages=571-578&author=W.+Duanauthor=J.+H.+Chanauthor=K.+McKayauthor=J.+R.+Crosbyauthor=H.+H.+Chooauthor=B.+P.+Leungauthor=J.+G.+Karrasauthor=W.+S.+F.+Wong&title=Inhaled+p38alpha+mitogen-activated+protein+kinase+antisense+oligonucleotide+attenuates+asthma+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice</span></div><div class="casAuthors">Duan Wei; Chan Jasmine H P; McKay Kelly; Crosby Jeffrey R; Choo Hui Hwa; Leung Bernard P; Karras James G; Wong W S Fred</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">571-8</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">The p38 mitogen-activated protein kinase (MAPK) plays a critical role in the activation of inflammatory cells.  Therefore, we investigated the antiinflammatory effects of a respirable p38alpha MAPK antisense oligonucleotide (p38alpha-ASO) in a mouse asthma model.  A potent and selective p38alpha-ASO was characterized in vitro.  Inhalation of aerosolized p38alpha-ASO using an aerosol chamber dosing system produced measurable lung deposition of ASO and significant reduction of ovalbumin (OVA-)-induced increases in total cells, eosinophils, and interleukin 4 (IL-4), IL-5, and IL-13 levels in bronchoalveolar lavage fluid, and dose-dependent inhibition of airway hyperresponsiveness in allergen-challenged mice.  Furthermore, inhaled p38alpha-ASO markedly inhibited OVA-induced lung tissue eosinophilia and airway mucus hypersecretion.  Quantitative polymerase chain reaction analysis of bronchoalveolar lavage fluid cells and peribronchial lymph node cells showed that p38alpha-ASO significantly reduced p38alpha MAPK mRNA expression.  Nose-only aerosol exposure of mice verified the p38alpha-ASO-induced inhibition of OVA-induced pulmonary eosinophilia, mucus hypersecretion, and airway hyperresponsiveness.  None of the effects of the p38alpha-ASO were produced by a six-base mismatched control oligonucleotide.  These findings demonstrate antisense pharmacodynamic activity in the airways after aerosol delivery and suggest that a p38alpha MAPK ASO approach may have therapeutic potential for asthma and other inflammatory lung diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCM3oekSwyXr5oR8RchjrrfW6udTcc2ebebhQTHyQ4hLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7itFKitA%253D%253D&md5=6d7ad445958db3a8c4eab9f0b459c535</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1164%2Frccm.200408-1006OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200408-1006OC%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DChan%26aufirst%3DJ.%2BH.%26aulast%3DMcKay%26aufirst%3DK.%26aulast%3DCrosby%26aufirst%3DJ.%2BR.%26aulast%3DChoo%26aufirst%3DH.%2BH.%26aulast%3DLeung%26aufirst%3DB.%2BP.%26aulast%3DKarras%26aufirst%3DJ.%2BG.%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26atitle%3DInhaled%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520antisense%2520oligonucleotide%2520attenuates%2520asthma%2520in%2520mice%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2005%26volume%3D171%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Array Biopharm. <a href="http://www.arraybiopharma.com" class="extLink">http://www.arraybiopharma.com</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Biopharm.+http%3A%2F%2Fwww.arraybiopharma.com+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>ClinicalTrials.gov. <a href="http://www.clinicaltrials.gov" class="extLink">http://www.clinicaltrials.gov</a> (accessed April 13,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+http%3A%2F%2Fwww.clinicaltrials.gov+%28accessed+April+13%2C+2011%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_contrib-group">MacNee, W.; Allan, R.; Jones, I.; De Salvo, M. C.; Tan, L.</span><span> </span><span class="NLM_article-title">A Randomised, Placebo Controlled Trial of 6 Weeks’ Treatment with a Novel Oral p38 Inhibitor in Patients with COPD</span>. Presented at the European Respiratory Society Meeting, Barcelona, Spain,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=W.+MacNee&author=R.+Allan&author=I.+Jones&author=M.+C.+De+Salvo&author=L.+Tan&title=A+Randomised%2C+Placebo+Controlled+Trial+of+6+Weeks%E2%80%99+Treatment+with+a+Novel+Oral+p38+Inhibitor+in+Patients+with+COPD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMacNee%26aufirst%3DW.%26atitle%3DA%2520Randomised%252C%2520Placebo%2520Controlled%2520Trial%2520of%25206%2520Weeks%25E2%2580%2599%2520Treatment%2520with%2520a%2520Novel%2520Oral%2520p38%2520Inhibitor%2520in%2520Patients%2520with%2520COPD%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_contrib-group">Selness, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durley, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Promo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickory, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blevis-Bal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalamanchili, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonder Embse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saabye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monahan, J. B.</span><span> </span><span class="NLM_article-title">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4066</span><span class="NLM_x">–</span> <span class="NLM_lpage">4071</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2Fj.bmcl.2011.04.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=21641211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4066-4071&author=S.+R.+Selnessauthor=R.+V.+Devrajauthor=B.+Devadasauthor=J.+K.+Walkerauthor=T.+L.+Boehmauthor=R.+C.+Durleyauthor=H.+Shiehauthor=L.+Xingauthor=P.+V.+Ruckerauthor=K.+D.+Jeromeauthor=A.+G.+Bensonauthor=L.+D.+Marrufoauthor=H.+M.+Madsenauthor=J.+Hitchcockauthor=T.+J.+Owenauthor=L.+Christieauthor=M.+A.+Promoauthor=B.+S.+Hickoryauthor=E.+Alviraauthor=W.+Naingauthor=R.+Blevis-Balauthor=D.+Messingauthor=J.+Yangauthor=M.+K.+Maoauthor=G.+Yalamanchiliauthor=R.+Vonder+Embseauthor=J.+Hirschauthor=M.+Saabyeauthor=S.+Bonarauthor=E.+Webbauthor=G.+Andersonauthor=J.+B.+Monahan&title=Discovery+of+PH-797804%2C+a+highly+selective+and+potent+inhibitor+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase</span></div><div class="casAuthors">Selness, Shaun R.; Devraj, Rajesh V.; Devadas, Balekudru; Walker, John K.; Boehm, Terri L.; Durley, Richard C.; Shieh, Huey; Xing, Li; Rucker, Paul V.; Jerome, Kevin D.; Benson, Alan G.; Marrufo, Laura D.; Madsen, Heather M.; Hitchcock, Jeff; Owen, Tom J.; Christie, Lance; Promo, Michele A.; Hickory, Brian S.; Alvira, Edgardo; Naing, Win; Blevis-Bal, Radhika; Messing, Dean; Yang, Jerry; Mao, Michael K.; Yalamanchili, Gopi; Vonder Embse, Richard; Hirsch, Jeffrey; Saabye, Matthew; Bonar, Sheri; Webb, Elizabeth; Anderson, Gary; Monahan, Joseph B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4066-4071</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of a novel N-arylpyridinone class of p38 kinase inhibitors are described.  Systematic structural modifications to the HTS lead led to the identification of a clin. candidate (phase II clin. studies) for the treatment of inflammatory diseases.  Addnl., the chiral synthesis and properties of said clin. candidate are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL54FATgVMdbVg90H21EOLACvtfcHk0liWzRP6H4pEKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVCisLk%253D&md5=eb900d70d0c84f642e3b09ecbeb0cf91</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.121%26sid%3Dliteratum%253Aachs%26aulast%3DSelness%26aufirst%3DS.%2BR.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DBoehm%26aufirst%3DT.%2BL.%26aulast%3DDurley%26aufirst%3DR.%2BC.%26aulast%3DShieh%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DJerome%26aufirst%3DK.%2BD.%26aulast%3DBenson%26aufirst%3DA.%2BG.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DMadsen%26aufirst%3DH.%2BM.%26aulast%3DHitchcock%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DT.%2BJ.%26aulast%3DChristie%26aufirst%3DL.%26aulast%3DPromo%26aufirst%3DM.%2BA.%26aulast%3DHickory%26aufirst%3DB.%2BS.%26aulast%3DAlvira%26aufirst%3DE.%26aulast%3DNaing%26aufirst%3DW.%26aulast%3DBlevis-Bal%26aufirst%3DR.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DM.%2BK.%26aulast%3DYalamanchili%26aufirst%3DG.%26aulast%3DVonder%2BEmbse%26aufirst%3DR.%26aulast%3DHirsch%26aufirst%3DJ.%26aulast%3DSaabye%26aufirst%3DM.%26aulast%3DBonar%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DMonahan%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520PH-797804%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4066%26epage%3D4071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanoje, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semwal, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1411-1425&author=P.+Chopraauthor=V.+Kanojeauthor=A+Semwalauthor=A.+Ray&title=Therapeutic+potential+of+inhaled+p38+mitogen-activated+protein+kinase+inhibitors+for+inflammatory+pulmonary+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DKanoje%26aufirst%3DV.%26aulast%3DSemwal%26aufirst%3DA%26aulast%3DRay%26aufirst%3DA.%26atitle%3DTherapeutic%2520potential%2520of%2520inhaled%2520p38%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%2520for%2520inflammatory%2520pulmonary%2520diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1411%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Millan, D. S.</span><span> </span><span class="NLM_article-title">What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1645</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.4155%2Ffmc.11.96" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=21942253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1635-1645&author=D.+S.+Millan&title=What+is+the+potential+for+inhaled+p38+inhibitors+in+the+treatment+of+chronic+obstructive+pulmonary+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?</span></div><div class="casAuthors">Millan, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1635-1645</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  P38 has been an intensely studied therapeutic target in the pharmaceutical industry.  With more than 20 compds. entering human trials, none have progressed beyond Phase II to the best of our knowledge.  The transient efficacy seen in many of the Phase II trials has raised some concerns for the future potential of this target, particularly in rheumatoid arthritis.  With this caveat, there is good evidence for p38 inhibition to be efficacious in chronic obstructive pulmonary disease and there are now several oral compds. currently in development for this disease, with encouraging data beginning to emerge.  With an inhaled agent likely to improve the therapeutic window between efficacy and some of the common adverse events obsd. with oral p38 inhibitors it would seem a sensible approach to take for a disease of the lung.  This review will highlight the potential for an inhaled p38 inhibitor in chronic obstructive pulmonary disease, as well as some of the design principles that are important to consider when developing an inhaled kinase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4waRvOu6S_LVg90H21EOLACvtfcHk0lghCufcOKBcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1WktrvK&md5=81104fda424ad56be567693b9207b4f3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.96%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DD.%2BS.%26atitle%3DWhat%2520is%2520the%2520potential%2520for%2520inhaled%2520p38%2520inhibitors%2520in%2520the%2520treatment%2520of%2520chronic%2520obstructive%2520pulmonary%2520disease%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1635%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Glossop, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, C. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perros-Huguet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, F. J.</span><span> </span><span class="NLM_article-title">Inhalation by design: novel ultra-long-acting β2-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6640</span><span class="NLM_x">–</span> <span class="NLM_lpage">6652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6640-6652&author=P.+A.+Glossopauthor=C.+A.+L.+Laneauthor=D.+A.+Priceauthor=M.+E.+Bunnageauthor=R.+A.+Lewthwaiteauthor=K.+Jamesauthor=A.+D.+Brownauthor=M.+Yeadonauthor=C.+Perros-Huguetauthor=M.+A.+Trevethickauthor=N.+P.+Clarkeauthor=R.+Websterauthor=R.+M.+Jonesauthor=J.+L.+Burrowsauthor=N.+Feederauthor=S.+C.+J.+Taylorauthor=F.+J.+Spence&title=Inhalation+by+design%3A+novel+ultra-long-acting+%CE%B22-adrenoreceptor+agonists+for+inhaled+once-daily+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease+that+utilize+a+sulfonamide+agonist+headgroup"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm1005989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005989%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DP.%2BA.%26aulast%3DLane%26aufirst%3DC.%2BA.%2BL.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DPerros-Huguet%26aufirst%3DC.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DClarke%26aufirst%3DN.%2BP.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%2BL.%26aulast%3DFeeder%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DS.%2BC.%2BJ.%26aulast%3DSpence%26aufirst%3DF.%2BJ.%26atitle%3DInhalation%2520by%2520design%253A%2520novel%2520ultra-long-acting%2520%25CE%25B22-adrenoreceptor%2520agonists%2520for%2520inhaled%2520once-daily%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%2520that%2520utilize%2520a%2520sulfonamide%2520agonist%2520headgroup%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6640%26epage%3D6652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lghCufcOKBcSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capolino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroe, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of the p38α MAP kinase inhibitor 1-(5-<i>tert</i>-butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)napthalen-1-yl]urea (BIRB 796)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4676</span><span class="NLM_x">–</span> <span class="NLM_lpage">4686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030121k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4676-4686&author=J.+Reganauthor=A.+Capolinoauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=R.+R.+Kroeauthor=M.+Madwedauthor=M.+Moriakauthor=R.+Nelsonauthor=C.+A.+Pargellisauthor=A.+Swinamerauthor=C.+Torcelliniauthor=M.+Tsangauthor=N.+Moss&title=Structure%E2%80%93activity+relationships+of+the+p38%CE%B1+MAP+kinase+inhibitor+1-%285-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl%29-3-%5B4-%282-morpholin-4-yl-ethoxy%29napthalen-1-yl%5Durea+%28BIRB+796%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm030121k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030121k%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DCapolino%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKroe%26aufirst%3DR.%2BR.%26aulast%3DMadwed%26aufirst%3DM.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTsang%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520the%2520p38%25CE%25B1%2520MAP%2520kinase%2520inhibitor%25201-%25285-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl%2529-3-%255B4-%25282-morpholin-4-yl-ethoxy%2529napthalen-1-yl%255Durea%2520%2528BIRB%2520796%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4676%26epage%3D4686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paregllis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">The kinetics of binding to p38 MAP kinase by analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Reganauthor=C.+A.+Paregllisauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=E.+R.+Hickeyauthor=G.+W.+Peetauthor=A.+Protoauthor=A.+Swinamerauthor=N.+Moss&title=The+kinetics+of+binding+to+p38+MAP+kinase+by+analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0liyzgp3iTpwJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DParegllis%26aufirst%3DC.%2BA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DThe%2520kinetics%2520of%2520binding%2520to%2520p38%2520MAP%2520kinase%2520by%2520analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramov, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberia, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carty, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortina, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danley, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipesa, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hynes, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMotte, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Y.</span><span> </span><span class="NLM_article-title">Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5728</span><span class="NLM_x">–</span> <span class="NLM_lpage">5737</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050346q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntVChsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5728-5737&author=K.+F.+McClureauthor=Y.+A.+Abramovauthor=E.+R.+Lairdauthor=J.+T.+Barberiaauthor=W.+Caiauthor=T.+J.+Cartyauthor=S.+R.+Cortinaauthor=D.+E.+Danleyauthor=A.+J.+Dipesaauthor=K.+M.+Donahueauthor=M.+A.+Dombroskiauthor=N.+C.+Elliottauthor=C.+A.+Gabelauthor=S.+Hanauthor=T.+R.+Hynesauthor=P.+K.+LeMotteauthor=M.+N.+Mansourauthor=E.+S.+Marrauthor=M.+A.+Letavicauthor=J.+Panditauthor=D.+B.+Ripinauthor=F.+J.+Sweeneyauthor=D.+Tanauthor=Y.+Tao&title=Theoretical+and+experimental+design+of+atypical+kinase+inhibitors%3A+application+to+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical and Experimental Design of Atypical Kinase Inhibitors: Application to p38 MAP Kinase</span></div><div class="casAuthors">McClure, Kim F.; Abramov, Yuriy A.; Laird, Ellen R.; Barberia, John T.; Cai, Weiling; Carty, Thomas J.; Cortina, Santo R.; Danley, Dennis E.; Dipesa, Alan J.; Donahue, Kathleen M.; Dombroski, Mark A.; Elliott, Nancy C.; Gabel, Christopher A.; Han, Seungil; Hynes, Thomas R.; LeMotte, Peter K.; Mansour, Mahmoud N.; Marr, Eric S.; Letavic, Michael A.; Pandit, Jayvardhan; Ripin, David B.; Sweeney, Francis J.; Tan, Douglas; Tao, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5728-5737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mimics of the benzimidazolone nucleus found in inhibitors of p38 kinase are proposed, and their theor. potential as bioisosteres is described.  A set of calcd. descriptors relevant to the anticipated binding interaction for the fragments 1-methyl-1H-benzotriazole, 3-methylbenzo[d]isoxazole, and 3-methyl[1,2,4]triazolo[4,3-a]pyridine, pyridine, and 1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one are reported.  The design considerations and synthesis of p38 inhibitors based on these H-bond acceptor fragments is detailed.  Comparative evaluation of the pyridine-, benzimidazolone-, benzotriazole-, and triazolopyridine-based inhibitors shows the triazoles I and II to be significantly more potent exptl. than the benzimidazolone after which they were modeled.  An X-ray crystal structure of II bound to the active site shows that the triazole group serves as the H-bond acceptor but unexpectedly as a dual acceptor, inducing movement of the crossover connection of p38α.  The computed descriptors for the hydrophobic and π-π interaction capacities were the most useful in ranking potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozbRRIfTs-bbVg90H21EOLACvtfcHk0ljLe_Dm0tSU-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntVChsLw%253D&md5=d53877752524d77f6e5f3b04d8e8e8ff</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm050346q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050346q%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DAbramov%26aufirst%3DY.%2BA.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DBarberia%26aufirst%3DJ.%2BT.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCarty%26aufirst%3DT.%2BJ.%26aulast%3DCortina%26aufirst%3DS.%2BR.%26aulast%3DDanley%26aufirst%3DD.%2BE.%26aulast%3DDipesa%26aufirst%3DA.%2BJ.%26aulast%3DDonahue%26aufirst%3DK.%2BM.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DElliott%26aufirst%3DN.%2BC.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHynes%26aufirst%3DT.%2BR.%26aulast%3DLeMotte%26aufirst%3DP.%2BK.%26aulast%3DMansour%26aufirst%3DM.%2BN.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRipin%26aufirst%3DD.%2BB.%26aulast%3DSweeney%26aufirst%3DF.%2BJ.%26aulast%3DTan%26aufirst%3DD.%26aulast%3DTao%26aufirst%3DY.%26atitle%3DTheoretical%2520and%2520experimental%2520design%2520of%2520atypical%2520kinase%2520inhibitors%253A%2520application%2520to%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5728%26epage%3D5737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Braganza, J. F.; Letavic, M. A.; McClure, K. F.</span><span> </span><span class="NLM_article-title">Preparation of Triazolo[4,3-<i>a</i>]pyridines as MAP Kinases, in Particular p38 Kinase Inhibitors, and Their Use as Antiinflammatory Agents</span>. WO2004072072,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=J.+F.+Braganza&author=M.+A.+Letavic&author=K.+F.+McClure&title=Preparation+of+Triazolo%5B4%2C3-a%5Dpyridines+as+MAP+Kinases%2C+in+Particular+p38+Kinase+Inhibitors%2C+and+Their+Use+as+Antiinflammatory+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBraganza%26aufirst%3DJ.%2BF.%26atitle%3DPreparation%2520of%2520Triazolo%255B4%252C3-a%255Dpyridines%2520as%2520MAP%2520Kinases%252C%2520in%2520Particular%2520p38%2520Kinase%2520Inhibitors%252C%2520and%2520Their%2520Use%2520as%2520Antiinflammatory%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feru, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazmirski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span> </span><span class="NLM_article-title">Enhanced selectivity profile of pyrazole-urea based DFG-out p38α inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4885</span><span class="NLM_x">–</span> <span class="NLM_lpage">4891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4885-4891&author=H.+Liuauthor=C.+Kuhnauthor=F.+Feruauthor=S.+L.+Jacquesauthor=G.+D.+Deshmukhauthor=P.+Yeauthor=G.+R.+Rennieauthor=T.+Johnsonauthor=S.+Kazmirskiauthor=S.+Lowauthor=R.+Coliauthor=Y.-H.+Dingauthor=A.+C.+Chengauthor=H.+Tecleauthor=J.+M.+Englishauthor=R.+Stantonauthor=J.+C.+Wu&title=Enhanced+selectivity+profile+of+pyrazole-urea+based+DFG-out+p38%CE%B1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DC.%26aulast%3DFeru%26aufirst%3DF.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DRennie%26aufirst%3DG.%2BR.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKazmirski%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DS.%26aulast%3DColi%26aufirst%3DR.%26aulast%3DDing%26aufirst%3DY.-H.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DTecle%26aufirst%3DH.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DStanton%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26atitle%3DEnhanced%2520selectivity%2520profile%2520of%2520pyrazole-urea%2520based%2520DFG-out%2520p38%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4885%26epage%3D4891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paine, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrighton, S. A.</span><span> </span><span class="NLM_article-title">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200677b&amp;key=10.1081%2FDMR-120000653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200677b&amp;key=11768770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200677b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=273-297&author=M.+B.+Fisherauthor=M.+F.+Paineauthor=T.+J.+Strelevitzauthor=S.+A.+Wrighton&title=The+role+of+hepatic+and+extrahepatic+UDP-glucuronosyltransferases+in+human+drug+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism</span></div><div class="casAuthors">Fisher, Michael B.; Paine, Mary F.; Strelevitz, Timothy J.; Wrighton, Steven A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3 & 4</span>),
    <span class="NLM_cas:pages">273-297</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review.  At present, the methods and enzymol. of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P 450 (CYPs).  About 15 human UGTs have been identified, and knowledge about their regulation, substrate selectivity, and tissue distribution has progressed recently.  Alamethicin has been characterized as a treatment to remove the latency of microsomal glucuronidations.  Most UGT isoforms appear to have a distinct hepatic and/or extrahepatic expression, resulting in significant expression in kidney, intestine, and steroid target tissues.  The gastrointestinal tract possesses a complex expression pattern largely contg. members of the UGT1A subfamily.  Thus, these forms are poised to participate in the first pass metab. of oral drugs.  The authors and others have identified a significant expression of UGT1A1 in human small intestine, an enzyme possessing considerable allelic variability and a polymorphic expression pattern in intestine.  Intestinal glucuronidation therefore plays a major role not only in first pass metab., but also in the degree of interindividual variation in overall oral bioavailability.  Due to issues such as significant genetic variability and tissue localization in first-pass organs, clearance due to UGT1A1 should be minimized for new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrThMjjbeI-nbVg90H21EOLACvtfcHk0ljLe_Dm0tSU-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVGqsg%253D%253D&md5=7a35a3d8dcba636ac4bcac54a13f47b1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1081%2FDMR-120000653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120000653%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DPaine%26aufirst%3DM.%2BF.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DWrighton%26aufirst%3DS.%2BA.%26atitle%3DThe%2520role%2520of%2520hepatic%2520and%2520extrahepatic%2520UDP-glucuronosyltransferases%2520in%2520human%2520drug%2520metabolism%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2001%26volume%3D33%26spage%3D273%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yis" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yis','PDB','2yis'); return false;">PDB: 2yis</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yiw','PDB','2yiw'); return false;">PDB: 2yiw</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yix" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2yix','PDB','2yix'); return false;">PDB: 2yix</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1kv2','PDB','1kv2'); return false;">PDB: 1kv2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/jm200677b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14373"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental procedures and analytical data for intermediates and final compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200677b/suppl_file/jm200677b_si_001.pdf">jm200677b_si_001.pdf (311.75 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200677b&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm200677b%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200677b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a49343cda21e9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
